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ABSTRACT
In this work, the synthesis of novel ligands for use in the transfer 
hydrogenation of ketones is described. A number of libraries were prepared 
incorporating hydroxy, imino and amino functionality. These ligands were 
tested in conjunction with a number of transition metal complexes to identify 
active catalysts. Optimisation led to the development of a number of highly 
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CHAPTER 1
ASYMMETRIC REDUCTION OF KETONES
11
1.1 INTRODUCTION
The enantioselective reduction of ketones to furnish non-racemic secondary 
alcohols continues to be an intensively studied area of research in organic 
chemistry. This transformation is a key step in the synthesis of many 
biologically important molecules and synthetic targets which, until relatively 
recently, was not possible without the use of enzymes. Asymmetric catalytic 
reduction of carbonyl functions to enantiomerically pure alcohols, without the 
use of biological systems, is a significant challenge for synthetic organic 
chemistry.
Over the past three decades much research has been conducted into methods of 
asymmetric catalysis in search of an efficient and cost-effective method for 
achieving this aim. Much of the work has involved the use of transition metal 
complexes for the catalysis. These metals are invariably complexed to a 
chelating ligand which can act as an activator as well as an asymmetric 
modifier. This chelating ligand is an enantiopure chiral compound because any 
chiral induction in the transformation from the prochiral substrate to the 
enantiomerically enriched product must stem from the effect of the ligand on 
the catalyst. The chiral ligands used have frequently been derived, via a 
number of steps, from natural products such as amino acids, alkaloids, hydroxy 
acids and carbohydrates.
Over the years a number of transformations have been investigated. In this 
introduction however, the scope will be limited to highlighting some
12
commonly used methods for the asymmetric reduction of ketones and some 
key developments in this field.
In particular catalytic hydrogenation, hydrosilylation and transfer 
hydrogenation will be considered as methods of accomplishing this 
transformation. The mechanisms of these reactions and some of the more 
efficient ligands that have been developed for them will be examined.
1.2 ASYMMETRIC HYDROGENATION
Asymmetric hydrogenation is the transfer of molecular hydrogen to a prochiral 
substrate molecule resulting in a non-racemic product. This was first carried 
out in the late 1930’s by depositing a metal catalyst on a chiral support and by 
the 1950’s the enantioselectivity achieved using these methods had reached 
over 60%. This sparked much interest in the subject and in 1972 Kagan 





Since this early work huge developments have been made in the use of bis- 
phosphine ligands for transition metal catalysed asymmetric hydrogenation. A 
vast array of phosphine based ligands have been tested since Kagan’s initial 
results in a bid to optimise the selectivity of the transformation. A number of 
transition metals have also been employed, such as Rh, Ru and Ir and the 
reaction has been adopted for the reduction of a number of chemical groups, 
such as alkenyl (C=C), carbonyl (C=0) and imino (C=N) groups.
Perhaps the single most important bis-phosphine ligand discovered to date for 




The ligand has shown itself to be excellent in many asymmetric 
transformations in conjunction with a range of transition metals. It has also 
proved an efficient ligand for the ruthenium catalysed hydrogenation of 
functionalised ketones. The complex 3 has achieved very high selectivities 
with a wide range of functionalised ketones such as p-keto esters and a-amino 
ketones. For example, reduction of the P-keto ester (scheme 1.1) using
14
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Scheme 1.1 Reduction of a p-keto ester
The catalyst 3 was generally very selective and tolerant of a number of 
functional groups. The main problem was that the catalyst required 
functionalised ketones (those bearing other functionalities such as hydroxyl or 
alkoxy groups) and attempts at reducing simple unfunctionalised ketones were 
generally unsuccessful, leaving little choice but to use other methods for the 
reduction.
This problem was resolved quite spectacularly by Noyori with the recent 
introduction of his mixed diamine-bisphosphine-Ru complex [(5)(5,5)-4]4 
which proved to be very active in the hydrogenation of ketones, even simple 
unfuctionalised ketones such as acetophenone. The catalyst proved highly 
active and very selective allowing for very large turnover numbers, with high 
turnover frequencies, while affording high enantioselectivities. For example, 
Noyori achieved the conversion of 1-acetonaphthone to the corresponding
15
alcohol in >99% conversion and 98% ee (R) using a catalyst loading of 
0 .001%.
The catalyst was however not so selective with acetophenone, giving complete 
conversion but with an ee of only 80% (R). The major flaw inherent in the 
reaction is the use of hydrogen at relatively high pressures. This requires 
expensive equipment and adds an element of risk to any industrial usage due to 
the need to handle hydrogen gas.
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1.3 ASYMMETRIC HYDROSILYLATION
The catalytic hydrosilylation of ketones (see scheme 1.2) was first achieved in 
the early 1970’s and has been an active area of research ever since. The 
reaction involves the oxidative addition of a hydrosilane (R^Si-H) to a metal 
catalyst giving a metal hydride complex (A). This is followed by insertion of a 
ketone C=0 into the metal-silicon bond to give complex B. This metal hydride 
complex then reductively eliminates to give a silylether, which is subsequently 
hydrolysed resulting in the formation of the alcohol.
R3Si-H 
L* (
1  1M oxidative
\  addition
L \
M -H  
SiR3 A
V R1
* r V _SiRi X ^  2
»■
Scheme 1.2 Mechanism of catalytic hydrosilylation
Early work by Ojima found that Wilkinson’s catalyst [RhCl(PPh3)3] was very 
effective in the hydrosilylation of acetophenone.5 This finding led to further
R1";f o ' H
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research into the use of chiral Rh(I) catalysts for the reaction. Indeed Rh was to 
become the metal of choice for much of the research that followed, which 
initially focussed on the use of phosphine based ligands in conjunction with 
rhodium (I) complexes. A number of phosphine ligands were used but on the 
whole these resulted in only moderate enantioselectivities.
In the 1980’s, Brunner investigated the use of imine containing ligands for the 
rhodium catalysed hydrosilylation of ketones.6 A number of these were 
prepared and tested in the reaction. These ligands were simple imines formed 
from the reaction of 2-heteroaryl carboxaldehydes, such as pyridine-2- 












Pyridine was generally the aryl group of choice and the enantioselectivities 
obtained from ligands 5 and 6 were significant. Higher selectivities were 
achieved using thiazolidine ligands such as 7 which directed the reduction of 
acetophenone in conjunction with [Rh(COD)Cl] 2  in up to 87% ee (R).7
In 1986, Brunner published the first use of a new class of ligand, a mono-
Q
oxazolinyl pyridine ligand (8, Pymox). This ligand type was to revolutionise 
the choice of ligand for use in enantioselective hydrosilylation. In 1989, 
Nishiyama published the use of both (S)-Pymox (8) and a bis-oxazolinyl 
analogue, (^Sj-Pybox (9). These ligands in conjunction with [Rh(COD)Cl] 2  
were able to reduce acetophenone in high yield and ee’s of 60% and 93% for 8 
and 9 respectively. With ligand 9 no activity was observed in the reaction 
unless an additive such as AgBF4 was added. The additive helps to free co­






More recently, research interest has focussed on the use of diphenylphosphine 
oxazoline ligands in the reaction. A number of these have been reported and 
three highly successful ligands are shown below.
Ligand 109 achieved the reduction of acetophenone in 94% ee (R) while l l 10 
achieved the reduction in up to 97% ee (R) using [Rh(COD)Cl]2 . Hidai 






Asymmetric hydrosilylation has provided chemists with a route to highly 
enantioselective reduction of ketones. However, the reaction suffers from the 
need to use a hydrosilane in stoichiometric quantities, or more commonly a 
dihydrosilane such as diphenylsilane. These compounds are relatively difficult 
to handle and are harmful, thus requiring special precautions to be taken in 
their use and disposal. These factors make hydrosilylation relatively 
undesirable as an industrial process.
20
1.4 ASYMMETRIC TRANSFER HYDROGENATION
Catalytic asymmetric transfer hydrogenation involves the reduction of a 71- 
bond by the transfer of hydrogen from a hydrogen donor to an acceptor, the 
process being promoted by a catalyst. The procedure provides a number of 
potential advantages to industry for the reduction of ketones based on the ease 
with which the reaction can be carried out. Generally, using suitable catalysts, 
the reactions can be carried out at room temperature and at atmospheric 
pressure, eliminating the need for special industrial equipment and any cost 
related to heating the reaction. The reaction also uses only relatively harmless 
reagents, unlike borane reductions, hydrosilylation or hydrogenation and 
eliminates the expense of handling and disposing of these chemicals.
Having a number of options in terms of which enantioselective reduction 
method one uses is also an advantage. There is a vast array of potential ketones 
which could be reduced to give enantiopure secondary alcohols. However, one 
method (e.g. transfer hydrogenation) may give better results with a particular 
ketone than another (e.g. hydrogenation). Having so many options when 
conducting a total synthesis, where the carbonyl reduction may be a key step, is 
invaluable.
The enantioselective transfer hydrogenation of ketones is a relatively new 
reaction with the earliest work being published in the early 1980’s. During the 
last 20 years, much progress has been made and the reaction has developed 
towards an efficient and highly enantioselective process for the reduction of 
aryl ketones.
21
This advancement has largely been a result of optimisation of both the metal 
catalyst used and the enantiopure ligands employed. The best catalysts 
contained platinum group metals (or PGMs), mainly using iridium, rhodium 
and ruthenium. A range of ligand types have been successfully utilised in 
conjunction with these and in this section some of the more notable examples 
will be highlighted. The ligands can be divided into 3 subsections. These are;
•  phosphine containing ligands,
•  amine based ligands
• amino alcohol ligands.
1.4.1 Phosphine containing ligands
A great many phosphine containing ligands have been developed, particularly 
in the earlier work, when many ligands were brought over from other reactions 
such as hydrosilylation where they had been successful. These now have been 
largely superseded by ligands that achieve higher levels of catalyst activation 
and selectivity.
One of the earliest catalysts reported was H4Ru4 (CO)8[(-)-DIOP]2  which had
proven effective in the reduction carbon-carbon double bonds by the transfer
hydrogenation reaction. However, in the reduction of acetophenone the catalyst
only managed to yield 1-phenylethanol in 35% yield and 4% ee.12 
11Later Krause investigated the use of chiral phosphine-iridium complexes in 
the reduction of ketones. For this purpose, he looked at 
menthyldiphenylphosphine (MDPP) and dimenthylphenylphosphine (DMPP)
22
in conjunction with Ir(COD)Acac. Of the 2 ligands, MDPP proved slightly 
superior in the reduction of acetophenone, providing (R)-1 -phenylethanol in up 
to 87% yield with 42% ee. On reducing the reaction temperature from 82°C to 
room temperature the ee was brought up as high as 48%, however the 







A number of other generally available chiral phosphine ligands were screened 
but these generally resulted in low selectivities.
More recently however, phosphine ligands have been developed, capable of 
higher selectivities. One example was the use of a Ru(II) catalyst complexed to 
(iS)-(/?)-pigiphos (13).14 After some optimisation of the ruthenium catalyst, to 
obtain {/hc-[(iS)-(R)-pigiphos]Ru(CH3 CN)3}(PF6), the group managed to 






Expanding from phosphine ligands, a number of groups have reported the use 
of mixed heteroatom ligands containing phosphines. These are commonly 
mixed P, N ligands and a number of them function as effective catalysts. One 
such ligand (14), developed my Sammakia,15 delivered superb results 















Zhang and co-workers have carried out research into developing mixed P, N 
ligands for transfer hydrogenation. During the course of their investigations 
they developed a number of tridentate ligands some of which are shown below. 
The first of these, (l/?,r/?)-2,6-bis-[l-(diphenylphosphino)ethyl]pyridine (15) 
proved effective in the reduction of acetophenone providing (R)-l- 
phenylethanol in 67% yield with an ee of 48%.16 This selectivity was improved
24
on with ligand 16, which resulted in a conversion of 72% but with an ee of 
79% (/?).'7
Following on from 16, Zhang developed a triamine analogue (17) which 
improved the selectivity of the catalyst significantly. Ligand 17, in conjunction 
with RuCl2(PPh3)3 delivered (5)-l-phenylethanol in an excellent 97% ee with 
91% conversion.18
1.4.2 Amine based ligands
Zhang’s triamine ligand (17), is only one of many amine-based ligands 
developed for use in transfer hydrogenation. Diamines have probably been the 
most commonly investigated ligand class for use in this reaction. A great many 
have been tested and some excellent ligands have been developed as a result. 
Lemaire first looked at chiral C2-symmetric diamines based around a (15,25)-
1,2-diphenylethylene diamine backbone, (DPEN, 18)19 and compared it with 














The most notable point was the increase in enantioselectivity achieved in using 
the TV^-dimethyl ligand 19 compared to the both the free diamine (18), and to
26
the di-isopropyl substituted diamine (20). Lemaire went on to investigate other 
C2 -symmetric diamine backbones20. He found that these ligands (21 & 22) 
gave inferior selectivities to their DPEN analogues. Ligand 21, though giving 
complete conversion, gave no enantioselection while ligand 22 showed no 
activity at all.
Noyori then developed a non-C2-symmetrical (lS^^-A^-toluenesulfonyl)-
1,2-diphenylethylene diamine [(S^-Ts-DPEN, 23] ligand.21 In conjunction 
with [RuCl2(mesitylene) ] 2  and KOH in isopropanol this ligand delivered (5)-l- 
phenylethanol in 95% yield and 97% ee, using 0.5 mol% Ru at room 
temperature.
Noyori later found that 23 worked well in alternative transfer hydrogenation 
conditions using a formic acid-triethylamine (5:2 v/v) mixture.22 Formic acid 
can act as a hydrogen donor and, unlike isopropanol, there is no possibility of 
the back reaction causing loss in enantiopurity. Noyori found that using 
conditions summarised in scheme 1.5, the ligand could achieve greater than 
99% conversion of acetophenone to (*S)-l-phenylethanol in up to 98% ee. Also, 
because the possibility of back reaction was eliminated, the substrate could be 





HC02H-Et3N; 5:2 mixture 
28°C
Scheme 1.5
The discovery of the Ts-DPEN ligand encouraged further research into 
developing mono-N-tosyl diamine analogues. Knochel23 prepared ligands 24 
and 25, to investigate their relative performance compared to Ts-DPEN. He 
found that they also showed very high activity in the Ru catalysed transfer 
hydrogenation of ketones. In the reduction of acetophenone these ligands 
achieved very high conversions at Ru loadings of 0.5 mol% with high ee’s. The 
results are summarised in scheme 1.6.




















Mono-Af-tosyl diamines had proved to be very effective in enhancing the 
activity of Ru(II) based catalysts. However, research into other diamine ligands 
continued. One example was the development of chiral thioureas as ligands.24 
A number of analogues were prepared and screened including ligands 26 and 
27.
26 27
Ligand 26 produces (5)-l-phenylethanol with a conversion of 94% and ee’s up 
to 89%. The methyl groups on the nitrogens of the diamine are vital to 
achieving high enantioselectivity. If the methyls are replaced by hydrogens as 









While the results achieved were desirable in themselves, the main advantage of 
thioureas over many of the ligands that have been developed for use in the 
transfer hydrogenation, is their ease and low cost of synthesis and their stability
29
in air by comparison to phosphines. However, the hydrogenation reactions 
needed elevated reaction temperatures, detracting from any cost advantage they 
may present.
1.4.3 Amino alcohols in transfer hydrogenation
In 1996, Noyori and co-workers, found that p-amino alcohols were very 
effective in the transfer hydrogenation of ketones . It was found that simple 
amino alcohols such as ethanolamine demonstrated a much larger rate 
enhancing effect on the ruthenium catalysed transfer hydrogenation of ketones 
than any other ligand type tested to date. In fact the reaction, which achieved 
turnover frequencies in excess of 22Oh'1 using ethanolamine as ligand, was 75 
times faster than the reaction without the amino alcohol added. Crucially, it 
was about 2.5 times faster than mono-iV-tosylated diamine ligands, such as 
Noyori’s Ts-DPEN ligand (23). During the course of the work, Noyori 
developed (15,25)-7V-methyl-2-amino-l,2-diphenylethanol (28) which proved 
to be a highly selective ligand for the reduction of acetophenone, in 
conjunction with [RuCl2(C6Me6 ) ]2  acting as the catalyst precursor. It achieved 
the reduction of acetophenone to (S)-1 -phenylethanol in 92% conversion with 
an ee of 94%. However, the selectivity from this ligand was highly dependant 
on the nature of the arene ligand on the Ru catalyst, with the ee dropping to 
56% when [RuCl2(C6H6 ) ]2  was used instead of the corresponding hexamethyl 











Table 1.2 Results from transfer hydrogenation of acetophenone
Noyori’s discovery led to further research into novel amino alcohol ligands for 
use in transfer hydrogenation reactions. Wills et a l26 found that (lR,2S)-c/s-l- 
amino-2-indanol (29) was capable of achieving very high selectivities in the 
reduction of acetophenone, this catalyst affording (S)-l-phenylethanol in 70% 








Later, Andersson developed (15',3^,4i?)-2-azanorbomylmethanol (30) for use 
in the Ru catalysed reaction. This ligand was also found to be highly 
selective, affording (S)-l-phenylethanol in 92% yield and 95% ee making it 











1.4.4 Reaction m echanism
Mechanistically a number of proposals have put forward to explain the 
reaction. These can be grouped into two categories;
• Direct hydride transfer from a donor molecule to an acceptor
• Transfer of hydrogen via a metal hydride intermediate.
The direct hydrogen transfer mechanism that has been proposed is similar to 
the Meerwein-Ponndorf-Verley (MPV) reduction which usually involves the 
formation of a metal alkoxide species. Lemaire has suggested in the past that 
the mechanism may be similar to this, in that the base used during the transfer 
hydrogenation reaction deprotonates the isopropanol to form a metal alkoxide 
species. Those who propose this mechanism suggest that the catalytic 
intermediate would be a 6-membered transition state 31 (scheme 1.10)
31
Scheme 1.10 Proposed 6-membered transition state
33
The reaction then occurs by the direct transfer of the hydride from the carbon 
of the alcohol (the donor) to that of the ketone (the acceptor). However, this 
direct hydride transfer mechanism is not supported by substantial experimental 
evidence. The catalytic intermediate has not been isolated and recent 
theoretical evidence from molecular modelling calculations has suggested that 
the reaction proceeds through a metal hydride.29 The metal hydride mechanism 
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Scheme 1.11 Metal hydride mechanism
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This mechanism involves a number of key steps. The first is the base promoted 
elimination of HC1 from the pre-catalyst I, to form the 16e' catalytic 
intermediate II. This intermediate is relatively stable, despite being a 16e‘ 
species, so that Noyori has managed to isolate a similar diamine Ru complexed 
intermediate (33, scheme 1.12).
Base
i \  -HCI 
C I"'?u"/NTs
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Scheme 1.12 Isolated catalytic intermediates
The reason for this observed stability is not fully understood but is believed to 
stem from substantial back bonding interactions between the lone pairs on the 
nitrogen and oxygen non-bonding orbitals and the vacant d-orbitals of the Ru 
atom giving rise to substantial double bond character in the Ru-N bond. This 
theory is further supported by the observation that the length of the Ru-NH 
bond in 33 is relatively short at 1.897A, the corresponding bond in 32 is
2.117A while in 34 it is 2.110A.30 Complex II can be considered as one of the 
active catalytic species. It is sufficiently reactive to dehydrogenate isopropanol 
to give the 18e' Ru hydride species V and acetone as a by-product. Again 
Noyori has isolated an analogue of this species (34) and so evidence exists for
35
its formation. V’ will then ligate to a ketone to give a complex similar to IV’. 
The hydride is then transferred to the ketone via this cyclic intermediate. 
Finally loss of the alcohol from IIP regenerates II and the cycle can begin 
again. Though the mechanism is still largely speculative, there is more 
evidence to support it than for the direct hydride transfer mechanism.
Recently, however, a new pericyclic mechanism has been proposed by 
Noyori31 in which the reaction proceeds through a 6-membered transition state 
(see figure 1.1). This mechanism, which is believed to be more applicable to 
diamine and amino alcohol catalysts is discussed more fully in chapter 5.
H H\ II I
Ru— N- r
X = N, O
Figure 1.1 Proposed 6-membered transition state
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1.5 AIMS OF THE PROJECT
This project is concerned with the development of novel enantiopure ligands 
for use in the transfer hydrogenation of ketones, in an attempt to improve upon 
those already available. The need for novel catalysts, and therefore ligands, 
stems from the belief that no single catalyst can be universally suitable for the 
reduction of all ketones due to the huge variety of possible ketone substrates. 
Specifically, it was envisaged that a parallel approach would be adopted for the 
screening of these novel ligands. A number of small libraries of distinctly 
different ligand types would be synthesised to verify their activity and 
enantioselectivity in the transition metal catalysed transfer hydrogenation of  
ketones. In planning a screening programme some variables were defined at the 
outset:
• Acetophenone was selected as the test substrate, since it has been 
extensively studied in other research programmes.
• In carrying out the initial screening of the ligands it was decided to use a 
relatively high loading of catalyst (5-6 mol%). This was to ensure that a 
highly selective catalyst would not be missed even if it were only capable 
of a limited number of turnovers.
• The ligand libraries investigated should offer a fair chance of success in the 
reaction, but over-analysis of each proposed library was not seen as being 
consistent with a parallel approach and would only lead to development of 
ligands similar to those already developed.
37
• The aim of initial screening was to isolate highly active and selective 
ligands. Any such hits would then be extended to the preparation of further 
related analogues to investigate the potential for optimisation. The 
optimised ligands would then be screened at lower catalyst loadings, and 
across a range of substrates, to ensure that their selectivity is wider than just 
to acetophenone.
In developing novel ligands, a number of criteria were thought important:
• The ligand should be relatively simple to prepare, with not more than 2-3 
steps needed for its preparation. To prepare a speculative ligand via a large 
number of steps would be inefficient and incompatible with a parallel 
approach.
• The ligand must be able to form chelate structures with a metal centre. This 
is crucial both in terms of obtaining enantioselection and in increasing the 
activity of the metal complex in the reaction.
• The backbone of any ligand library should be either commercially available 
or easily accessible and, if possible, relatively cheap.
• The ligand library should allow for a large degree of diversity to be 
incorporated.
• Both enantiomers of the ligand should be accessible.
• C2-symmetric or quasi C2-symmetric ligands would be an advantage.
38
CHAPTER 2
DEVELOPMENT OF NOVEL DIAMINE LIGANDS
39
2.1 INTRODUCTION
There is a large amount of evidence for the efficacy of diamine ligands in the transfer 
hydrogenation of ketones, some of which have been highlighted in chapter 1. The 
most notable of these ligands, and perhaps still the most effective developed to date, is 
the Ts-DPEN ligand (23)32 developed by Noyori. With this relatively simple and 
stable mono-iV-substituted ligand, Noyori achieved high activities and superb 
enantioselectivities in the Ru catalysed hydride reduction of a range of methyl aryl 
ketones. Because of this, we wished to investigate a novel range of mono-substituted 
diamines for use in this reaction.
2.2 A ROUTE TO MONO-ARYLATED DIAMINE LIGANDS
The high activity of Noyori’s Ts-DPEN-ruthenium catalyst owed much to the 
electronic properties conferred on it by the tosyl substituent. Though this has proved 
to be an effective ligand, derivatives of this type are not trivial to produce in many 
cases, perhaps explaining why few mono-substituted diamine ligands have been 
tested. The palladium catalysed amination reaction developed by Hartwig and 
Buchwald, 33 offered a potential route to a new class of chiral arylated diamines which 
had not been previously investigated in asymmetric synthesis.
It was hoped that the Pd-catalysed amination reaction could lead to a range of mono- 
arylated chiral diamine ligands in which the aryl substituent could be varied to induce 
differences in both the steric and electronic properties of the ligand. These ligands 
could be obtained in one step from their constituent diamines and aryl bromides (see
40
scheme 2.1). The large range of aryl substrates available would allow for a high 
degree of fine tuning, permitting the ligands to be optimised for reactivity and 
selectivity in the hydride transfer reaction.
Scheme 2.1
H — x
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From the results of the mechanistic studies carried out by Hartwig and Buchwald, it is 
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Schem e 2.2 Palladium catalysed amination
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The catalytic cycle, using a chelating bis-phosphine ligand, begins with the oxidative 
addition of the aryl bromide to the Pd(0) species to give I, which is then attacked by 
the amine to give II. This is followed by the base promoted removal of HBr from the 
catalytic species to give the Pdu-amido complex (III). Reductive elimination from III 
would furnish the desired TV-arylated amine (IV). It was hoped that the product would 
not undergo further reaction and that any formation of aryl by-products from the p- 
hydride elimination of intermediate III should be minimised by the use of optimised 
reaction conditions.
Literature
There was little precedence for the arylation of polyamines, with only the paper by 
Beletskaya et al.34 in which the arylation of polyamines, including diamines, was 
investigated. Beletskaya found that polyamines could be mono-arylated in most cases 
For example, Arv/V'-bis-(3-aminopropyl)-ethylenediamine could be mono-arylated with 
4-bromobiphenyl in 88% yield (see scheme 2.3).
f ]  Pd(DPPF)CI2 \  / = \
rNH Nh2+ Br^ p ^ = ) ______ . rNHHN^ C H O




The reaction was substrate dependent, so that o-MeOC6H4Br and /?-MeCOC6H4Br 
gave poorer yields (<20%). With more reactive aryl bromides, such as 1- 
bromonaphthalene, Beletskaya reported that poly-arylation could occur.
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Initial work
To investigate and optimise the mono-arylation of 1,2-diamines, (+/-) 1,2- 
diaminocyclohexane was predominantly used as the test substrate. Aryl bromides, 
such as 1 -bromonaphthalene, were used because the chromophore has an intense UV 
absorption which is useful for the efficient characterisation of the products by tic. A 
summary of the attempts made to optimise the reaction is given below.
Initial reaction between 1,2-diaminocyclohexane and 1-bromonaphthalene (see 
scheme 2.4), using our standard conditions similar to previous work on 
peptidomimetics,35 gave a low yield of less than 10%, but it was felt that by changing 
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Schem e 2.4 Initial test reaction
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2.3 OPTIMISATION OF THE REACTION
Changing the loading of diamine used
To ensure that mono-arylation would be favoured, the intention was to use an excess 
of diamine to aryl bromide, so the effect on the yields of changing the ratio of diamine 
to the aryl bromide was investigated. This ratio was varied from the initial three 
equivalents of diamine to aryl bromide to as low as 1.1 equivalents. As can be seen 
from table 2 .1 , reducing the loading of 1 ,2 -diaminocyclohexane from three 
equivalents to 1.4 equivalents resulted in a large increase in isolated yield from 7% to 
43%. However, bringing the loading down further to 1.1 equivalents caused the 
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Table 2.1 Effect of diamine to aryl bromide ratio on the isolated yield of 
naphthyl)cyclohexane 1,2-diamine (35).
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The effect of solvent
The effect of solvent was also investigated. Tetrahydrofuran, toluene and m-xylene 
were tested and the results are given in table 2.2. As can be seen there is no noticeable 
solvent effect, in terms of the reaction yield, with the yield only differing by about 2% 
in the 3 cases. The solvents were chosen to test for any difference that solvent polarity 
and higher temperatures would cause. On this basis it was decided to use THF as the 
solvent of choice, as it gave near identical yields and higher reflux temperatures were 
seen as unfavourable due to the possibility of racemisation with chiral amines (see 
below).
ArBr Diamine Complex Ligand Solvent % Yield




9 mol% THF 41




9 mol% toluene 40




18 mol% m-xylene 40
Table 2.2 Effect of changing the solvent on yield of 
naphthyl)cyclohexane 1,2-diamine (35)
Investigating the effect of catalyst loading on the reaction
Changing the amount of base in the reaction had minimal effect on the yield within
the range of 1.2 to 2.5 eq. and so the next parameter investigated was that of the
catalyst used. For example doubling the loading o f Pd2(DBA)3  from 3 mol% to 6
mol% resulted in identical yields of 41% (see table 2.3).
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18 mol% THF 41
Table 2.3 Effect of the catalyst loading on yield of 1-A-(1- 
naphthyl)cyclohexane 1,2-diamine (35).
Modification of the catalytic system
The source of Pd was changed from Pd2(DBA)3  to Pd(DBA)2  and Pd(DPPF)Cl2 and 
the phosphine ligand changed from DPPF to BINAP and [2,2]phanephos. The 
changing of ligand should affect the properties of the palladium catalyst, due to the 
differing steric and electronic properties. The electronic differences, for example, 
should affect the ease with which the oxidative addition step occurs. Many of the 
initial reactions had been carried out using Pd2(DBA)3  and 3 equivalents of DPPF as 
the ligand. These conditions were known in the literature and had been very efficient 
in earlier work synthesising peptidomimetics . On trying Pd(DPPF)Cl2 as the Pd 
source with three equivalents of DPPF the yields were slightly improved over the 
previous system. For example in the reaction with amide 37, changing from 
Pd2(DBA)3  to Pd(DPPF)Cl2 increased the isolated yield by 10% from 41 to 51%, 
though in both cases the aryl bromide was completely consumed (see table 2.4). The 
yields obtained when using Pd2(DBA)3  and Pd(DBA)2  together with DPPF were
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nearly identical in all cases. This was to be expected because they are similar catalysts 
differing only in the level of aggregation. Therefore, the Pd(DPPF)Cl2 /DPPF catalyst 

















Used diamine: ArBr ratio of 1.5:1
Table 2.4 Comparison of catalysts
It was becoming clear that the problem was not solely confined to a lack of complete 
reaction because in the majority of reactions, the aryl bromide substrates were 
completely consumed. This was particularly the case, with sulphonamide 40, amide 
37 and also, in some cases, 1-bromonaphthalene where the aryl bromides were fully 
consumed within a few hours but the isolated yields were only moderate and arene 
by-products could be observed in most cases by tic.
S -N
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It was hoped that by further changing the nature of the catalytic system the problems 
of side products and occasionally incomplete reactions could be resolved. The next 
parameter to be changed was the ligand. Other investigators have shown that a 
number of phosphine ligands can be used in the reaction.36 However, in choosing the 
ligands it was decided that it should be confined to readily available bis-phosphine 
ligands. The use of bidentate ligands rather than mono-phosphines, which had been 
shown to be active in the amination reaction,37 was necessary to reduce the likelihood 
of racemisation of the chiral amine due to possible (3-hydride elimination from a 
catalytic intermediate (see section 2.3).38 To this end, three different bis-phosphine 










(+/-J-BINAP (2) (+/-)-[2.2]phanephos (39)
Scheme 2.5 Structures of phosphine ligands used
BINAP was examined because it was known to be effective in the reaction. Also it is 
believed that the formation of the Pd-BINAP complex is more energetically 
favourable than Pd-DPPF due to the smaller bite angle of BINAP. This leads to a 
more tightly bonded complex and should therefore reduce any potential poisoning of 
the catalyst by the diamine. Changing from DPPF to BINAP as ligand gave a 

















Ratio of 1-bromonaphthalene/diaminocyclohexane; 1:1.4 
Table 2.5 Effect of changing ligand on reaction yields
Noting that the Pd(DPPF)Cl2/DPPF system was superior to Pd2 (DBA)3/DPPF it was 
then compared to Pd(DBA)2/BINAP in the synthesis of 41. As can be seen a 
significant yield increase was observed from 52% to 70% at a 6 mol% loading of Pd 
(table 2.6).















Table 2.6 Preparation of 41
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Attempted use of [2,2]phanephos (39), a novel bisphosphine ligand39 developed by 
Merck, in the test reaction failed to give any detectable product, highlighting the 
importance of careful selection of the bis-phosphine ligand. The observation that 
BINAP was superior to DPPF as the ligand suggested that the problems may have 
stemmed in part from a potential competitive effect between the diamine and the bis­
phosphine for complexation to palladium. In the event of ligand competition the Pd 
catalyst would effectively be poisoned and this could explain the failure of the 
reaction in some cases to go to completion. Interestingly, when attempting the 
reaction using 3 equivalents of diaminocyclohexane to 1-bromonaphthalene and 
BINAP as the ligand, the isolated yield is roughly equivalent (ca. 50%) to that 
achieved in the previously optimised conditions when using only 1.5 equivalents of 
ArBr (see table 2.1). This suggests that the reaction is more tolerant of excess diamine 
with BINAP than when using DPPF. However, the differences in observed yields 
from using different catalytic systems most probably lies in variable levels of side 
reactions. During the course of this work the bis-phosphine ligand was always added 
in excess to the palladium. The extent of this loading seemed to have no noticeable 
effect on the yield within the ranges used in the experiments (1.5 to 4 equivalents of 
bis-phosphine to Pd).
Attempts at using CS2CO3 as the base instead of NaOf-Bu did not lead to higher yields 
and the use of Pd(OAc) 2  as the catalyst precursor together with BINAP proved 
inferior to using Pd(DBA)2 .
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Use of other additives
The use of additives such as 18-crown-6 and LiCl failed to improve the reaction 
yields. In fact very poor yields were observed in both cases. The use of 18-crown-6 
would be expected to have an activating effect on the base - presumably why 
Buchwald has reported room temperature amination reactions using this as an 
activator.40 However, addition of crown ether to the arylation of 1,2- 
diaminocyclohexane at 60°C gave a very low yield of 8%.
It is known that the addition of lithium chloride can improve the reactivity and yield 
in the palladium catalysed Heck reaction41. However, the reaction using LiCl resulted 
in a yield of only 11%.
Reactions were typically allowed to reflux over a period of about 16-24 hours, or less 
if the reaction was complete. It was thought that this time period should suffice, 
especially considering the relatively high loadings of palladium used. In some cases, 
particularly when using 1-bromonaphthalene or 4-bromobiphenyl, the aryl bromide 
was not completely consumed, but elongating the reaction time to several days usually 
resulted in slightly lower yields.
Changing conditions had only provided limited success in attaining higher yields of  
the desired products. Tic analyses of these reactions showed that starting material 
remained in some cases, but in most cases other arene side products were visible. It 
was originally thought that the side products formed were a result of the reduction of 
the aryl bromide, to give the corresponding arene. Some evidence for this came from 
GC studies of the reactions of 1-bromonaphthalene and 4-bromobiphenyl which 
showed the formation of a peak of similar retention time to that of the respective 
arene. However, the levels of this product were quite small and fluctuated somewhat
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over time, suggesting that the peak could also have been derived from a reaction 
intermediate. Throughout the work it had been thought that the bis-arylated products 
were not being formed, due to the use of excess diamine to aryl bromide and the 
findings of other work carried out within the group. It was therefore assumed that any 
side products were probably the result of reduction o f the aryl bromide or other side 
reactions. However, NMR analysis of the reactions of 1-bromonaphthalene and 
isolation of the arene by-product showed that the main by-product was bis-arylated 
diamine. These products were of very similar Rf to the arene starting material but 
stained with vanillin.
In the reaction with diaminocyclohexane (1.4 equivalents used to 1- 
bromonaphthalene) the ratio of mono-arylated diamine (35) to bis-arylated diamine 
(42) was approximately 2:1 from the ^-nmr of the crude reaction (see scheme 2.6). 
The bis-arylated product (42) had a characteristic doublet at 6.80ppm and a multiplet 
at 3.63ppm, each peak corresponding to two protons while the corresponding peaks in 
the mono-arylated diamine (35) came in at 6.72ppm and 3.20ppm respectively, each 
integrating for one proton.
A similar observation was made in the reaction of bromonaphthalene with DPEN (see 
scheme 2.7). Here too there was a significant amount of the bis-arylated product (44) 
but this time the proportion of mono-arylated product (43) was higher at about 80% 
after a period of 4 hours.
The formation of the bis-arylated products in these quantities explains the moderate 
yields of the desired mono-aryl products. Though the reactions in some cases did not 
lead to complete consumption of the aryl bromide, the main problem appeared to be 












Reaction time % 35 % 42
24 hrs 64 36
48 hrs 58 42










43, 80% 44, 20%
Schem e 2.7
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In conclusion, some success was achieved in bringing the initially very low yields up 
to at least moderate and, in some cases high yields. While the reaction could benefit 
from further optimisation, it was felt that for the purposes of this project the current 
results were sufficient.
Due to the high cost of (lS^Sj-DPEN, this was prepared following the procedure of 
Corey4 2 (scheme 2.8).
PhT °  + NH4OAc, c h 3c o 2h  ^ PY > 0
L J  120°C, 1 hour P h ''" 'V
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Li , PhY V - A  2N h c i , Phy NH2 
THF-NH3 DCM
45 46 (+/-)-DPEN
PhS ^ ^ H 2 L-(+)-tartaric acid Ph/, ^ N H 3 H0V ^ C 0 2 NaOH
(S.S)-DPEN
Ph NH2 P h ^ N H 3 HOx C 0 2’
(+/-)-DPEN
Scheme 2.8
A number of analogues of both (li?,2/?)-diaminocyclohexane and (1S,2S)-DPEN 
were prepared and their structures are given in schemes 2.9-2.10. The yields obtained 
show pronounced substrate effects dependent on both the nature of the aryl bromide
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and of the diamine. So, for example, DPEN proved the better diamine substrate, 
resulting in higher yields of the desired product in most cases. This effect is almost 
certainly due to a lower level of the bis-arylated by-product formed with this 
substrate.
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NH2 Ar_Br ^ s ^ N - A
Pd(DBA)2 / Ligand
''NH2  ^ ^ ' vNH22 NaOf-Bu 2
THF
Ligands prepared from (1 R ,2R)(-) -1,2-diaminocyclohexane
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2.3 INVESTIGATION OF CHIRAL INTEGRITY
For the reaction to be useful in preparing enantiopure diamine ligands, it was 
essential that it proceeded without any significant deterioration of the 
enantiomeric purity of the diamine. Buchwald et al, 43 examined palladium 
catalysed arylation of a number of optically active amines in which they 
investigated the effect that different catalytic systems have on levels of 
racemisation. In a test case, the reaction between (/?)-a-methylbenzylamine and 
4-bromobiphenyl (table 2.9), he found that when using Pd2 (DBA) 3  in 
conjunction with either BINAP or DPPF no significant loss in enantiomeric 
purity was observed. However, when using P(o-tolyl) 3  as the ligand the 















He found that racemisation also occurred when using other monodentate 
phosphine ligands such as P(l-naphthyl)3  and P(o-methoxyphenyl)3 . The extent 
of racemisation with P(o-tolyl)3  was little affected by the ratio of phosphine to 
Pd but as the reaction temperature was increased the extent of racemisation 
increased. The use of bidentate ligands was crucial in maintaining the 
enantiomeric purity of the amine during the reaction. Through further probing 
of the mechanism, Buchwald suggested a reason for this observed effect (see 
scheme 2.11).
It is thought that the racemisation that occurs with monophosphine ligands is a 
direct result of the formation of the two Pdn-amino complexes I and V. 
Reductive elimination of I results in the desired arylated amine. However, p- 
hydride elimination, a potentially competitive and reversible reaction, initially 
leads to a ^-coordinated Pd]I-imino complex (II). This can undergo reductive 
elimination to give an imine and the hydrodehalogenated arene (ArH). 
Buchwald suggested that II could also interchange from the rc-coordinated 
complex (II) to the a-coordinated Pdn-imino complex (III). Due to relatively 
low barriers to rotation, this in turn could return to the enantiomeric Jt-complex 
(IV), which is ^-coordinated on the opposite prochiral face of the imine to that 
of complex II. Complex IV could go on to form the a-bonded complex (V), 
and reductive elimination of this complex would result in the opposite 
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catalytic cycle as 
in scheme 2.2
Scheme 2.12
The use of a bis-phosphine ligand probably prevents the (3-hydride elimination of 
of r  thus not allowing the formation of II' and so preventing any racemisation. It is 
believed that with bis-phosphine ligands both phosphorus atoms stay bonded to the 
palladium throughout the catalytic cycle. The square planar Pd complex I' is 
therefore 4-coordinate, unlike with monophosphine ligands where a phosphine can 
fall off the metal forming a 3-coordinate species. This 4-coordinate species makes 
(3-hydride elimination unfavourable due to the lack of a suitable empty d-orbital for 
the (3-hydride to attack.
Buchwald has also argued that even if II' were to form, formation of the G- 
coordinated intermediate III' would be unfavourable due to steric interactions 
between the methyl group of the imine and the bulky metal centre (see scheme 
2 .12).
Ph»,. >M e
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It was necessary to check the enantiopurity of the prepared mono-aryl diamine 
ligands. However, attempts at using chiral HPLC proved unsuccessful and so 
Mosher’s amides were formed from the diamines by reacting them with 
enantiomerically pure (/?)-MTPA-Cl (scheme 2.13). The enantiomeric excesses of 
the amines were derived from the diasteromeric excesses of the amides observed by
I9 f -n m r .
o
, H C l ^ f - C F 3 " ' Y
R ^  r\k»A J.
Ph 1 ^Kn rV  .N-Ar
° Me




Scheme 2.13 Synthesis of MTPA-amides
All the amides investigated were diastereomerically pure (>97% de) with only one 
significant 19F-NMR peak corresponding to the amide observed. The 'H-NMR 
spectra also indicated only one diastereomer was present. Scheme 2.13 lists the 





Compound no Ar F-nmr signal
53 1-Ci0 H7 -69.47




P h ^ N H 2
Compound no. Ar 19F-nmr signal
56 i - c 10h 7 -6 8 . 8 8
57 p- Ph-C6H4- -68.99
58 /7-(C6H5CH2N(C6H5)S02)C6H4- -69.20
Scheme 2.13 Amides prepared
"OMe
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To check that I9F-nmr was suitable for distinguishing between these 
diastereomers, a number of Mosher’s amides were prepared from racemic 
modifications of the aryl diamines. In each case, these showed 2 peaks, of equal 
intensity, each corresponding to one diastereomer. So for example, 53 prepared 
from rac-35 showed peaks corresponding to the diastereomers at -69.11 and -  
69.47 ppm and 56 (prepared from rac-48) at -68.90 and -69.26 ppm. The fact 
that the diastereomeric amides could be distinguished by 19F-nmr indicated that 
this was a suitable method for checking enantiomeric purity of the diamines. A 
more definitive picture would have been obtained if  amides from c/s-diamine 
analogues had been prepared, as this would have given 19F-nmr peaks for all 
the possible diastereomers. However, the data obtained was relatively 
conclusive, showing that no noticeable racemisation had occurred.
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2.4 RESULTS FROM  TRANSFER H YDR O G EN ATIO N
The ligands were tested in the ruthenium catalysed transfer hydrogenation of 
acetophenone, summarised in table 2.10. The results were quite disappointing, 
with all ligands giving significantly lower ee’s than either TsDPEN (23) or 
TsCYDN (51), which were prepared as shown in scheme 2.14.
n y v  \ - .../ ii DOM o
r 2^ n h 2 O qoc R n h 2
Ligands;
H 8
, / r c "-
vNH2
(R,R)-TsCYDN, 51 (S,S)-TsDPEN, 23
Yield=41% Yield=60%
Scheme 2.14
The most effective of the novel ligands tested, /^-sulfonamide 50, resulted in 
(iS)-l -phenyl ethanol in a relatively high ee of 60% at 40°C with [Ru(/?- 
cymene)Cl2 ]2 - While this is a fair level of selectivity, ligand 51 resulted in an 
ee of 77% at 40°C. The selectivity of 50 in conjunction with [Ru(C6 H6 )Cl2 ] 2  
was significantly lower at 43%. This variation in selectivity with the change of
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arene has already been noted in literature. In general, the rates of the reactions 
with the ligands developed here were relatively slow, and in some cases, 
activity was very low with the reactions giving poor conversions even at these 
relatively high catalyst loadings (5-6mol%).












35 [Ru(/?-cymene)Cl2 ] 2 80°C 
2 1  hrs
<5 n.d.
R= ~ o ~ o
47 [RuO-cymene)Cl2 ] 2 80°C 
2  hrs
< 1 0 4 (R)
R= —0 _"sv Ph




51 [RuO-cymene)Cl2 ] 2 40°C 
1.5 hrs
58 77(A)





48 [Ru(C6 H6 )C12 ] 2 40-45°C 
5 days
6 6 21(5)
r = —rvv0 Ph
50 [Ru(p-cymene)Cl2 ] 2 40°C 
11.5 hrs
95 60 (5)
K \_ y  n'
^Ph




23 [Ru(/?-cymene)Cl2 ] 2 0°C 
14 hrs
93 96(5)
Table 2.10 Results from transfer hydrogenation of acetophenone
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The results also showed that the sulfonated iV-aryl ligands (41 & 50) were more 
active than the other analogues tested, possibly due to the electronic properties 
of the substituent. There is precedence for this effect in, for example, the 
comparison of ligands 23 and Me-DPEN 59 (see section 3.1). Noyori found 
that the selectivity of both ligands were similar in the transfer hydrogenation of 
ketones. However, he suggested that the higher activity of the sulfonamide 
ligand is due to the electron withdrawing properties of the Ts group. The 
results also indicate that the DPEN analogues generally have significantly 
higher activities than their cyclohexyl derivatives.
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CHAPTER 3
NOVEL AMINE BASED LIGANDS VIA SNAR
CHEMISTRY
68
3.1 MONO-ARYLATED DIAMINE LIGANDS
We wished to investigate the effect of more electron withdrawing substituents 
on the activity of mono-substituted diamine ligands. The success of the Noyori 
ligand and the observed higher activity of the aryl sulphonamide ligand (50) 
compared to other ligands prepared in the chapter 2 , begged the question of 
whether electronic effects were the key determinant of ligand activity. Noyori 
noted that Ts-DPEN (23) is more active than the more electron rich NH(CH3) 
analogue 5944, even though the two ligands showed similar enantioselectivities 




It was hoped that the effect of electron withdrawing substituents could be 
investigated by preparing a range of mono-substituted nitro aryl diamines by 
nucleophilic aromatic substitution (scheme 3.1). The introduction of mono- and 

















The ligands were prepared by reacting aryl fluoride with diamine in the 
presence of a base. Little difference was observed between using MeCN or 
THF as the solvent. However, the choice of base proved to be important in
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optimising the reaction yields. Lower yields were observed when using NaO/- 
Bu as opposed to K2 CO3 or Et3N. Attempts to form the 2,4,6-trinitrophenyl 
substituted analogues resulted in very poor yields due to uncontrollable 
formation of bis-arylated by-products. The three-step mechanism is illustrated 
in scheme 3.2. The first step, usually rate determining, step involves the 
addition of the amine nucleophile to the aryl halide forming a charged 
intermediate (I) while the second and third steps, involve the abstraction of a 
proton from the ammonium intermediate and ejection of fluoride respectively.
The rate of SnAt reactions increases with greater electronegativity of the 
halide, due to reduced electron density of the adjacent carbon, making aryl 
fluorides more reactive than chlorides and bromides. However, simple aryl 
halide species are usually not sufficiently activated to undergo nucleophilic 




Schem e 3.2 Mechanism of Aromatic nucleophilic substitution
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Such substituents stabilise the negative charge of the intermediate which is 
mostly localised at the ortho and para positions. Thus electron withdrawing 
groups ortho or para to the halide are most effective. Nitro groups are 
commonly used because these are both electron withdrawing and allow for 
charge stabilisation through resonance delocalisation (see scheme 3.3).
Scheme 3.3
The ligands were tested in the ruthenium catalysed transfer hydrogenation 
reaction (see table 3.1). The conversions were very poor, with less than 10% 






ligand structure ligand % conversion
^kx\NH
0 ^ n h 2
60 1
no2








conditions: See procedure B
Table 3.1 Transfer hydrogenation results after 40 hours using nitroaryl 
diamines
The failure of these ligands probably stems from the nitro functionality. While 
these groups were required for the activation of the aryl species to aromatic
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nucleophilic substitution, it is possible that the decreased activity o f the 
ruthenium catalyst was caused by the complexation of the nitro groups with the 
metal centre, effectively poisoning the catalyst.
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3.2 TRIDENT ATE LIGANDS IN TRANSFER HYDROGENATION
Some success in the transfer hydrogenation of ketones has been achieved using 
tridentate ligands in conjunction with Ru(PPh3)3Cl2 . In particular, Zhang and
1 ftco-workers achieved high enantioselectivities using a bis-(oxazolinyl)amine 
ligand (21) with which 1-phenylethanol was obtained in up to 97% ee.
Following the disappointing results achieved with the 2-nitrophenyl diamine 
ligands, we wished to investigate whether reducing the nitro functionality to an 
NH2 group would result in a more active triamine ligand. 62 Was reduced at 
room temperature using 10% Pd on carbon and hydrogen gas to give the 
desired tridentate ligand 64 (scheme 3.4).
o 2n h 2n
H ) = \  10% Pd on carbon H / = \
" \ J  hi --
Ethanol L  J-,.
NH2 62 'NH2 64
93%
Schem e 3.4 Synthesis of 64
75
This methodology allows for a high degree of diversity in the chiral backbone 
and two amino alcohol derivatives (65 and 66) were also prepared in similar 







Scheme 3.5 Preparation of ligands 65 and 66
Ligand 65 was found to be quite unstable with discoloration occurring quite 
rapidly even when stored at 4°C. Tic showed degradation products forming, 
though the nature of these was not investigated.
Though the ligands lacked C2 -symmetry, unlike 21, it was thought that 
complexation to the metal may be influenced by steric factors, ensuring that the 
ligand complexes in a single preferred geometry.
The ligands were screened in the transfer hydrogenation of acetophenone at 
82°C in isopropanol using 5 mol% of Ru(PPh3)3 Cl2 . Ligand 6 6  gave no
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significant product formation after 1 day, and while triamine 64 showed some 
reactivity with a conversion of 8 8 % after 15 hours, the enantioselectivity was 
low at 14% ee (S).
3.3 1,5-DIAMINE LIGANDS
The vast majority of diamine and amino alcohol ligands described in the 
literature for transfer hydrogenation are a,p-bidentate ligands. These usually 
form 5-membered chelate structures around a metal. We wished to investigate 
whether mono-N-tosylated 1,5-diamine ligands could act as active catalysts in 
the reaction by forming an 8 -membered metal chelate. Though there have been 
no 8 -membered metal chelates used in transfer hydrogenation, 1,5- 
bisphosphine ligands such as bis[2 -(diphenylphosphino)phenyl]ether 
(DPEphos) have been used in the palladium catalysed amination reaction45 and 
Evans4 6  has shown that ligand 67 is active in the samarium catalysed 
















To investigate whether a 1,5-mono-N-tosylated diamine would be effective a 
small library was prepared (see scheme 3.7).





These ligands were screened in the transfer hydrogenation of acetophenone 
using [(p-cymene)RuCl2 ]2  at 40°C with a 5 mol% loading of Ru. However, the 
catalysts failed to give any significant conversion under these conditions (see 
table 3.2).





Reaction conditions: See experimental conditions A 
Table 3.2 Results from transfer hydrogenation of acetophenone using 1,5- 
diamine based ligands
Raising the temperature to 60°C, ligand 68 gave a conversion after 1 day of 
49% but unfortunately with a near racemic product (3.6% ee (R)). It is possible 
that the ligands may be tridentate but no further screening was carried out after 
the poor results from the initial screen.
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3.4 AMINO ALCOHOLS ON A NOVEL LIGAND BACKBONE
Enantiopure 1,2-amino alcohols have been effective ligands in the catalysis of 
a number of asymmetric reactions and, in particular, have been highly effective 
ligands for the acceleration of the ruthenium catalysed transfer hydrogenation 
of ketones. 2 5 ' 27
We wanted to investigate whether we could develop amino alcohol based 
ligands via SNAr chemistry. We chose 2,4-dichloro-1,5-dinitrobenzene (71) 
(scheme 3.8) as a novel backbone which is very active towards SnAt reactions.




C |^ _ C|
+ K2 SO 4  + 2 H20
o 2 n ^ ^ ^ n o 2
71
Scheme 3.8
The nitro functionality may be expected to give the ligand some water 
solubility in its complexes and it was hoped that the reaction could be 
controlled to give substitution at either one or both C-Cl bonds.
The ligands were prepared in anhydrous acetonitrile using triethylamine to trap 
the HC1 formed (scheme 3.9). With the amino alcohols the amine was the 
attacking nucleophile in all cases and this was confirmed by ’H-nmr where the 
NH peak was visible as a doublet at 8 8-9 ppm.
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H2Y , o H h  o h
a w ®  R ^ R 2 ci^ ^ V n ^ r 2
o
1 / 1   *  1 1
, N ^ ^ N O ,  Et3N, MeCN OjN ^ ^  NOj
Ligands prepared;
H OH OH H H OH H OH
CIY ^ f N^ P h  
0 2N ^ ^ N 0 ?2h &h2N ^ ^ N O ^  0 2N ^ ^ N c 4 f
72 73 74
QH H H ? H
ph'AY NY <:V NY '^ p h
75
Scheme 3.9 Preparation of ligand library
Mono substitution proved easy to achieve. This may be due to the 
electronegativity difference between chlorine and nitrogen (3.16 to 3.04 
Paulings), causing the second substitution to be less favoured than the first. 
This activity difference was sufficient to allow for control over the 
substitutions, which was vital to allow for potential ligand optimisation. Thus 
the introduction a second enantiopure group to act as a chiral modifier, or the
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introduction of an amino acid ester (to increase the water solubility of the 
ligand, permitting catalyst recovery by aqueous extraction) could be considered 
as possible methods for optimisation.
It was envisaged that the ligand would complex to the metal centre of the p- 
cymene ruthenium chloride to form a well precedented 5-member chelate as 
shown in scheme 3.10 and that the bis-amino alcohol ligands may form bis- 
ruthenium catalyst species.
Scheme 3.10 Proposed structure of 5-membered chelate catalyst precursor
For the purposes of the ligand library however, it was important that the 
activity of the initial library was tested prior to any further functionalisation. 
Results from the transfer hydrogenation of acetophenone were poor, with both 
low conversions and low enantioselectivities obtained (see table 3.3) and so no 
further development of this library was carried out.
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[RuCI2(p-cymene)]2
r f ^ V ^ M e   *
[I J  Ligand
/-PrOH / KOH
Structure Ligand % Conversion/ (% ee)
H 0Hc,v v U
72 8
?H H H ? H 73 8
H 0H
clY Y V p^
74 15 ( 0 )
g H  H H OH
ph'^YNY^YN - Ph
75 1 1
OH H H OH
V y ^ Y
P h ^ 2N> s ' ^ N 0 2 Ph
76 1 2
clY \ Nr ^
0 2N ^ N ( £ e
77 2 0 ( 6 )
conditions: see experimental section 6.7- Procedure B
Table 3.3 Results from transfer hydrogenation at 40°C after 40 hours.
The inactivity of these ligands could be a result of deactivation of the catalyst 
by the ortho-nitro groups. These groups could complex to the ruthenium centre 
thus deactivating it. It is also possible that the nitrophenyl group electronically 
deactivates the amino alcohol complex. Furthermore, it was later found, during
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the work with amino alcohols (see chapter 5), that the substituent on the amine 
terminus of an amino alcohol should be electron donating (e.g. alkyl groups) to 
achieve highly active Ru catalysts.
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CHAPTER 4
IMINO ALCOHOL LIGANDS IN TRANSFER 
HYDROGENATION
85
4.1 INTRO DUCTIO N
A number of groups have reported the use of ligands incorporating imine 
functionality for the transfer hydrogenation of ketones. Several ligands acting 
as bis-imino chelates have been tested in the reduction of acetophenone. An 
early example was reported by Zassinovich et a l41 who used (£)-2-pyridinal-l- 
phenylethylimine (78) in conjunction with [Ir(COD)Cl2 ] 2  to give 










While the selectivity was quite low with acetophenone, the reduction of 
ketones such as f-butyl phenyl ketone resulted in the corresponding alcohol in 
high yield (94%) and a greater ee of 80% (S). Soon after this Gladiali et a l4S 
published results from the use of optically active phenanthrolines in 
conjunction with a Rh(I) catalyst. Using phenanthroline 79, the catalyst 
delivered 1-phenylethanol in up to 96% conversion with 62% ee (scheme 4.2).
86
9 [Rh(1,5-hexadiene)CI] 2
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The use of bis-oxazolines in the Ir catalysed reaction was investigated by Pfaltz 
et al.49 using 80. This ligand proved moderately effective, resulting in a 









Later on, a number of mixed functionality imine based ligands were tested. 
Noyori5 0 investigated the effectiveness of a bis-imino phosphine ligand (81).
= N




The ligand showed poor activity in the Ru(II) catalysed transfer hydrogenation 
of acetophenone, resulting in a very low conversion (3%), while the amino 
phosphine analogue (82) was more reactive, giving a conversion of 93% and an 








Noyori reasoned that this was due to the requirement for an acidic hydrogen in 
the form of an NH moiety. However, in the same year, Helmchen51 reported 
the successful use of an imidato phosphine ligand, 83, which reduced 








Uemura et al.52 reported the use of another imidato phosphine ligand (84) in 
the Ru(II) catalysed transfer hydrogenation of acetophenone and obtained 1- 







Zhang53 developed a NPN-type tridentate ligand (85) incorporating two 
oxazoline groups attached via a spacer to a phenyl phosphine group. He found 
that the ligand was effective in the reduction of acetophenone, giving the 








There was clear precedent for imine based ligands being effective in the 
transfer hydrogenation reaction. However, to the best of our knowledge, the 
use of imino alcohol ligands had not been reported although considerable 
evidence exists showing amino alcohol ligands54 to be active ligands.
To investigate this possibility, a library of imines and imino alcohols derived 
from readily available thiophene carboxaldehydes and amino alcohols were 
prepared via a facile condensation reaction in refluxing anhydrous methanol
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(see scheme 4.8). The reactions proceeded to completion in all cases to give the 
imino alcohol ligands in quantitative yields.
H ^





The ligands would be expected to form a 5-membered chelate ring with the 




Though there is sufficient evidence for the formation of such complexes, it was 
unclear what orientation the ligand would adopt. We speculated whether or not 
there may be any weak interaction between the lone pair on the sulfur atom and 
the empty J-orbital on the ruthenium and also whether any such interaction 
would result in either a significant loss in activity or an increase in ee. We 
expected that the thiophene moiety would at least act as a steric block, 
influencing the approach of the incoming ketone and orienting it relative to the 
ruthenium core.
Initial testing of the ligands in ruthenium catalysed transfer hydrogenation 
showed that the imino alcohol ligands were active in the reaction, with the 
reactions going to completion within 2 hours at 40°C (see table 4.1). The 
imines however showed very poor activity, with very low conversions 
observed even after 40 hours. The selectivity with imine ligand 8 6  was also 
very low, with the product being nearly racemic. The enantioselectivities
92
obtained from the im ino alcohols varied considerably ranging from on ly  10% 






Structure Ligand % conversion [% ee] 
after 2 hours
%  conversion [% ee] 
after 40 hours
Me
86 4 [ n.d. ] 15 [ < 1 © ]
APh^N N_.Ph
Me Sle
87 2 [ n.d. ]* n.d.
N Ph 
HO
88 94 [ 20 (R) ] 93 [ 1 9 ( A ) ]
y^ph
HO
89 95 [ 1 0  (S) ] 93 [ 1 0 ( 5 ) ]
P h ^ N  N ^ ph
"'OH HO
90 95 [ 1 3  (S)] 94  [ 1 3 (5 )  ]
H ^ .M e
H O ^ P h
91 86 [ 70 (R) ] 88 [ 62  (A) ]
* Reaction after 3 hours
Table 4.1 Results (GC) with im ine and im ino alcohol ligands after 2 and 
40 hours at 40°C
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After elongated reaction times (40 hours) there was a slight fall off in 
enantioselectivities, possibly due to back reaction, a process known to occur 
when using isopropanol as the hydrogen source. It is for this reason that a 
dilute substrate solution is used. Avoiding the use of the isopropanol/KOH 
conditions and switching to the Et3N/formic acid mixture instead would 
eliminate this problem, the reaction then being essentially irreversible. 
However, attempts to use this system with 91 gave very low conversions, 
probably due to catalyst instability in this medium.
Imino alcohols had proven effective ligands for the ruthenium catalysed 
reaction. However, the mechanism when using imino alcohols cannot be 
identical to that described for amino alcohol catalysts (see scheme 1.11). In 
this proposed mechanism the first step is the base promoted elimination of HC1 
from I to give II which then accepts an equivalent of hydrogen to generate the 
active Ru-H catalyst III (see scheme 4.9).
O R u- -R u --.
Scheme 4.9
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However, with imino alcohol ligands this step is not possible due to the 
nitrogen being aprotic. We believe that isopropanol promotes the elimination 
of HC1, by the mechanism shown (scheme 4.10), to give the ruthenium hydride 
catalyst V.










The active imino alcohol ligands were then screened across a range of platinum 
group metal (PGM) precursors, namely, [Ir(COD)Cl]2 , [RuC12(DMSO)4], 
[Rh(NBD)Cl] 2 and Ru(OAc)2 (PPh3)2. While there is some literature evidence 
for the use of [Ir(COD)Cl] 2 55 and [Rh(NBD)Cl]256, the other PGM sources have 
not been used in the reaction previously and we wished to investigate whether 
they were suitable and what effect the choice of metal source would have. The
95
reactions again were carried out at 40°C and the results are summarised in 
graph 4.1.
As can be seen, only the reactions with [Ir(COD)Cl] 2  showed any significant 
conversion in the transfer hydrogenation of acetophenone.
PGM source
Graph 4.1 Transfer hydrogenation of acetophenone at 40°C using different 
PGM sources
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The results with [Ir(COD)Cl] 2  after 3 hours are shown in table 4.2. The 
conversions were high but the enantioselectivities were less than when using 
[(p-cymene)RuCl2 ]2 - In particular, 91 gave an ee of only 23% using Ir 







Structure Ligand [lr(COD)CIJ [(p-cymene)RuCI2]2
% conv. [% ee] % conv. [% ee]
N Ph
HO
88 98 [ 15 (R) ] 94 [ 20 (R) ]
NV^Ph
HO
89 96 [7  (R)] 95 [ 10 (S) ]
Aph^ v N ^ ph
"s,OH HO
90 98 [4  (R)] 95 [ 13 (S) ]
N^Me
HO^ Ph
91 61 [ 23 (R) ] 86 [ 70 (R) ]
Table 4.2 Results from the Ir catalysed transfer hydrogenation
The configuration of the alcohol product with the iridium catalyst was reversed 
with ligands 89 and 90, affording predominantly the .ft-alcohol, as opposed to 
the ruthenium catalyst where the major product was (S)-1 -phenylethanol. This 
enantioselection was not reversed with ligands 88 and 91 however.
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The imino alcohols had shown a high degree of activity in the reaction and it 
was decided that they warranted further optimisation. The ligand design allows 
for a degree of diversity and modifications were easily achieved by changing 




91 92 93 94
Two new ligands (92 and 93) were prepared from (S)-valinol, and a C2 - 
symmetric bis-imino alcohol ligand (94) was prepared from (\R,2S)- 
norephedrine. Results from the transfer hydrogenation of acetophenone at 40°C 
are summarised in table 4.3.




93 >95 9 (5)
norephedrine
ligands
94 49 72 (A)
91 8 6 70(A)
Table 4.3 Results from the reduction of acetophenone at 40°C using 
mono- and bis- imino alcohols
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As can be seen from the results, the enantioselectivities of the bis-imino 
alcohol ligands are not significantly different from those of their mono­
analogues, when comparing 92 and 93 or 91 and 94. However, the reaction did 
not go to completion using the bis-norephedrine ligand 94, even after 24 hours 
where the conversion was nearly identical (47%), suggesting that the second 
imino alcohol group only serves to lower activity, and possibly poisons the 
catalyst. Due to the similarity in ee obtained, it is probable that the active 
catalyst has the metal bound to one of imino alcohol units, the second imino 
alcohol either being redundant or complexing to a second ruthenium atom. 
Ligands 92 and 93 were active ligands in the reaction but resulted in low ee’s 
which fell off over an extended period of time. The norephedrine analogues 
gave the highest selectivity o f the catalysts screened, though it is possible that 
other chiral amino alcohols could lead to higher enantioselectivities.
An interesting aspect of these imino alcohols appeared while preparing them. 
In some cases (e.g. 92 and 93), there appeared to be a minor impurity present in 
the ^-nmr when run in CDCI3 which was inconsistent with either of the 
starting materials. The impurity was not due to any imine E/Z isomerism as 
only 1 peak could be seen for the imine proton by nmr. We believe that the 







Scheme 4.11 Formation of oxazolidine in solution
The !H-NMR peaks for the minor impurity fitted this assumption with peaks 
seen for both diastereomers of the oxazolidine (see section 6.5). However, the 
extent of this tautomerisation was dependent on the solvent used; 92 showed 
that the minor isomer accounted for ca. 15% of the total in CDCI3 while it was 
present in negligible quantities in both d3-MeCN and CD3OD.
The initial product formed is however the free imine and this was shown by the 
X-ray crystal structure of 92 (see figure 4.2). The C-N bond between C(5) and 
N(l) has a length of 1.258A, which is consistent with a C=N double bond 
(1.28A) and much shorter than a typical C-N single bond (1.47A).
Figure 4.2 Crystal structure of 92
100
It is probable that the oxazolidine formed in CDCI3 because the solvent was 
sufficiently acidic to catalyse the interconversion.
Attention next turned to the role of the arene moiety (thiophene), if any, in the 
catalyst. Though it was believed that it exerted merely steric influences, the 
possibility of a weak interaction between sulfur and ruthenium could not be 
ruled out. Thus, it was decided to investigate whether such interactions could 
be of benefit to the reaction. To this end, a small number of imine derivatives 
of norephedrine were prepared with varying aryl groups.
^
OH N ^ M e  M N ^ M e  N ^ M e  N ^ M e
H O ^ P h  H O ^ P h  H O ^ P h  H O ^ P h
95 96 97 91
Ligands 95 and 96 each had a heteroatom in close proximity to the imine 
nitrogen while 97 had no heteroatom. The transfer hydrogenation results from 
these three ligands are given in table 4.4.
Ligand % conversion % ee
95 46 77 (R)
96 7
-
97* 96 83 (R)
91 92 76 (R)
* Ligand prepared in situ - result after 2 hours o f reaction
Table 4.4 Results using after 16 hours at 20°C.
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There is a lowering in activity in cases where there is a third chelating group on 
the ligand. However, most ligands showed some degree of activity, with even 
the phenolic ligand giving a moderate conversion of 46% at room temperature 
after 16 hours. The enantioselectivities obtained in all cases were above 70%. 
The notable exception was pyrrolic ligand 96, which formed a very unreactive 
catalyst. The pyrrole NH was unlikely to complex to the metal centre, but the 
NH is rather acidic (pKa ca. 17) and so it can be deprotonated by KOH in the 
reaction medium, thus enabling complexation of the pyrrole nitrogen anion to 
the metal centre. The low reactivity is probably due to this complexation. Of 
the most active ligands, 91 and 97, there was a difference in the 
enantioselectivity o f the catalysts, with phenyl 97 giving a slightly higher ee 
than either thiophenyl 91 or phenolic 95. Therefore, the weak binding of the 
third heteroatom, if present, had no positive effect on the enantioselectivity of 
the catalyst, but had a detrimental effect on reactivity.
Attempts to increase the enantioselectivity with these ligands further, by 
lowering the temperature to as low as 0°C, had limited success. Ligand 91, at 
0°C, gave (R)-1 -phenylethanol in 84% ee but with a slow reaction resulting in 
a conversion of only 60% and that after 6 days. Ligand 97 was more active 
than 91, resulting in conversion to 1-phenylethanol of 93% within 2 hours, 
using 5 mol% Ru at 10°C, with an ee of 86.7% (R).
Though we believed that the imino alcohol was the active ligand there was a 
possibility that the imino alcohol was reduced in situ and was therefore not in 
fact the active catalyst. It is well known that the reduction of imines is possible
c*j
by transfer hydrogenation. It may be imagined that initial reduction of the
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ruthenium bound imino alcohol ligand, resulting in a Ru-amino alcohol 
complex, could serve as the active catalyst. If this occurred, then a one-pot 
reaction could occur in which the ligand, the pre-catalyst and then the catalyst 
would form in sequence. We knew that imino alcohols could be formed in 
isopropanol and that the reaction could be carried out in situ.
We wanted to investigate whether reduction, or perhaps hydrolysis of the imine 
bond was taking place. We first attempted to reduce imino alcohol 91 by 
transfer hydrogenation using catalytic ruthenium but this failed to give any 
detectable reduction products (scheme 4.12), indicating that imino alcohols are 
not readily reduced via this procedure.
O k
S ' " ! ]  OH [(p-cymene)RuCl2]2 /91 S ' ]  9 H
Ny S h   X --------------  HNY ^ p h
Me /.PrOH / KOH Me
91 99
Scheme 4.12 Attempted reduction of 91
One possible reason for this failure to reduce an p-imino alcohol is a 
deactivating effect from the hydroxy moiety on the catalyst (scheme 4.13). If 
one considers the imine bound catalytic species, the oxygen atom of the imino 
alcohol could bind to the ruthenium to form a 5-membered chelate ring 
effectively poisoning the catalyst by blocking all available ruthenium d-orbitals 
necessary for catalysis.
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Attempts were then made to investigate whether the imino function was 
reduced while complexed to stoichiometric ruthenium. [(p-Cymene)RuCl2 ] 2  








The reaction resulted in the formation of a complex with loss of the imine CH 
resonance peak in the NMR. There was no peak seen for the formation of 
hydrolysis products. Under the normal transfer hydrogenation conditions the 
same pattern was observed, with the imine peak being lost.
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When the identical reaction was run in CDCI3 the imine peak was not lost 
indicating that, in isopropanol at least, reduction of the imine bond may be 
occurring.
Thus we decided to investigate amino alcohol ligands in transfer hydrogenation 
and a number o f analogues were prepared and tested. This matter is discussed 
in the next chapter.
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CHAPTER 5
AMINO ALCOHOL LIGANDS IN TRANSFER 
HYDROGENATION
106
5.1 DEVELOPMENT OF AN AMINO ALCOHOL LIGAND 
LIBRARY
The most successful of the imino alcohol ligands tested were 91 and 97. The 
corresponding amino alcohol analogues of these (98 & 99) were prepared, in 







These ligands were also active in the ruthenium catalysed transfer 
hydrogenation reaction at 40°C, but the enantioselectivities were greater than 
those from the corresponding imines (see table 5.1).
Enantioselectivities were increased substantially on lowering the reaction 
temperature from 40°C to 28°C, much more so than with the imino alcohols. 
The ee’s from both the imino and amino alcohol ligands were higher than 
comparable ee’s from (1/?, 2S)-norephedrine.
O
[(p-cymene)RuCI2]2
r f ^ V ^ M e  -------------------------------------------- *
H I KOH, /-PrOH
40°C
R Ligand Temp / °C % Conv. % ee (config.)
$ - N v S 91 40 96 65 (R)
20 92 7 6(1?)
n ' H s
99 40 97 83 (R)
28 96 93 (R)
97 40 93 80 (R)
20 96 83(H)
e H
98 40 93 79 (R)




z"1 norephedrine 40 96 58 (R)
Table 5.1
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5.2 MECHANISTIC CONSIDERATIONS & RATIONALE FOR
OBSERVED ENANTIOSELECTIVITY
5.2.1 Transfer hydrogenation mechanism using amino alcohol ligands
Recently there has been some debate over the exact mechanism of the
C O
ruthenium catalysed reaction when using amino alcohol ligands. Noyori and 
Andersson59 have, as a result of modelling calculations, suggested that the 
lowest energy pathway involves a mechanism in which no metal alkoxide is 
formed. Instead, the hydride and proton are transferred in a concerted manner 
via a 6-membered cyclic transition state (TS) I (figure 5.1). This differs from 




The modelling calculations indicate that TS I has a lower activation energy 
than II (12.9kcal/mol vs. 20.1kcal/mol). Andersson suggested that in the 
alkoxide TS mechanism the aryl group hapticity changes during the reaction 
from T|6 to Tj2 (rather than to the expected rj4) to accommodate the increase in 
coordination number. This change in hapticity is energetically unfavourable 
and results in the higher energy barrier of this pathway. Bearing this in mind, it 
is reasonable to assume that the reaction may proceed via TS I with the 
mechanism shown in scheme 5.2. The mechanism involves the formation of 
the 16e‘ catalytic species A which accepts hydrogen from isopropanol via TS I 
to give the Ru-H species B. This in turn transfers hydrogen to the ketone 
substrate, via TS I’, to regenerate A and release the alcohol product.
This suggested mechanism is rather unique in transition metal mediated 
homogenous catalysis. In most catalytic reactions the ligand’s function is to 
modify the electronic and steric properties of the metal. The catalysis usually 
involves initial complexation of the reagent (e.g. ketone) to the metal centre. 
The bond forming and breaking reactions then occur while the substrate 
remains complexed to the metal. The mechanism here however, exhibits metal- 
ligand bifunctional catalysis, in which both the metal and the ligand are 
actively involved in the reaction. As a consequence, the choice of ligand is 









It is thought that the complexation of the chiral amino alcohol ligand to the 
metal results in the formation of a single diastereomer of Ru-H. A preference 
has also been noted for the a-conformation in which the carbinol carbon is 
below the plane of the ring and so is closer to the hydride (see figure 5.2) than 
in the P-conformation (carbinol carbon above plane of the ring and on the 
opposite face to hydride).
Figure 5.2 Ruthenium hydride complex in the a-conformation
In the transition state the calculations show that the over-riding determinant of 
the preferred conformation is not the orientation of the carbinol carbon, but 
rather the H-N-Ru-H dihedral angle ( 0 d ) .  The TS prefers this 1,4-dipole to be 
near planar, with a dihedral angle approaching zero. The conformation of the 
complexed ligand in the transition state can therefore change from that of the 
Ru-H intermediate to allow for increased planarity. With ethanolamine 
however, Andersson found that the Ru-H TS also adopts the a-conformation to 
reduce the dihedral angle to -10° (figure 5.3).
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a-conformation (favoured) P-conformation (disfavoured)
(H-Ru-N-H)-  -1 0 °  (H-Ru-N-H)-  "2 3 °
• = H
Figure 5.3 Calculated transition state for an ethanolamine-Ru-H complex 
5.2.2 Enantioselectivity
Though many chiral ligands have been developed for the reaction there is still 
no completely satisfactory rationale for the observed enantio-induction in pro- 
chiral ketones such as acetophenone. The problem is that the observed chiral 
induction does not fit with any steric repulsion argument between substituents 
on the chiral ligand and those on the substrate. Instead, it is argued that chiral 
induction is caused by the geometry of the fully assembled 5-membered metal 
chelate ring and that this is governed by the structure of the chiral ligand. The 
chirality transfer may then be aided by a CH-tc interaction between the arene 
ligand on the Ru complex and the aromatic group on the hydrogenation 
substrate (e.g. phenyl group on acetophenone).
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5.3 LIGAND OPTIMISATION
5.3.1 Rationale for observed selectivity
In the course of this investigation, we discovered a very effective amino 
alcohol ligand scaffold. iV-Benzyl substituted norephedrine 98 had, in 
conjunction with a Ru(II) complex, resulted in a highly reactive and selective 
catalyst capable of giving (R)-1 -phenylethanol in 91% ee at 28°C.
We believe that the Ru hydride complex with W-benzyl-(lR,25)-norephedrine 
forms exclusively the (S)-a 5-membered ring diastereomer II (see scheme 5.3). 
This diastereomer would be expected to have an a-conformation because this 
allows the phenyl group on the carbinol carbon to orient itself in an equatorial 
position. The smaller jryn-methyl group on the carbon adjacent to the nitrogen 
must then occupy an axial position to minimise repulsive steric interactions 
with the equatorial phenyl group. We believe that the methyl group plays a 
major part in ensuring the diastereoselectivity of the formation of ruthenium 
hydride. Approach of isopropanol from the upper face of I is prohibited by 
steric crowding against the methyl (and, to a lesser extent, the phenyl) group 
which points upwards. The less crowded lower face is therefore much preferred 
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Scheme 5.3 Rationale for the exclusive formation of (5)-a-98-Ru-H
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In the ruthenium hydride II, the axial methyl group also forces the iV-alkyl 
group equatorial which in turn forces the NH proton to become axial and the 
N-H bond to point into the same plane as the Ru-H, thus minimising the H-Ru- 
N-H dihedral angle in TS’.
These factors give ruthenium hydride II a favourable geometry for the 
complexation of a ketone. The TS’ (scheme 5.3) leads to formation o f (R)-1- 
phenylethanol. We believe this enantioselectivity may be partly due to a 1,3- 
interaction between the axial proton on the carbinol carbon and the substituents 
of the incoming ketone. The lowest energy transition state TS’ has 
acetophenone exposing its pro-R face to the metal hydride, so that the smaller 
methyl substituent of the ketone points toward the carbinol proton. The pro-5 
alignment would push the larger phenyl group toward the proton increasing the 
energy of TS” . The selectivity may also be due to favourable interactions 
between the phenyl group of the substrate and the aryl group on the metal, as 
well as to the benzyl group, but these are discussed later.
5.3.2 The importance of the jV-benzyl moiety
We wanted to investigate whether the enhancement in selectivity of iV-benzyl 
norephedrine (98) over norephedrine was due to the specific properties of the 
iV-benzyl group or whether the introduction of any group with some degree of 
steric bulk on the amine terminus would result in a similar degree of 
enantioselectivity.
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We prepared Af-trityl-norephedrine (100) and screened both this ligand and 
(17?,25)-(-)-ephedrine (101) in the transfer hydrogenation of acetophenone at 






P h ^ O H
M e ^ N - R
H
[Ru] :Ligand:KOH 
1 : 100 : 5
R Ligand % conversion % ee (config.) Time / hours
C U
98 95 91 W 2
99 92 92 (R) 3
-CPh3 100 95 si m 1
-Me 1016U 96 88 (R) 1
Table 5.2
The enantioselectivities obtained from N-trityl 100 and 7V-methyl 101 were 
lower than those obtained for N-benzyl 98 and A^-methylthiophenyl 99. The 
results indicated that the choice of R group on the amine terminus was 
important in optimising the enantioselectivity of the catalyst but that simply 
increasing the size of this group was not a clear determinant of 
enantioselectivity.
Having found that //-benzyl norephedrine ligands were more effective than 
their methyl or trityl analogues, we wanted to investigate what effect, if any, 
alteration of its steric properties would have on the selectivity of the catalyst. 
Thus, further derivatives were prepared (scheme 5.4).








In 102 and 103 the size of the flat phenyl group is increased to a more bulky 
orr/w-substituted benzene. With 104, the phenyl ring was converted to a 
cyclohexyl unit which is no longer flat. The ligands would also have slightly 
different electronic properties, having a small effect on the basicity of the 
amine. These three ligands were tested in the transfer hydrogenation of 
acetophenone. The results, summarised in table 5.3, show a fall in the ee’s 
obtained from both 102 and 103 when compared to N-benzyl norephedrine 98, 
while N-cyclohexylmethyl 104 gave similar selectivities but with a slower 
reaction. Though 2-bromophenyl 102 still delivered a reasonably high 
conversion with an ee of 88% (R), the reaction was much slower than with 98. 
2,6-Dichlorophenyl 103 displayed much reduced activity, with the reactions 






Me N -R  
H
[Ru] :Ligand:KOH 
1 : 100 : 5
R group Ligand % conversion %  ee (config.) Time / hrs
2-Br-Ph-CH2- 102 83 88 (R) 18
2,6-Cl2-Ph-CH2- 103 23 23 (R) 19
cyclohexyl-CH2- 104 94 93 (R) 16
Ph-CH2- 98 95 91 (R) 2
Table 5.3
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We believe that these observations are largely due to increased steric crowding 









Scheme 5.5 Possible reasoning for poor activity of ligand 103
It is believed that the catalytic cycle involves the formation of a ruthenium 
hydride I. Transition state II would experience significant steric repulsion 
between the o/T/zo-chlorine atoms of the benzyl group and the reacting ketone. 
This would cause its formation to be less favourable than the corresponding 
intermediate with 98 (R=PhCH2 ) making this catalyst less reactive. 
jV-Cyclohexylmethyl derivative 104 provides a larger group than ZV-benzyl 98, 
but it has less potential for steric crowding than 2,6-dichlorophenyl 103 due to 
the absence of or/Zzo-substituents pointing into the reaction pocket. While the 
observed effects are most likely due to steric factors, the introduction of a 
cyclohexyl group would also make the NH slightly more electron rich, 
potentially having an electronic effect on catalyst activity (whereas 102 and 
103 are relatively electron withdrawing). The initial results from 104 were 
encouraging, with the ligand achieving both a high conversion and
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enantioselectivity at 28°C. The reaction was somewhat slower than the 
corresponding reaction with the iV-benzyl ligand 98.
5.3.3 Electronic effects of the nitrogen R-group
Though we believe that the lower catalytic activity of ligands 102 & 103 in 
comparison to 98 is predominantly due to the steric factors described above, an 
electronic effect could not be ruled out as a contributing cause of lower 
reactivity. It is notable that the least reactive analogue (103) is also that with 
the most electron withdrawing substituent on the amine terminus and that, 
conversely 98, the most active ligand, has a relatively electron donating R- 
group. The explanation solely in terms of steric crowding also seems 
inconsistent with the N-trityl analogue 100 which was more reactive than N- 
benzyl 98 even though it has a larger R-group (though lacking ortho- 
substituents). To the best of our knowledge, no study has discussed the 
electronic effects of amine substituents on amino alcohol catalysts. To 
investigate whether electron withdrawing groups might in fact reduce catalyst 
reactivity we prepared Af-tosyl (105) and N-Boc (106) norephedrine. Both 
groups are electron withdrawing, with large Hammett a-coefficients.
105 106
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These ligands were then tested in the ruthenium catalysed transfer 
hydrogenation of acetophenone, at 40°C, in which neither gave any significant 
conversion. These results indicate that electronic properties of the amine 
substituent may play an important role in determining the activity of the 
catalyst. This observed effect might be due to the resulting change to the 
polarisation of the Ru-N bond with changing electronic properties of the R- 
group. The Ru-N 16-electron complex relies on a high degree of bond 
polarisation with a substantial fractional charge on the nitrogen, to initiate the 
dehydrogenation of isopropanol. With electron withdrawing R-groups, such as 
tosyl or Boc, the polarisation of this bond is somewhat decreased with a 
concomitant reduction in dehydrogenative activity. This results in slower or 
negligible formation of the Ru-H catalyst and hence slower reaction rates.
5.3.4 Effect of lowering reaction temperature
The effect of lowering reaction temperature on the selectivity of these catalysts 
in the reduction of acetophenone was investigated and the results are shown in 
table 5.4.
The thiophene ligand 99 showed a noticeable increase in ee from 82% to 93% 
on reducing the reaction temperature from 40°C to 28°C. However, the ee did 
not increase any further upon reducing the temperature to 10°C. The reactivity 
dropped substantially at this temperature with the reaction achieving a 
conversion of only 32% using 5 mol% Ru.
122
Ligand
P h ^O H
Ligand =
M e^ N -R
H
R Ligand 10°C 28°C 40°C
% conv % ee % conv % ee % conv % ee
O u
98 82 93 95 91 93 79
C H .
99 32 93 92 92 97 83
C o *
104 87 95 94 93 n.d.
Table 5.4 Results from transfer hydrogenation of acetophenone with 
varying temperature
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The pattern was similar with iV-benzyl ligand 98 where the reduction in 
temperature caused a noticeable increase in selectivity but a concomitant 
decrease in activity. However, the catalyst was still active at 10°C, with the 
reaction going to 82% conversion within 4 hours. The ee’s increased from 83% 
at 40°C to 94% at 10°C. This reactivity pattern mirrors that of the imino 
alcohol ligands where the presence of the thiophenyl moiety led to a decrease 
in activity compared to phenyl. This gives further evidence that the sulphur 
atom of the thiophene may be interacting with the Ru centre, having a 
detrimental effect on activity. However, this interaction is probably a weak one 
and hence the catalyst remains active. The results also show that there is no 
overall gain in selectivity in having a thiophenyl moiety on the ligand with 
both ligands 98 and 99 giving near identical selectivities.
Ligand 104 again showed only a slight increase in selectivity (94 to 95% ee) 
upon reducing the temperature from 28°C to 10°C but the selectivities with this 
ligand were slightly higher than with the other two analogues.
It therefore seemed that reactions run at 28°C provided an optimal balance 
between activity and enantioselectivity.
5.4 ATTEMPTED OPTIMISATION OF THE AMINO ALCOHOL 
BACKBONE
The most effective ligands prepared had all been based around (1R,2*S)- 
norephedrine. To investigate whether ligands based around (l£,2R)(+)-2- 
amino-l,2-diphenylethanol, a ligand with a complementary geometry, could
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provide higher selectivities than N-benzyl norephedrine ligands, we prepared 
107 and 108. However, when tested in the transfer hydrogenation of 
acetophenone at 40°C, neither ligand gave any significant conversion. This 
observation was consistent with previous findings showing that this ligand 
backbone was ineffective53.
We believe that analogues of (15',2/?)(+)-2-amino-l,2-diphenylethanol cannot 
form active catalysts because of the requirement for an axial phenyl group (see 
figure 5.5). This requirement would probably make the 5-membered 
metallocycle highly unstable and may even prohibit its formation. Even if the 
Ru-H complex were to form, there may be significant steric repulsions between 




Figure 5.5 Proposed rationale for failure of ligand 107
125
We then wished to investigate whether a 1,2-anti-p-amino alcohol ligand might 
be more effective in the reaction. An attempt was made to convert (\R,2S)~ 
norephedrine to (lS,25)-norephedrine by treatment with HC1, using a 
procedure developed by Fodor et al.6\  but the attempt was unsuccessful with 
the product obtained not being enantiomerically pure.
We therefore prepared (l^,2/?)(+)-2-amino-l,2-diphenylethanol (110), a ligand 
known to be effective53, using the procedure given in scheme 5.6.
Cl
c s * °i
Ph/, .OH HCONH2 Ph/,.^OH 1)SOCI2 P h /,.^ 0
Ph'' N H ®  84% P h " ^ N - f  ^  Ph'' N—^
0  H H H H
109
S‘N
Ph/, TCIP h ^ O H  2) Ice PhV ° \
92%
NH- Dh''' M Pit'' NPh NH2 PhN' N
110
Scheme 5.6
9The key step in the synthesis, developed by Weijlard et al. , is the inversion of 
the alcohol group of A-formyl-2-amino-1,2-diphenylethanol (109) using 
thionyl chloride. The reaction mechanism, shown in scheme 5.6, proceeds via 
formation of an oxazoline intermediate which is then hydrolysed to give 110.
+ S 0 2
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The product was obtained in high overall yield and possessed an optical 
rotation in line with the literature value.
Ligand 111 was prepared by reductive amination of cyclohexane 





The ligand was moderately active in the reduction of acetophenone, the 
reaction going to 92% conversion within 20 hours at 28°C, but the 
enantioselectivity was lower than that obtained with 104 at only 76% ee (R). 
We believe that this lower enantioselectivity may be caused by the 111-(p- 
cymene)Ru intermediate (see scheme 5.8). Unlike Af-cyclohexylmethyl 
norephedrine 104, which has a methyl group pointing axially up from the plane 
of the ring, ligand 111 only possesses an axial proton. Furthermore, its 
equatorial phenyl group on the amino carbon may partially obstruct the lower 
face. This reduces the difference in steric crowding between the two ring faces 
of the 16e' intermediate. Therefore hydrogen delivery from isopropanol may 
occur on either the upper or lower face. The minor (i^-diastereomer may be 
selective for the pro-5 face of acetophenone, so making the reaction less 
enantioselective. However, the (ft)-Ru-diastereomer is probably less active
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than the (Sj-diastereomer, due to its higher H-N-Ru-H dihedral angle and so 
the majority of the reaction probably goes through the (S)-Ru-diastereomer.
Proton is less effective than methyl at 
blocking /-PrOH approach from top face
\
Methyl blocks approach of /-PrOH from top face
16e‘ catalytic 
















Scheme 5.8 Proposed rationale for lower selectivity of ligand 111 compared 
to 104
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We then investigated what effect the substitution pattern of the amino alcohol 
backbone has on the selectivity of these N-benzyl amino alcohol catalysts. We 
wished to see whether a substituent on the carbinol carbon would have a larger 
effect on enantioselectivity than a substituent on the amino carbon. This in turn 
could provide further information as to the nature of the catalyst structure as 
well as an insight into where ligand improvements could be made. To 
investigate this we prepared ligands 112 and 113 (schemes 5.9 & 5.10).
Ph OH
P h - ^ p  +








Ligand 112 was prepared by opening (7?)-(+)-styrene oxide with benzylamine 
while 113 was prepared in two steps by formation of the imine with subsequent 
reduction using sodium borohydride. The ligands were then tested in the 
transfer hydrogenation of acetophenone and the results are summarised in table 
5.5.
Structure Ligand % Conversion %  ee (config.) Time (hrs)
P h ^ O H
N ^Ph 
H
112 96 76% (R) 2
^O H
P h '" '^ N ^ P h
H
113 86 24% (R) 20
P h ^ O H  
Pit' N—v.
" b
111 92 16% (R) 20
P h -^ O H  
Ph" NH2
110 96 33% (.R) 2
Ph/, .OH
P tr " N - M e
H
114 975J 59% (S) 1
Table 5.5 Results from transfer hydrogenation of acetophenone using 
[Ru(p-cymene)Cl2 ] 2  at 28°C
Both ligands 112 and 113 proved active in the reaction but differed in their 
selectivities. Ligand 112 provided (7?)-l-phenylethanol in substantially higher 
enantiomeric purity than 113, suggesting that the substituent on the carbinol 
carbon of the amino alcohol is more effective in controlling enantioselectivity 
than the substituent on the amine carbon. Notably 111, which has a phenyl 
group on both positions, delivers an ee of 76% (R) that is identical to that
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obtained from 112 (substituent only on carbinol carbon), but the reaction is 
much slower. This indicates that the equatorial substituent on the amine carbon 
hinders the approach of the substrates somewhat.
Ligand 112 showed a marked fall off in ee over time, with the ee falling to 
50% (R) after 22 hours of reaction. Though the amine carbon substituent does 
not have a large effect on the selectivity of the catalyst, it does slow the transfer 
hydrogenation reaction down. As a consequence of microscopic reversibility 
the more active a catalyst is in the reduction direction, the faster it is in the 
reverse process. Further, if the catalyst predominantly gives the (^)-alcohol 
then the reverse process with that same catalyst will selectively dehydrogenate 
the (^)-alcohol back to the ketone faster than the (5)-alcohol. What should be 
remembered when designing a catalyst for transfer hydrogenation of ketones 
under these conditions is that the reaction is effectively a kinetic resolution 





Since the reactants (isopropanol and ketone) are so similar to the products 
(acetone and secondary alcohol) the transfer hydrogenation reaction is 
reversible. However, the products are separated long before the competing 
reversible reactions (ki and ki) have time to reach equilibrium. But if  the 
favoured branch (ki) equilibrates rapidly, then there will always be a low 
concentration of ketone present that can be slowly bled off into the undesired 
enantiomer over elongated time frames.
If the activation energy of the forward reaction is increased (i.e. the reaction is 
slowed down) this would also slow the rate of back reaction (k2). So a catalyst 
could be found where the rate of the forward reaction was still fast enough to 
be practical, but the back reaction was sufficiently slow so as to allow 
elongated reaction times without significant loss of ee. The A-benzyl 
norephedrine catalysts developed within this project exhibit this optimal 
property (see section 5.6).
These results also showed the iV-benzyl group playing a significant role in the 
catalyst’s ability to differentiate between the opposing pro-chiral faces o f the 
ketone. Amino alcohol ligands without a substituent on nitrogen lead to poor 
enantioselectivities. However, the A-benzyl group gives even higher 
enantioselection than other groups such as methyl (c.f. table 5.5, entries for 111 
and 114) or trityl (c.f. table 5.2 entries for 98 & 100). An alkyl group at this 
position should help to increase reactivity, because its preference for an 
equatorial orientation forces the NH proton into an axial orientation (see sect. 
5.3.1). However, the increased ability of A-benzyl ligands to differentiate 
between the opposite pro-chiral faces o f acetophenone is believed to be due to
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a favourable 7i-stacking interaction between the phenyl groups of the V-benzyl 
moiety and that of the acetophenone substrate (figure 5.6). This re-enforces the 
effect of the favourable CH/7C interactions, proposed by Noyori,57 between the 
substrate and the Ru aryl ligand (e.g. /?-cymene).
Figure 5.6 Proposed favourable stacking interaction in the TS for ligand 98
With ligands 104 & 111, possessing V-cyclohexylmethyl groups, there may be 
a favourable Van der Waals ring-stacking interaction between the cyclohexyl 
ring and phenyl ring of acetophenone. In theory, the V-benzyl ligands should 





5.5 OPTIMISATION OF THE METAL COMPLEX
It has been shown that modifications to the arene group on the Ru complex can 
affect the enantioselectivity obtained from the catalyst.53 In particular, Noyori 
showed that the selectivity obtained when the aryl group is hexamethylbenzene 
is greater than when it is benzene. To investigate whether ligands 104 and 111 
could deliver higher enantioselectivities, hexamethylbenzene ruthenium 
chloride dimer was prepared by reacting [(p-cymene)RuCl2 ] 2  with excess 
hexamethylbenzene. The two ligands were then tested in the transfer 
hydrogenation of acetophenone at 28°C using 1 mol% Ru and the results are 
summarised in table 5.6.
Structure Ligand Metal % Conversion % ee (config.)
Ph^ ,OH 104 [(C6Me6)RuCl2]2 44 93 (R)
Me^ NH 104 [(p-cymene)RuCl2]2 94 93 (R)
Ph^ -OH 
PtN' N—\
111 [(C6Me6)RuCl2]2 18 84 (R)
n il'
" b
111 [(/?-cymene)RuCl2]2 92 76 m
Table 5.6 Results from the reduction of acetophenone with varying Ru- 
Aryl
The selectivities were broadly in line with or slightly above those obtained with 
[(p-cymene)RuCl2]2 , but the reactions were noticeably slower and did not go to
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completion. It is known that reactions using this Ru catalyst are slower, due to 
the effect of the increased size of the aryl group.
The results from changing [Ru(p-cymene)Cl2 ] 2  for [Ir(COD)Cl] 2  showed a 
similar pattern to that with imino alcohol ligands (table 4.2), with significantly 
lower enantioselectivities observed for the reduction of acetophenone. Table
5.7 shows the results obtained after 22 hours at 40°C using 5 mol% of Ir. 
Though active, it appears that these amino alcohol based ligands are not ideally 
suited to [Ir(COD)Cl]2 .
Structure Ligand % Conversion % ee (config.)
CC»
H’°
99 74 2 1 («)
CX.OH 
HsC K~\
98 74 26 W
P h ^ -O H  
M e ^ N H  Br
1 0 2 97 19 W
N ^ M e  
HO Ph
91 96 26 (-ft)
Me,, N N ^ M e  
Ph''' OH H O ^ P h
94 96 25 W
Table 5.7 Results from transfer hydrogenation of acetophenone at 40°C 
using [Ir(COD)Cl] 2
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5.6 INVESTIGATION OF CATALYST ACTIVITY
The relative rates of catalysis in the reduction of acetophenone using the most 
successful ligands developed during this work were investigated. The reactions 
were monitored over the course of the first hour of reaction, by removing 
aliquots at time intervals, quenching the reaction by the addition of ether and 
elution through a pad of flash silica to remove any catalyst present. The 
aliquots were then analysed by chiral GC to obtain both conversion and ee 
data. The results are summarised in table 5.8 and graphically in charts 5.1 and 
5.2. Ligand 98 was the most active of the V-benzyl ligands developed, with an 
average turnover frequency (TOF) of 126 turnovers/hour over the first 30 
minutes of reaction. This was over twice the rate observed for ligands 99 and 
111, while the V-trityl ligand (100) was the most active however with an 
average TOF of 300 turnovers/hour.
Chart 5.2 shows that the ee’s remained near constant over the reaction period. 
Interestingly, the ee’s do not fall significantly over extended periods with these 
V-benzyl ligands, with 99 for example, giving 1-phenylethanol in 92% ee after 
70 hours, the same as it was after 2 hours. This suggests a near negligible rate 
of back reaction.
The rate of reaction on reducing temperature drops quite dramatically with 
ligand 104 giving a conversion of only 35% after 1 hour at 10°C compared to a 
conversion of 72% after 1 hour at 28°C. However, the reaction does proceed 

















98 8 8 126 92
Cl ™
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5.7 TR AN SFER H YDR O G EN A TIO N  ACRO SS KETO NES
Of the ligands developed, 98, 99 and 104 delivered the highest selectivities in 
the reduction of acetophenone with [(p-cymene)RuCl2 ]2 - The generality of 
these catalysts in terms of both activity and selectivity was investigated by 
reducing a number of alternative aryl ketones to their corresponding alcohols. 
For this purpose, three other ketones were used, namely 4- 
methoxyacetophenone, 4-bromoacetophenone and 2-acetonaphthone. 4- 
Methoxyacetophenone is a relatively electron rich ketone which would 
presumably be less active than 4-bromoacetophenone, having an electron 
withdrawing substituent. 2-Acetonaphthone is sterically different from 
acetophenone and would give some indication of the generality of the 
catalyst’s selectivity. The reactions were run at 28°C using [(/?-cymene)RuCl2 ] 2  















% conv (% ee)
acetophenone 95 (91) 92 (92) 94 (93)
4-methoxyacetophenone 55 (89) n.d. 72 (87)
4-Br acetophenone >99 (8 6 ) 98 (81) 99 (8 6 )
2 -acetonaphthone 94 (78) 87 (8 6 ) 96 (87)
Table 5.9 Results from the reduction of a number of ketones
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High enantioselectivities were obtained with all the ketones investigated with 
all three ligands, though the highest ee’s were observed for the reduction of 
acetophenone.
5.8 CONCLUSIONS
During the course of this study, a number of enantiopure ligands have been 
developed for the transfer hydrogenation of pro-chiral ketones. Of these, a new 
class of amino alcohol ligand, capable of producing alcohols with very high 
enantiomeric excesses, has been found. These iV-alkylated, particularly N- 
benzyl, amino alcohols are competitive in terms of enantioselectivity with the 
best ligands currently known in literature.
We have highlighted a number of properties we believe are important to an 
amino alcohol ligand, to enable high selectivity. In particular we have shown 
the importance of the group attached to the carbinol carbon, the nitrogen bound 
group and the arene ligand. An opportunity exists to prepare ligands, which 
further explore these areas in order to obtain a more highly selective catalyst. 
The effect of changing the A-benzyl group is especially interesting. Perhaps 
such groups (e.g. -CH2-naphthyl, -CH2-anthracene) can be selected to 
maximise favourable 7i-interactions, allowing one to match a particular ligand 






In this chapter a summary of the preparative chemistry performed and the 
analytical data for the products are presented. These products are organised 
into 4 sections. Section 6.3 concerns the aryl diamine ligands prepared in 
chapter 2 via the Pd catalysed amination reaction. Section 6.4 lists the ligands 
prepared in chapter 3. Section 6.5 lists the imine ligands listed in chapter 4 
while the amino alcohols of chapter 5 are described in section 6 .6 . Section 6.7 




All NMR experiments were carried out on either the Jeol EX 270, Jeol JMX 
400MHz or Varian Gemini 400MHz machines. All chemical shifts, 6 , are 
given in parts per million (ppm) and coupling constants, J, given in Hertz.
The following abbreviations are used in the assignments of the NMR spectra;
s - singlet
d - doublet
dd - double doublet
ddd - double double doublet
dt - double triplet
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q - quartet 
m - multiplet 
br. - broad 
sex - sextet
In 13C-spectra non-CH peaks are defined as CH3 , CH2 or ipso, where data was 
available.
Mass Spectroscopy
Carried out by the University of Bath Mass Spectroscopy service using a 
Kratos MS 80 Mass Spectrometer.
IR spectroscopy
Carried out using a Perkin Elmer 1600 Fourier transform IR spectrometer. 
Optical Rotation
Obtained using an Optical Activity AA-10-automatic polarimeter 
Melting Points




Performed using Merck 60 mesh silica gel.
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Chiral HPLC
Carried out using a Thermo Separation Products-Spectraseries UV 100 
machine. Chiral columns used were manufactured by Daicel Chemical 
Industries and were either the Chiracel OD or OJ columns.
Chiral GC
Carried out using a CE Instruments HRGC 8000 series machine in conjunction 
with a Supelco P-Dex 120 column or a Restek RT-PDEXse™ column.
Materials used
Dry solvents
Dichloromethane and acetonitrile were dried over calcium hydride. 
Tetrahydrofuran was dried over sodium wire. Isopropanol was dried over 3A 
molecular sieves and degassed prior to use.
Metal complexes
Ruthenium and palladium complexes were either bought from Aldrich or 




Compound name No. Page
jV-BenzyM-bromo benzoyl anilide 37 148
iV-Benzyl-4-bromobenzenesulfanilamide 40 149
(1 R,2R)-1 -N-( 1 -Naphthyl) 1,2-diaminocyclohexane 35 150
(1 R,2R)-1 ,2-A i^V-Bis( 1 -naphthyl)-1,2-diaminocyclohexane 42 151
(IR,2R)-1 -N[4-(iV-Benzylsulfanilamido)phenyl] 1,2- 
diaminocyclohexane
41 151
(\R,2R)-1 -iV-(4-Biphenyl)-1,2-diaminocyclohexane 47 152
(1 5,25)-iV-( 1 -Naphthyl)-1,2-diphenyl-1,2-ethanediamine 48 153
(1 S,2*S)-i\^AT-Bis( 1 -naphthyl)-1,2-diphenyl-1,2-ethanediamine 44 154




(1 R,2R)~ 1 -Ar-[(2/^)-2-methoxy-2-phenyl-3,3,3- 
trifluoropropanoyl] -2 -N-( 1 -naphthyl)-1,2-diaminocyclohexane
53 157













benzylsulfanilamido)phenyl]-1 ,2 -diphenyl-1 ,2 -diaminoethane
58 162
(15,25)-JV-(2-Nitrophenyl)-1,2-diphenyl-1,2-ethanediamine 60 164
(15,25)-Af-(2,4-Dinitrophenyl)-l ,2-diphenyl-1,2-ethanediamine 61 165
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(\R,2R)~ 1 -Ar-(2-Nitrophenyl)cyclohexane-1,2-diamine 62 166
(\R,2R)~ 1 -N-(2,4-Dinitrophenyl) 1,2-diaminocyclohexane 63 167
(1 R,2R)~ 1 -N-(2-Anilino) 1,2-diaminocyclohexane 64 168
( lR,25)-2-JV-(2-Nitrophenyl)-1 -phenyl-2-aminopropanol 115 169
(li?,25)-2-Ar-(2-Anilino)-1 -phenyl-2-aminopropanol 65 170
(25)-2-Ar-(2-Nitrophenyl)-3-phenyl-2-aminopropanol 116 171
(25)-2-iV-(2-Anilino)-3-phenyl-2-aminopropanol 6 6 172
(1 5)-(2-Nitrophenoxy)-1 -Ar-(4-toluenesulfonyl)-1 - 
phenylaminoethane
117 172









(1 R,2S)-1 -(2-Nitrophenoxy)-1 -phenyl-2-AT-(4-toluenesulfonyl)- 
2 -aminopropane
119 177
















(R)-1 -7V-(5-Chloro-2,4dinitrophenyl)-1 -cyclohexyl-1 - 
aminoethane
77 183
Thiophene-2-carboxaldehyde-(R)-1 -cyclohexylethyl imine 8 6 185
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Thiophene-2,5-dicarboxaldehyde-bis[( li?,2*S)-1 -hydroxy-1 - 
phenylprop-2 -yl] imine
94 192
2-Hydroxybenzaldehyde[( 1 R,2S)-1 -hydroxy-1 -phenylprop-2- 
yl]imine
95 192
Pyrrole-2-carboxaldehyde [(1 ,^2*S)-1 -hydroxy-1 -phenylprop-2- 
yl]imine
96 193
(1/?, 2S)-Ar-Benzyl-2-amino-1 -phenylpropan-1 -ol 98 195
(\R, 25)-1 -Phenyl-2-iV-(2-thiophenylmethyl)amino propan-1 -ol 99 196
(1 R,2S)-N-T rityl-2-amino-1 -phenylpropan-1 -ol 1 0 0 197
(l/?,25)-A^-(2-Bromobenzyl)-2-amino-l-phenylpropan-l-ol 1 0 2 198
(li?,2»S)-Ar-(2,6 -Diehl orobenzyl)-2-amino-1 -phenyl propan-1 -ol 103 199
(1 i?,25)-iV-(Cyclohexylmethyl)-2-amino-1 -phenyl propan-1 -ol 104 2 0 0
( \R,2S)-N-(4-T oluenesulphonyl)-2-amino-1 -phenyl propan-1 -ol 105 2 0 1
( li?,2S)-iV-tert-Butyloxycarbonyl-2-aniino-1 -phenyl propan-1 -ol 106 2 0 1
(17?,27?)-Ar-(Cyclohexylmethyl)-2amino-1,2-diphenylethanol 1 1 1 2 0 2
(1 ^ )-iV-Benzyl-2-amino-1 -phenylethanol 1 1 2 204
(7?)-Ar-Benzyl-2-amino-2-phenylethanol 113 205
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6.3 EX PER IM ENTAL FO R C H APTER 2
A-Benzyl-4-bromo benzoyl anilide (37)
/V-Benzylaniline (149mg, 0.81mmol) was taken up in dry DCM (6 ml). To the 
solution was added 4-bromobenzoylchloride (253mg, 1.15mmol) followed by 
DMAP (99mg, 0.81mmol) and triethylamine (0.46ml, 3.3mmol) and the mixture was 
then heated at reflux for 2 hours. The crude product was purified by flash 
chromatography (ethyl acetate-light petroleum, 3:7 v/v) to give a colourless solid 
(270mg, 91%). Tic (ethyl acetate - light petroleum, 3:7 v/v) Rf 0.59; m.p. 79-80°C; 
IR (neat) vmax 1645 (s); 8 H (CDC13) 5.11 (s, 2H), 6.89 (dd, 2H, J  7.9, 1.8), 7.13 
(m, 3H), 7.20 (m,3H), 7.28 (m, 6 H); 6 c (CDC13) 53.91 (CH2), 124.15 (ipso), 
126.97, 127.47, 127.71, 128.46, 128.49, 129.21, 130.47, 130.96, 134.85 
(ipso), 137.28 (ipso), 143.19 (ipso), 169.29 (ipso); HRMS (El) Found m/z 
365.0410 (calcd for BrC2oH16NO (M+) 365.0415); Anal. Calcd for BrC2 0Hi6NO: C, 




TV-Phenylbenzylamine (150mg, 0.82mmol) and 4-bromobenzene sulphonyl chloride 
(296mg, 1.16mmol) were taken up in dry DCM (7ml). To the solution were added 
triethylamine (0.76ml) then DMAP (98mg, 0.8mmol) and the reaction carried out as 
in 36 to give, after purification by flash column chromatography (DCM eluent), a 
colourless crystalline powder (40, 325mg, 99%). Tic (ethyl acetate - light petroleum, 
1:9 v/v) R{ 0.46; M.p. 177-178°C; IR (KBr) 1571 (m), 1346 (s), 1158 (s);
8h (CDC13) 4.73 (s, 2H), 6.97 (m, 2H), 7.22 (m, 8 H), 7.50 (d, 2H, J  8 .6 ), 7.62 
(d, 2H, J  8 .8 ); 6 c (CDC13) 54.89 (CH2), 127.73, 128.08, 128.39, 128.52,
128.92, 129.01, 129.16, 132.16, 138.54 (ipso), 137.63 (ipso), 135.54 (ipso); 
HRMS (El) m/z 401.0076 (calcd for BrC,9Hi6N02S (M+) 401.0085); Anal. Calcd 
for BrCi9Hi6N 0 2S: C, 56.70; H, 4.00; N, 3.48. Found C, 56.30; H, 4.00; N, 
3.52.
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(l/? ,2/?)-l-/V -(l-N aphthyl)l,2-d iam inocyclohexane (35)
To an oven dried Schlenk tube was added (l/?,2/?)-(-)-l,2-diaminocyclohexane 
(288mg, 2.5mmol), Pd(DBA) 2  (29.4mg, 0.05mmol), BINAP (63mg, 0.1 mmol) and 
NaCft-Bu (588mg, 4.04mmol). The solids were taken up in dry THF (4ml) and to the 
solution was added 1-bromonaphthalene (292pl, 2.1 mmol). The tube was sealed and 
the reaction heated at 80°C for 20 hours. The reaction was then diluted with Et2 0 , 
dried over Na2 SC>4 and filtered through celite. Purification by flash silica column 
chromatography (gradient elution, 100% DCM up to methanol - DCM, 25:75, v/v) 
gave the product after drying in vacuo as an off white solid (120mg, 24%).
Tic (methanol-DCM, 2:8 v/v) Rf 0.28; m.p. 101-103°C (decomp); IR (DCM) vmaz 
3352,3304; 8 H (CDC13) 1.04 (m, 1H), 1.31 (m, 3H), 1.74 (d, 2H, J  6.9), 2.01 
(dd, 1H, J  3.1, 5.9), 2.26 (dd, 1H, J  10.2, 3.1), 2.35 (br s, 2H, NH2), 2.61 (br. s, 
1H) 3.21 (dt, 1H, J  10.2, 3.4), 4.20 (br. s, 1H, NH), 6.73 (d, 1H, J  7.8), 7.23 (d, 
1H, 7 8.2), 7.32 (t, 1H, 78.0), 7.45 (m, 2H), 7.78 (dd, 1H, J  8.2, 1.8), 7.89 (dd, 
1H, J  8.4, 2.0); 8 c (CDC13) 23.93 (CH2), 24.77 (CH2), 30.40 (CH2), 31.06
(CH2), 54.10 (CH), 55.33 (CH), 106.17, 117.78, 121.64, 123.91 (ipso),
124.68, 125.94, 126.87, 128.46, 134.41 (ipso), 141.96 (ipso); HRMS (El) m/z 
240.1622 (calcd for Ci6 H2oN2 240.1626).
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(l/? ,2^)-l,2-A yV -B is(l-naphthyl)-l,2-d iam inocyclohexane (42)
By-product obtained as a colourless powder. IR (KBr) vmaz 3408 (br); 8 h (CDCI3) 
1.37 (m, 2H), 1.52 (m, 2H), 1. 8 6  (m, 2H), 2.56 (dd, 2H, J  2.4, 11.3), 3.63 (m, 
2H), 4.73 (br s, 2H, NH2 ), 6.80 (d, 2H, J  7.4) 7.27 (m, 4H), 7.38 (m, 4H), 7.65 
(d, 2H, J  8 .6 ), 7.76 (dd, 2H, J  0.8, 8.2); 5c (CDCI3) 24.68 (CH2), 31.60 (CH2), 
57.95, 120.28, 124.27 (ipso), 124.97, 125.72, 126.05, 128.38, 134.25 (ipso); 
HRMS (FAB) m/z 367.2170 (calcd for C2 6H2 7N2 (MH+) 367.2174).
(l/?,2/?)-l-Ar[4-(ALBenzylsulfanilamido)phenyl]l,2-diaminocyclohexane (41)
Ph
To a dry Schlenk tube under argon was added Pd(DBA) 2 (17.9mg, 0.028mmol), 
BINAP (29mg, 0.046mmol) and Cs2 C0 3  ( 324mg, 0.99mmol). These were taken up 
in dry THF (4ml) and to the solution was added 40 (250mg, 0.62mmol) and
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(li?,2/?)(-)-l,2-diaminocyclohexane (41, 99mg, 0.87mmol). The reaction was carried 
out as in 48 to yield a colourless solid (109mg, 40%). Tic (methanol - DCM, 2:8 
v/v) Rf 0.25; [a ] D 2 0  -34.4 (c 0.32, DCM); IR (DCM) vmax 3369, 3253, 3254, 1596, 
1340,1151; 8h (CDC13) 1.14 (t, 1H, J  11.4), 1.29(m,3H), 1.76(m,2H), 2.05 
(br. m,4H), 2.60 (dt, 1H, J 6.1, 9.5), 3.09 (m ,lH ), 4.25 (d, 1H, 8.3, NH), 4.69 
(s, 2H), 6.61 (d, 2H, 8.3), 7.03 (ddd, 2H, J  2.6, 5.1, 7.5), 7.19 (m, 8 H), 7.40 (d, 
2H, J  8.3); 8c(CDC13) 25.04, 25.25, 32.36, 35.19, 54.71, 56.01, 59.24, 
112.39, 125.34 (ipso), 127.68, 127.79, 128.54, 128.74, 128.98, 129.21,
130.09, 136.55 (ipso), 139.75 (ipso), 151.93 (ipso); HRMS (El) m/z 435.1981 
(calcd for C25H29N30 2S (M+) 435.1980).
(lfl,2/?)-l-N-(4-biphenyl)-l,2-diaminocyclohexane (47)
To a dry Schlenk tube under argon was added Pd(DBA) 2 (29.4mg, 0.051mmol), 
BINAP (64mg, O.lOmmol) and NaO/-Bu (148mg, 1.54mmol). These were taken up 
in dry THF (1ml) and to this solution was added 4-bromobiphenyl (200mg, 
0.86mmol) and (l/?,2R)(-)-l,2-diaminocyclohexane (133mg, 0.99mmol). The 
reaction was carried out as in 35 to yield a pale yellow oil (119mg, 52%).
Tic (methanol-DCM, 3:7 v/v) Rf0.50; [a ] D 3 0 -26.9 (c 0.26, DCM); IR(DCM)vmax 
3372.6; 5H (CDC13) 0.96 (dd, 1H, J  12.2, 11.7), 1.27 (m, 4H), 1.7 (m, 2H),
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2.03 (d, 1H, 79.5), 2.13 (d, 1 H ,/ 13.1), 2.48 (m, 1H), 3.02 (br s, 3H), 3.13 (dt, 
1H, J  10.3, 3.6), 6.76 (d, 2H, J  8 .6 ), 7.25 (m, 1H), 7.37 (t, 2H, J7.6), 7.43 (d, 
2 H, J  8.5), 7.51 ( d ,2 H , /7.3); 5C (CDC13) 24.73 (CH2), 24.97 (CH2), 32.07 
(CH2), 33.90 (CH2), 55.66, 58.66, 113.85, 126.07, 126.16, 127.95, 128.63,
130.36 (ipso), 140.99 (ipso), 147.23 (ipso); HRMS (FAB) m/z 267.1857 (calcd 




To an oven dried pressure tube cooled under argon was added PdDBA2 (16.5mg, 
0.0029mmol), BINAP (35.4mg, 0.0057mmol), and NaCh-Bu (89mg, 0.92mmol). 
These were taken up in dry THF (2ml) and to the suspension was added 1- 
bromonaphthalene (80pl, 0.58mmol) followed by ( l iS,25)(-)-l,2-
diphenylethylenediamine (146mg, 0.69mmol) after which the tube was sealed under 
argon. The mixture was stirred at 80°C for 6  hours, after which time tic showed that 
the reaction was complete. The reaction mixture was taken up in Et20  (7ml) and the 
solids removed by filtration through Celite. The crude mixture was purified by flash 
silica column chromatography (w-hexane - EtOAc, 7:3 v/v) to afford a pale yellow 
oil (122mg, 62%). Tic (methanol - DCM, 1:9 v/v) Rf 0.53; IR (thin film) vmax 3379
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(br,NH2), 1581, 1524, 1477, 1409; 8 H (CDC13) 1.79 (br. s, 2H, NH2 ), 4.40 (d, 
1H, 7  4.3), 4.63 (d, 1H, 7  4.3), 6.15 (dd, 1H, 7  6.2, 2.3), 6.18 (br. s, 1H, NH),
7.07 (m,2H), 7.21 (m,2H), 7.26 (d, 2H, 7  8 .6 ), 7.29 (d, 2H, 7  7.0), 7.33 (d, 2H, 
7  7.0), 7.42 (m, 2H), 7.47, (dd, 1H, 7 8.2, 1.6 ), 7.49 (dd, 1H, 7 8.2, 1.6 ), 7.74 
(dd, 1H,78.0, 1.0), 8.06 (d, 1H,78.2);
8c (CDCI3) 61.48, 63.10, 105.56, 116.51, 120.12, 123.47 (ipso), 124.45,
125.44, 126.40, 126.68, 126.75, 127.15, 127.38, 128.31, 128.44, 134.11 
(ipso), 141.08 (ipso), 142.10 (ipso), 142.64 (ipso); HRMS (El) m/z 338.1781 
(calcd for C2 4H22N2 (M+) 338.1783); Anal. Calcd for C2 4 H22N2 : C, 85.17; H, 6.55; 




By-product obtained as a colourless solid.
Tic (ethyl acetate - light petroleum, 2:8 v/v) Rf 0.54; 8 h (CDCI3) 4.94 (s, 2H), 
5.40 (br. s, 2H), 6.38 (dd, 2 H ,J 7.4, 7.8), 7.15 (m,2H), 7.21 (d, 2H, 77.0), 7.26 
(m, 6 H), 7.34 (m,4H), 7.44 (m, 4H), 7.78 (dd, 2H, 76.3, 7.0), 7.89 (dd, 2H, 7 
6 .6 , 7.0); HRMS (FAB) m/z 465.2332 (calcd for C34H29N2 (MH+) 465.2331).
154
(lS ,2S)-l-7V -[4-{A f-Benzylsulfanilam ido)phenyl]-l,2-diphenyl-l,2-diam inoethane
(50)
To a dry Schlenk tube under argon was added Pd(DBA) 2 (16.2mg, 0.028mmol), 
BINAP (33.8mg, 0.054mmol) and NaCh-Bu ( 82mg, 0.85mmol). These were taken 
up in dry THF (3ml) and to the solution was added A-benzyl-4- 
bromobenzenesulfanilamide (40) (200mg, 0.5mmol) and (15',2*S)(-)-l,2-
diphenylethylenediamine (129mg, 0.61 mmol). The reaction was carried out as in 48 
(see above) to yield a colourless powder (50, 224mg, 84%). Tic (methanol - DCM, 
1:9 v/v) Rf 0.53; [a ] D 2 0 =+5.4 (c 5.0, DCM); IR (DCM) vmax 3368 (br), 1512, 1343 
(s); 5h (CDC13) 1.48(br. s , 2 H,NH 2 ), 4.35 (d, 1H, 7  3.8), 4.51 (dd, 1 H, 7  6 .1 ,
4.0), 4.60 (s, 2H, CH2 ), 5.89 (d, 1H, 76.1, NH), 6.38 (d, 2H, 7 8 .8 ), 6.95 (dd, 
2H, 77.0, 2.7), 7.12 (m,4H), 7.16 (m,4H), 7.24 (d, 2H, 7 7.2), 7.25 (d, 2H, 7
9.0), 7.33 (m ,8 H); 6 C (CDC13) 54.28 (CH2), 60.75, 62.68, 112.39, 124.83
(ipso), 126.59, 126.66, 127.26, 127.32, 127.55, 128.13, 128.36, 128.44,
128.54, 128.72, 128.83, 129.43, 136.24 (ipso), 139.42 (ipso), 140.36 (ipso), 
142.44 (ipso), 150.86 (ipso); HRMS (FAB) m/z 534.2212 (calcd for C3 3 H32N3 0 2S 
(MH+) 534.2216); Anal. Calcd for C3 3 H3 iN3 0 2 S: C, 74.27; H, 5.85; N, 7.87. 
Found C, 74.10; H, 5.90; N, 7.69.
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( l^ S V A ^ -B ip h e n y O -l^ -d ip h e n y l- lj l-e th a n e d ia m in e  (49)
NH
To a dry Schlenk tube under argon was added Pd(DBA) 2  (7.8mg, 0.014mmol), 
BINAP (17.4mg, 0.028mmol) and NaCh-Bu (59mg, 0.61 mmol). These were taken up 
in dry THF (1ml) and to the solution was added 4-bromobiphenyl (80mg, 0.34mmol) 
and (lS,2S)(-)-l,2-diphenylethylenediamine (101 mg, 0.48mmol). The reaction was 
carried out as in 48 to give a pale yellow oil (50mg, 40%). Tic (methanol - DCM, 
1:9 v/v) Rf 0.50; [a ] D 25 -19 (c 1.0, DCM); IR (DCM) 3372 (m); 8 H (CDC13)
1.55 (br. s, 2H, NH2 ), 4.26 (d, 1H, J  4.4), 4.43 (d, 1H, J  4.6), 5.21 (br. s, 1H,
NH), 6.45 (dd, 2H, J  2.9, 6.7), 7.24 (m, 15H), 7.37 (dd, 2H, J  1.2, 8.3); 8 c
(CDCI3) 61.18, 63.31, 113.62, 125.83, 126.17, 126.72, 126.92, 127.24,
127.44, 127.66, 128.39, 128.51, 128.59, 129.77 (ipso), 141.25 (ipso), 141.53 
(ipso), 142.86 (ipso), 146.85 (ipso); HRMS (FAB) m/z 365.2027 (calcd for 
C2 6H25N2 (MH+) 365.2018).
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M osher’s Am ides
(l/?,2 /?)-l-AL[(2 /?)-2 -methoxy-2 -phenyl-3 ,3 ,3 -triflu0 ropropanoyl]-2 -/V-(l- 
naphthyl)-l,2-diaminocyclohexane (53)
NH
(l^,2/?)-l-A^-(l-Naphthyl)l,2-diaminocyclohexane (35) (43mg, 0.18mmol) was 
taken up in anhydrous dichloromethane (4ml). To this solution was added (R)(-)-a- 
methoxy-a-(trifluoromethyl)phenylacetyl chloride (37.6mg, 0.15mmol). The
solution was stirred briefly and then 4-dimethylaminopyridine (3.6mg, 0.03mmol) 
was added followed by triethylamine (31 pi, 0.22mmol). The reaction was stirred at 
room temperature overnight resulting in formation of a single product. The reaction 
was then washed with water and the aqueous phase back extracted three times with 
DCM. The combined organic phases were dried over sodium sulphate and purified 
by flash silica filtration (eluent; light petroleum followed by ethyl acetate-light 
petroleum, 2:8 v/v). This gave a colourless solid (53, 57mg, 83%); Tic (ethyl 
acetate - light petroleum, 2:8 v/v) Rf 0.37; IR (neat) vmaz 3406, 1684; 5f (CDCI3) 
-69.47; 5h (CDC13) 1.26 (m ,lH ), 1.47 (m,4H), 1.83 (d, 1H, /  10.9), 1.89 (d, 
1H, /  8 .6 ), 2.16 (m, 1H), 2.45 (d, 1H, J  12.5), 3.17(s,3H), 3.40 (dt, 1H, J  3.9,
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10.5), 4.13 (m ,lH ), 6.53 (d, 1H, 7  7.4), 6.61 (t, 2H, 7  7.8), 6.97 (t, 1H, 7  7.6),
7.03 (d, 1H, 7  8 .6 , NH), 7.15 (d, 2H, 7  7.8), 7.20 (dd, 1H, 7  1.6 , 8.2), 7.25 (dd, 
1H, 71.6, 9.8), 7.31 (d, 1H, 77.8), 7.39 (t, 1H, 77.4), 7.55 (d, 1H, 78.2), 7.76 
(d, 1 H, 7 8.2); 5c (CDC13) includes 24.50 (CH2), 25.02 (CH2), 31.30 (CH2),
32.53 (CH2), 52.77 (CH3), 54.74, 59.32, 82.78 (q, 7  25.3) 120.44, 123.43
(ipso), 125.06, 125.78, 126.00, 127.70, 128.15, 128.97, 131.27 (ipso),
134.36 (ipso). 168.00 (ipso); HRMS (El) m/z 456.2020 (calcd for C2 6 H2 7 F3N2 0 2 
(M+) 456.2024).
Racemic modification





(R)(+)-a-methoxy-a-fluoromethylphenyl acetic acid (lOOmg, 0.43mmol) was taken 
up in thionyl chloride (0.94ml, 13mmol). To the solution was added catalytic NaCl
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(2.5mg) and the mixture was allowed stirred at 90°C for 40 hours by which time 
complete consumption of the acid had occurred. Thionyl chloride was removed by 
rotary evaporation and the residue was taken up in dry DCM (3ml). To this was 
added (\R,2R)~ 1 -iV-(4-biphenyl)-1,2-diaminocyclohexane (47) (77mg, 0.28mmol), 
triethylamine (600|il, 4.3mmol, lOeq.) and DMAP (6mg, 0.05mmol). The reaction 
was stirred at room temperature for one hour. The mixture was then washed with 
brine solution and back extracted four times with DCM. The combined organic 
layers were dried over Na2SC>4 and the solids filtered under suction. The product was 
then further purified by flash column chromatography («-hexane - ethyl acetate 95:5 
v/v) to give a colourless oil (54, 22mg, 16%). Tic (ethyl acetate - hexane, 1:1 v/v) 
Rf 0.65; IR (neat) vmax 1639; 5F (CDC13) -69.21; 5H (CDC13) 1.35 (m, 5H),
1.79 (d, 2 H , / 12.1), 2.03 (d, 1H, .712.5), 2.32 (dd, 1H, J3.5, 13.7), 3.21 (dt, 1H, 
J 3.5, 10.2), 3.29 (s, 3H), 3.90 (dq, 1H, 3.7, 10.2), 6.63 (d, 2H, J  8.6), 7.25 (tt, 
1H, J  1.2, 7.4), 7.41 (dd, 2H, J  2.0, 8.6), 7.37 (m, 5H), 7.52 (m, 4H); 5c
(CDC13) includes 24.44 (CH2), 24.72 (CH2), 29.71 (CH2), 32.29 (CH2), 52.93, 
55.01 (CH3), 58.16, 126.09, 126.24, 127.44, 128.01, 128.53, 128.65,
129.50, 133.00 (ipso), 141.14 (ipso), 146.88 (ipso), 167.25 (ipso); Tic (ethyl 
acetate -  «-hexane) Rf 0.65; HRMS (FAB) m/z 482.2186 (calcd for C2 gH3 oF3N 2 0 2  
(MH*) 482.2181). 
racemic modification
5f (CDC13) -69.40, -68.98
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(l/?,2/?)-l-7V-[(2/?)-2-methoxy-2-phenyl-3,3,3-trifluoropropanoyl]-2-./V-[4-
(benzylsulfanilam ido)phenyl]-l,2-diam inocyclohexane (55)
Ph
^Me
( \R,2R)~ 1 -Af-[4-(N-Benzylsulfanilamido)phenyl]-1,2-diaminocyclohexane (41) 
(20.3mg, 0.047mmol) and (R)(-)-oc-methoxy-(X-(trifluoromethyl)-phenylacetyl
chloride (9.8mg, 0.039mmol) were taken up in anhydrous DCM (3ml). To the 
solution was added 4-dimethylaminopyridine (lmg, 0.008mmol) and triethylamine 
(8.2 j l l 1, 0.06mmol). The reaction was carried out as for 53 above to give a colourless 
oil (55, 24mg, 95%). Tic (DCM) Rf 0.47; IR (neat) Vnaz 3342, 1684; 5F (CDC13) 
-69.34 (97.5%), -69.95 (2.4%); 6 H (CDC13) 1.39 (m, 6 H), 1.83 (d, 1 H, 7  9.8),
1.88 (d, 1H, J9.0), 2.07 (d, 1H, 79.8), 2.26 (d, 1H, 7  12.5), 3.19 (m, 1H), 3.24 
(d, 3H, 70.8), 3.97 (m, 1H), 4.69 (d, 1H, 7  14.5), 4.73 (d, 1H, 7  14.4), 6.39 (d, 
2H, 7  9.0), 7.04 (m, 1H), 7.05 (d, 1H, 7 7.9), 7.05 (d, 1H, 7  8.2), 7.12 (d, 1H, 7  
8.2), 7.15 (d, 1H, 7  7.8), 7.23 (m, 10H), 7.40 (dd, 2H, 7  2.7, 9.0); 8 C (CDC13) 
includes 24.36 (CH2), 24.93 (CH2), 32.23 (CH2), 32.40 (CH2), 52.40, 54.49 
(CH3), 54.79 (CH2), 58.97, 77.21, 110.99, 124.53 (ipso), 127.29, 127.34,
127.65, 128.13, 128.33, 128.57, 128.61, 129.48, 129.74, 131.53 (ipso),
136.15 (ipso), 139.40 (ipso), 150.50 (ipso), 167.82 (ipso); HRMS (El) m/z
651.2375 (calcd for C3 5 H3 6F3N3 0 4S 651.2378).
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(l*S',25)-l-AL[(2/?)-2-m ethoxy-2-phenyl-3,3,3-trifluoropropanoyl]-2-Ar- ( l -
naphthyl)-l,2-d iphenylethane 1,2-diam ine (56)
(15,25)-//-(l-Naphthyl)-1,2-diphenyl-1,2-ethanediamine (48) (34mg, O.lOmmol) and 
(/?)(-)-a-methoxy-a-(trifluoromethyl)-phenylacetyl chloride (21.2mg, 0.084mmol) 
were taken up in anhydrous DCM (2ml). To the solution was added 4- 
dimethylaminopyridine (2mg, 0.016mmol) and triethylamine (17.6|il, 0.13mmol). 
The reaction was carried out in similar fashion to 53 to give a colourless solid (56, 
46mg, 99%). Tic (ethyl acetate - light petroleum, 2:8 v/v) Rf 0.42; IR (neat) vmaz 
3310,1687; 8F (CDC13) -68.875; 6H (CDC13) 3.29 (s, 3H), 4.87 (d, 1H, J  8.7), 
5.43 (t, 1H, J  8.2), 6.33 (dd, 1H, y  0.8, 6.3), 7.06 (m, 2H), 7.10 (d, 1H), 7.14 
(m, 6H), 7.25 (dd, 3H, J  2.7, 6.2), 7.34 (m, 3H), 7.41 (d, 2H, J  8.2), 7.45 (dt, 
1H, J2.0, 5.1), 7.45 (d, 1H, 79.4), 7.56 (d, 1H, J 7.8), 7.74 (dd, 1H, J 2.4, 6.9),
7.88 (dd, 1 H ,/2.0, 9.4); 8C (CDC13) includes 55.16 (CH3), 59.50, 63.65, 98.38, 
105.73, 117.60, 120.16, 123.47 (ipso), 124.78, 125.60, 126.06, 127.21,
127.30, 127.47, 128.09, 128.19, 128.32, 128.45, 128.58, 129.43, 132.02
(ipso), 134.03 (ipso), 137.53 (ipso), 139.05 (ipso), 141.43 (ipso), 167.12 
(ipso); HRMS (El) m/z 554.2195 (calcd for C3 4H2 9F3N2 O2 (M+) 554.2181).
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Racemic modification






(/?)(+)-a-Methoxy-a-trifluoromethylphenylacetic acid (37.9mg, 0.16mmol) was 
taken up in thionyl chloride (4ml), NaCl (catlaytic) was added and the mixture stirred 
at reflux for 3 days. The solvent was then evaporated and the mixture taken up in dry 
DCM (3ml) and to the solution was added ( \R,2R)-\-N[4-(N- 
Benzylsulfanilamido)phenyl] 1,2-diaminocyclohexane (41) (25mg, 0.047mmol),
triethylamine (0.23ml) and DMAP (catalytic). The reaction was stirred at room 
temperature for 1 day, brine was added and the layers extracted with DCM (3x). The 
combined organic layers were dried over Na2 SC>4 and the crude product purified by 
flash column chromatography (ethyl acetate - light petroleum, 1 : 1  v/v) to give the 
product as a colourless oil (58, 8 mg, 23%).
5f (CDC13) -69.20; 5H (CDC13) 3.27 (s, 3H), 4.63 (s, 1H), 4.64 (s, 1H), 4.69 
(m, 1H), 5.34 (dd, 1H, J  8.5, 9.1), 5.82 (d, 1H, J  6.2), 6.36 (d, 2H, J  9.1), 6.97 
(m, 2H), 7.03 (m,2H), 7.09 (m, 2H), 7.16 (m, 1 OH), 7.29 (m, 5H), 7.32 (d,
162
2H, J  8.5), 7.40 (t, 1H, J  7.3), 7.45 (d, 2H, J  7.6), 7.60 (d, 1H, J  8.2); 5c
(CDC13) includes 29.69, 54.46, 54.98, 59.24, 64.76, 77.21, 112.26, 125.86, 
127.37, 127.75, 127.83, 128.23, 128.44, 128.57, 128.67, 128.91, 128.99,
129.55, 129.81, 131.90, 136.24, 136.76, 138.72, 139.45, 150.21, 168.39; 
HRM S.(FAB) m/z 750.2607 (calcd for C4 3 H 3 9 F3N 3 O4 S (M H+) 750.2614).
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(lS,2.S)-(-)-DPEN ( 1 1  lmg, 0.52mmol) was taken up in dry acetonitrile ( 1 0 ml). 
To the solution was added 2-fluoronitrobenzene (55|il, 0.52mmol) and 
triethylamine (182pl, 3mmol). The reaction was heated at 80°C for 8  hours, 
then the solvent was evaporated and the product purified by flash column 
chromatography (gradient elution; ethyl acetate - «-hexane, 1:9 v/v followed by 
ethyl acetate - w-hexane, 2:8 v/v) to afford a yellow oil (60, 65mg, 37%). Tic 
(ethyl acetate - «-hexane, 2:8 v/v) R{ 0.45; [a ] D 2 3 -153.0 (c 1.33, CHC13); IR 
(neat) vmax 3357, 1618, 1586, 1352; 6 H (CDC13) 1.60 (br. s, 2 H, NH2 ), 4.49 
(d, 1H, 7  2.9), 4.68 (dd, 1H, J  2.9, 6 .6 ), 6.40 (d, 1H, J  8 .8 ), 6.50 (ddd, 1H, 
J  1.1, 7.0, 8 .6 ), 7.12 (ddd, 1H, J  1.5, 6 .8 , 8.3), 7.30 (m, 8 H), 7.50 (d, 2H, J
7.0), 8.11 (dd, 1H, J  1.5, 8 .6 ), 9.42 (br. d, 1H, J  6.2, NH); Sc (CDC13)
60.86, 63.31, 115.16, 115.20, 126.59, 126.70, 127.72, 127.82,
128.49, 132.30 (ipso), 135.77, 140.10 (ipso), 142.13 (ipso), 144.60
(ipso); HRMS (FAB) m/z 334.1566 (calcd for C2oH2oN3 0 2  (MH+) 334.1556).
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2,4-Dinitrofluorobenzene (270mg, 1.45mmol) was taken up in dry DMF 
(20ml). To the solution was added (1S,2S)-DPEN (400mg, 1.88mmol). The 
mixture was stirred briefly before addition of potassium carbonate (241 mg, 
1.74mmol). The reaction was stirred for 18 hours at room temperature. After 
this the solvent was evaporated and the solids taken up in ether, filtered 
through Celite and the filtrate was purified by flash column chromatography 
(gradient elution; 1 0 0 % light petroleum to ethyl acetate - light petroleum, 2 : 8  
v/v, in 5% increments) to give the product as a yellow solid after evaporation 
of the solvent (61, 452mg, 82%). Recrystallisation from light petroleum ether - 
ethyl acetate, 5:1 v/v, gave yellow crystals. Tic (methanol - DCM, 1:9 v/v) Rf 
0.53; [oc] D 23 +33.8 (c 0.73, CHC13); IR (KBr) vmax 3383, 3326; 5H (CDC13) 
1.54 (s, 2H, NH2 ), 4.54 (d, 1H, /2 .3 ), 4.73 (dd, 1H, /2 .3 , 6.3), 6.44 (d, 
lH ,/9 .4 ), 7.27 (m ,lH ), 7.36 (m, 5H), 7.43 (dd, 2H, J  1.2, 8 .6 ), 7.51 (d, 
2H, 7  7.0), 7.95 (ddd, 1H,70.8, 2.7, 9.4), 9.08 (d, 1H,72.3), 10.04 (d, 1H, 
/6 .2 , NH); 5c (CDC13) 60.81, 64.16, 115.59, 124.37, 126.50, 126.71, 
128.30, 128.64, 129.00, 129.60, 130.09, 131.02 (ipso), 138.88 (ipso), 
141.71 (ipso), 147.85 (ipso), 189.70 (ipso); HRMS (FAB) m/z 379.1404
165
(calcd for C2 0 H19N4 O4  (MH+) 379.1407); Anal. Calcd for C2 oH18N4 0 4: C, 
63.49; H, 4.79; N, 14.81. Found C, 63.5; H, 4.88; N, 14.7.
(l/^/^-l-A-^-NitrophenyOcyclohexane-l,2-diamine (62)
o 2n
(lR,2R)(-)-l,2-Diaminocyclohexane (313mg, 2.74mmol) and 2-
fluoronitrobenzene (289ml, 2.74mmol) were taken up in dry MeCN (10ml). 
Et3N (0.95ml, 6.82mmol) was added and the reaction was carried out as for 60. 
After purification, a yellow powder was obtained (62, 467mg, 72%). Tic 
(methanol - DCM, 2:8 v/v) R{ 0.48; m.p. 64 °C. [a ] D 31 -144 (c 0.5, DCM); 
IR (neat) vmax 3353, 1618, 1572, 1508; 5H (CDC13) 1.31 (m, 4H), 1.59 (s,
2H, NH2 ), 1.78 (m,2H), 2.0 (dd, 1H ,74.0, 11.3), 2.10 (dd, J  3.1, 10.1),
2.79 (m, 1H), 3.31 (dq, 1H, J  3.9, 9.1), 6.61 (dt, 1H, J, 1.1, 7.8), 7.01 (d, 
1H, 78.6), 7.40 (dt, 1H, J  1.5, 7.8), 8.08 (d, 1H, 78.2, NH), 8.15 (dd, 1H,7
1.5, 8.5); 8 c (CDC13) 24.56 (CH2), 24.93 (CH2), 31.99 (CH2), 34.71
(CH2), 55.50, 59.09, 114.43, 115.23, 126.99, 131.91 (ipso), 136.19,
145.68 (ipso); HRMS (FAB) m/z 236.1402 (calcd for Ci2H,8N3 0 2  (MH+) 
236.1400); Anal. Calcd for Ci2 H 17N30 2: C, 61.20; H, 7.29; N, 17.60. 




To an oven dried flask under N2 was added (\R,2R)(~) 1,2-diaminocyclohexane 
(208mg, 1.82mmol). This was taken up in MeCN (8 ml) and to the solution was 
added 2,4-dinitrofluorobenzene (229pl, 1.82mmol) followed by NaCh-Bu 
(211 mg, 2.2mmol). The reaction was stirred at room temperature for 1 hour 
before being heated to 80°C for a further 2 hours. Tic analysis showed that the 
reaction was complete with formation of two products. The mixture was 
filtered through Celite and then purified by flash column chromatography 
(gradient elution, 100% DCM followed by MeOH - DCM, 1:9 v/v). This gave 
the title product as a dark yellow powder (63, 186mg, 36%). Tic (methanol - 
DCM, 15:85 v/v) R{ 0.48; m.p. 157-158 °C; [oc] D 23 -73.8 (c 0.52, CHCI3); 
IR (neat) vmax 3340, 1618, 1591, 1524; 5H (CDC13) 1.39 (m, 4H), 1.54 (s,
2H, NH2), 1.83 (d ,2H ,7  8.3), 2.03 (dd, 1H, 79.3, 4.4), 2.13 (dd, 1H, 73.9,
11.2), 2.86 (dt, 1H, 73.9, 9.6), 3.42 (dq, 1H, 73.9, 9.3), 7.12 (d, 1H, 79.8),
8.21 (dd, 1H, 7  2.9, 9.8), 8.64 (d, 1H, 7  8.3, NH), 9.10 (d, 1H, 7  2.4); Sc 
(CDCI3) 24.33 (CH2), 24.55 (CH2), 31.59 (CH2), 34.97 (CH2), 55.24,
59.75, 114.62, 124.35, 130.00, 130.11 (ipso), 135.60 (ipso), 148.45
(ipso); HRMS (FAB) m/z 281.1253 (calcd for Ci2 Hi7N4 0 4  (MH+) 281.1250); 
Anal. Calcd for Ci2H16N4 0 4: C, 51.40; H, 5.75; N, 19.90. Found C, 51.10; 
H, 5.68; N, 19.60.
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Tridentate ligands
(l/? ,2 /?)-l-A r-(2-A nilino)l,2-diam inocyclohexane (64)
(\R,2R)~l-/V-(2-Nitrophenyl)cyclohexane- 1,2-diamine (62) (354mg, 1.5mmol) 
and 10% Pd on carbon (35mg) were taken up in ethanol (100ml). The flask was 
evacuated, flooded with argon 3 times and then flooded with hydrogen. The 
reaction was stirred at room temperature for 2 2  hours under a positive pressure 
of hydrogen and the suspension was then filtered though a pad of Celite. The 
solvent was evaporated, the crude oil was taken up in DCM, washed with brine 
solution and the layers separated. The aqueous phase was back extracted (3x) 
with further DCM. The combined organic phases were dried over Na2 SC>4 , and 
evaporated to dryness under reduced pressure. Attempts to purify the crude 
product by precipitation of a hydrochloride salt failed, so the residue was 
purified by running through a short pad of silica (gradient elution; 100% DCM 
to methanol - DCM, 4:6 v/v). This gave after evaporation of solvent a cream 
coloured solid (64, 285mg, 93%).
Tic (methanol: DCM, 6:4 v/v) Rf0.23; m.p. 77-78°C; [a ] D 2 4  -153.5 (c 0.99, 
CHCI3 ); IR (DCM) i w  3337; 8 H (CDCI3 ) 1.03 (ddd, 1H, 3.1, 10.9, 12.9) 
1.28 (m, 3H), 1.73 (m, 2H), 1.99 (m, 1H), 2.18 (m, 1H), 2.57 (ddd, 1H,
3.9, 9.8, 10.5), 2.90 (ddd, 1H, J3.9, 9.8, 10.9), 6.73 (m, 4H); 8 c (CDCI3)
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24.99 (CH2), 25.07 (CH2), 32.06 (CH2), 35.29 (CH2), 55.61, 59.57, 
113.59, 116.70, 118.83, 120.17, 135.08 (ipso), 136.71 (ipso); HRMS 




(l/?,2S)-Norephedrine (300mg, 1.98mmol) was taken up in dry THF (8 ml). To 
this was added 2-fluoronitrobenzene (209.2pl, 1.98mmol) and Et3N (209pl, 
1.5mmol). The reaction was heated to 50°C and stirred overnight. The solvent 
was then evaporated, the crude mixture taken up in DCM and washed with 
brine. The aqueous phase was back extracted a further three times with DCM. 
The organic phases were dried over Na2 SC>4 and the solvent was evaporated 
under reduced pressure. The product was further purified by flash column 
chromatography (eluent: DCM) to give a yellow oil (240mg, 44%).
Tic (DCM) Rf0.33; [a ] D 3 0  +325.6 (c 0.43, DCM); IR (neat) vmax 3583,
3362; 8h (CDC13) 1.17 (dd, 3 H ,J  6.7, 2.6), 2.61 (br. s, 1H), 3.98 (m, 1H),
4.94 (br. s, 1H), 6.59 (dd, 1H, J7.9, 8,5), 6.90 (d, 1H, 8.5), 7.29 (m, 1H),
7.37 (m, 5H), 8.11 (dd, 1H, J  1.5, 8 .6 ), 8.3 (br. d, 1H, 7.9); 8 c (CDCI3)
14.52 (CH3), 53.47, 75.46, 114.14, 115.23, 126.13, 127.05, 127.93,
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128.49, 131.95, 136.14, 140.67, 144.71; HRMS (FAB) m/z 273.1238
(calcd for C 15H 17N2 O3 (MH+) 273.1240).




(1 R,2S)-2-A/-(2-Nitrophenyl)-l -phenyl-2aminopropanol (114) (190mg,
0.70mmol) was taken up in absolute ethanol (40ml). To the solution was added 
10% Pd on carbon (30mg), the flask was evacuated and flooded with argon 
three times, and then evacuated and flooded with hydrogen. The reaction was 
stirred at room temperature under hydrogen for 24 hours. The solids were then 
filtered off and the solvent evaporated. The crude product was purified by flash 
column chromatography (gradient elution: DCM followed by methanol - DCM, 
5:95 v/v) to give a pale yellow oil (65, 176mg, 100%). Tic (methanol - DCM, 
5:95 v/v) Rf 0.46; IR (neat) vmax 3380; 6 H (CDC13) 1.04 (d, 3H, J  6.4),
3.32 (br. s, 4H), 3.73 (dq, 1H ,/3 .1 , 6.7), 4.94 (d, 1H,73.1), 6.72 (dd, 2H, 
J  1.2, 4.6), 6.83 (m,2H), 7.27 (m, 1H), 7.37 (m, 4H); 5C (CDC13) 14.31 
(CH3), 54.67, 74.15, 114.29, 117.53, 119.79, 121.04, 126.20, 127.60, 
128.55, 135.36 (ipso), 136.27 (ipso), 141.81 (ipso); HRMS (FAB) m/z






(S)-Phenylalaninol (734mg, 4.85mmol) was taken up in dry THF (13ml) and to 
this was added 2-fluoronitrobenzene (563|il, 5.34mmol) and Et3N (1.7ml, 
12.2mmol). The reaction was stirred at reflux for two days, allowed to cool to 
room temperature, the solvent evaporated and the crude mixture taken up in 
DCM. This was washed with brine and the layers separated. The aqueous phase 
was back extracted a further two times with DCM and the combined organic 
phases were dried over Na2 SC>4 . The solids were filtered and the solvent 
evaporated to leave a yellow oil. The crude product was purified by flash 
column chromatography (eluent: ethyl acetate-light petroleum, 3:7 v/v) to give 
after evaporation of the solvent, an orange oil (721 mg, 55%). Tic (ethyl 
acetate-light petroleum, 4:6 v/v) Rf 0.31; [oc]d30 -426 (c 1, CHCI3); IR (neat) 
vmax 3362; 8 H (CDC13) 1.89 (br. s, 1H), 2.96 (dd, 1H, J  6.3, 13.7), 3.04 
(dd, 1H, J  6.4, 13.7), 3.72 (d, 1H, J  10.7), 3.79 (d, 1H, J  10.7), 3.98 (m, 
1H), 6.62 (ddd, 1H, 71.0, 6 .8 , 8.3), 6.89 (d, 1H, 7 8 .8 ), 7.25 (m, 4H), 7.38 
(ddd, 1H, 71.5, 6 .8 , 8 .8 ), 8.14 (dd, 1H, 7  1.5, 8 .8 ), 8.23 (d, 1H, 78.3, NH); 
5c (CDCI3 ) 37.67 (CH2), 55.56, 63.42 (CH2), 114.10, 115.60, 126.83,
127.07, 128.71, 139.28, 132.22 (ipso), 136.19, 137.27 (ipso), 144.95
(ipso).;
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(IS ^ -A ^ -A n iliiio ^ -p h e n y l-Z -a n im o p r o p a n o I  (66)
(2iS)-2-Af-(2-Nitrophenyl)-3-phenyl-2-aminopropanol (115) (617mg, 2.27
mmol) was taken up in ethanol (80ml). 10% Pd on carbon (6 8 mg) was then 
added. The reaction was carried out as previously to give after purification a 
colourless solid (6 6 , 475mg, 8 6 %). Tic (methanol - DCM, 1:9 v/v) Rf 0.52; 
[oc] D 23 + 1 2 . 8  (c 0.39, CHC13); IR (KBr) vmax 3360, 3339; 6 H (CDCI3 ) 2.83 
(dd, 1H, J 7.6, 13.9), 2.96 (dd, 1H,7 5.5, 13.7), 3.17 (br. s, 4H), 3.50 (dd, 
1H, 74.7, 10.2), 3.70 (m,2H), 6.72 (m, 2H), 6.77 (d, 1H, J  7.4), 6.84 (m, 
1H), 7.22 (dd, 2H, J  1.6, 7.4), 7.25 (dd, 1H, J  2.0, 7.8), 7.30 (d, 1H, J  7.4),
7.32 (m, 1 H); 6 C (CDC13) 37.98 (CH2), 56.48, 63.27 (CH2), 114.35,
117.48, 119.80, 121.00, 126.68, 128.76, 129.54, 135.33 (ipso), 136.32 
(ipso), 138.52 (ipso); HRMS (El) m/z 242.1425 (calcd for Ci5H,8N20  (M+) 
242.1419). Anal. Calcd for Ci5Hi8N20: C, 74.35; H, 7.49; N, 11.56. 
Found C, 74.50; H, 7.45; N, 11.30.
(lS)-(2-Nitrophenoxy)-l-AL(4-toluenesulfonyl)-l-phenylaminoethane (117)
172
(1S)-2-(Ar-Tosylamino)-2-phenylethanol (500mg, 2.2mmol) and 2- 
fluoronitrobenzene (232|il, 2.2mmol) were taken up in dry THF (15ml). To this 
mixture was added NaO/Bu (529mg, 5.5mmol). The reaction was stirred at 
room temperature for 20 hours. The solvent was evaporated and the mixture 
was taken up in DCM. The suspension was then filtered through Celite. The 
crude product was purified by flash column chromatography (eluent: ethyl 
acetate - w-hexane, 3:7 v/v) to give after evaporation of solvent a colourless 
solid (736mg, 81%). This was recrystallised from DCM - cyclohexane (1:1 
v/v) to give colourless needles. Tic (w-hexane - ethyl acetate, 1:1 v/v) Rf 0.42; 
m.p. 119-120 °C; [cx] D20 -142.6 (c 0.51, CHC13); 8 H (CDC13) 2.33 (s, 3H),
4.23 (dd, 1H, J 4.5, 9.2), 4.29 (dd, 1H, /4 .4 , 9.1), 4.72 (ddd, 1H, J 4.4, 4.7, 
6.7), 5.77 (d, 1H, J 6.1, NH), 6.90 (dd, 1H,J 1.0, 8.3), 7.05 (ddd, 1H, J  1.2, 
7.2, 8.3), 7.11 (d, 2H, J  7.9), 7.24 (m, 5H), 7.48 (ddd, 1H, J  1.8, 7.2, 8.3),
7.59 (d, 2H, J  8.5), 7.89 (dd, 1H, J  1.8, 8.2); 5C (CDC13) 21.89 (CH3),
57.24, 72.84 (CH2), 114.81, 121.46, 126.33, 127.30, 127.45, 128.31,
128.74, 129.61, 134.79, 137.10 (ipso), 139.49 (ipso), 143.45 (ipso),
151.76 (ipso); HRMS (FAB) m/z 413.1163 (calcd for C21H21N2O5S (MH+) 
413.1172); Anal. Calcd for C21H20N2O5S: C, 61.15; H, 4.89; N, 6.79. 





(15)-(2-Nitrophenoxy)-1 -7V-(4-toluenesulfonyl)-1 -phenylaminoethane (116)
(391 mg, 0.95mmol) was taken up in abs. EtOH (100ml). To the solution was 
added 10%Pd on carbon and the reaction with hydrogen was carried out as for 
6 6  above to give a colourless crystalline powder (340mg, 94%). This was 
recrystallised from DCM-cyclohexane (1:1, v/v) to give colourless needles. Tic 
(methanol-DCM, 1:9 v/v) Rf 0.79; m.p. 138-139 °C; [a ] D 2 0  -52.6 (c 0.57,
CHC13); IR (nujol mull) vmax 3347, 3365, 3302; 8 H (CDCI3) 2.34 (s, 3H), 
3.63 (br. s, 2H, NH2), 4.05 (d, 2H, J  5.6), 4.71 (dd, 1H, J  5.9, 12.0), 5.85 
(d, 1H, J6.4, NH), 6.59 (m, 1H), 6.61 (dd, 1H, J  1.5, 7.0), 6.65 (dd, 1H, J
1.5, 7.6), 6.77 (dt, 1H, J  1.8, 6 .8 , 7.9), 7.11 (d, 2H, J7.9), 7.22 (m, 5H), 
7.61 (d ,2 H ,J  8.2); 5C (CDC13) 21.90 (CH3), 57.47, 71.35 (CH2), 112.29, 
115.65, 118.54, 122.20, 127.14, 127.23, 128.16, 128.75, 129.63,
136.56 (ipso), 137.35 (ipso), 143.42 (ipso), 145.72 (ipso); HRMS (El) m/z 
382.1347 (calcd for M+ 382.1351); Anal. Calcd for C2 1H22N2O3 S: C, 65.9; 





(S)-Af-Tosylphenylalaninol (1.24g, 4.06mmol) and 2-fluoronitrobenzene 
(428.4ml, 4.06mmol) were taken up in dry THF (20ml). To the mixture was 
added NaO/Bu (976mg, 10.2mmol). The reaction was carried out as for 117 
above to give, after purification, a yellow crystalline powder (1.64g, 92%). 
Tic («-hexane - ethyl acetate, 1:1 v/v) Rf 0.56; m.p. 100-101 °C; [oc]d23
+4.81 (c 1.04, CHCI3 ); IR (CDCI3 ) vmax 3299; 5H (CDC13) 2.34 (s, 3H),
2.83 (dd, 1H, J  6.9, 13.6), 3.00 (dd, 1H, /7 .9 , 13.5), 3.79 (m, 1H), 3.92 
(dd, 1H, .74.7, 9.4), 4.01 (dd, 1H, .7 2.9, 9.1), 5.35 (d, 1H, .78.2, NH), 6.83 
(dd, 1H, .70.9, 8.5), 7.03 (m, 3H), 7.13 (d, 2H, J  8.5), 7.16 (m, 3H), 7.45 
(ddd, 1H, J  1.8, 7.5, 8.5), 7.61 (dd, 2H, J  1.8, 8.5), 7.86 (dd, 1H, J  1.8, 8.2); 
8 c (CDCI3 ) 21.93 (CH3), 38.19 (CH2), 54.63, 69.72 (CH2), 114.73,
121.08, 126.10, 126.96, 127.02, 128.88, 129.45, 129.86, 134.75,
136.82 (ipso), 137.49 (ipso), 139.53 (ipso), 143.51 (ipso), 151.91 (ipso); 






(117) (1.1 lg, 2.39mmol) and 10% Pd on carbon (96mg) were taken up in abs. 
ethanol (150ml). The reaction with hydrogen was carried out as for 68 above to 
give a pale brown solid (69, 835mg, 8 8 %). Tic (methanol - DCM, 1:9 v/v) Rf 
0.69; m.p. 130-132 °C; [oc] D 23 -2 0 . 8  (c 1.0, CHC13); IR (nujol mull) vmax 
3484, 3386, 3316; 6 H (CDC13) 2.38 (s, 3H), 2.88 (dd, 1H, J  5.7, 13.6),
2.95 (dd, 1H, J  7.0, 13.8), 3.81 (m, 5H), 5.27 (d, 1H, J 7.3, NH), 6.55 (d, 
1H, J  8.2), 6.63 (ddd, 1H, J  1.5, 7.6, 7.6), 6.69 (d, 1H, J  7.6), 6.79 (ddd, 
1H, J  1.2, 7.3, 7.6), 7.04 (m,2H), 7.16 (d, 2H, 77.9), 7.20 (m, 3H), 7.64
(d ,2H ,/7 .9 ); 6 C (CDC13) 21.94 (CH3), 38.86 (CH2), 54.65, 68.77 (CH2), 
112.01, 115.60, 118.65, 122.01, 126.99, 127.07, 128.89, 129.53,
129.89, 136.44 (ipso), 136.75 (ipso), 137.59 (ipso), 143.51 (ipso), 145.96 






(l/?,2*S)-A-Tosyl-norephedrine (947mg, 3.1 mmol) and 2-fluoronitrobenzene 
(327jil, 3.1 mmol) were taken up in dry THF (50ml) and to the solution was 
added NaO/-Bu (745mg, 7.75mmol). The reaction was carried out as for 117 
above to give a yellow powder. This was recrystallised from DCM - 
cyclohexane (1:1, v/v) to give pale yellow needles (496mg, 38%). Tic (n- 
hexane - ethyl acetate, 6:4 v/v) R? 0.46; m.p. 148 °C; [a]o2 0  +200.9 (c 1.07, 
CHCls); IR (nujol mull) vmax 3272; 8 H (CDC13) 0.98 (d, 3H, 76.7), 2.34 (s, 
3H), 3.79 (ddq, 1H, 72.6, 6.7, 9.7), 5.33 (d, 1H, 72.6), 5.42 (d, 1H, 79.7, 
NH), 6.52 (d, 1H, 78.5), 6.98 (ddd, 1H, 71.2, 7.9, 8.2), 7.17 (d, 2H, 78.5),
7.24 (m, 3H), 7.31 (m, 4H), 7.74 (d, 2H, 7  8.2), 7.86 (dd, 1H, 71.5, 8.2);
8c (CDC13) 14.21 (CH3), 21.91 (CH3), 55.38, 84.30, 116.19, 121.03, 
125.80, 125.97, 126.87, 128.57, 129.13, 129.85, 134.35, 136.55 (ipso), 
138.55 (ipso), 139.73 (ipso), 143.43 (ipso), 151.45 (ipso); HRMS (FAB) 
m/z 427.1322 (calcd for C2 2 H23N2 0 5 S (MH+) 427.1328); Anal. Calcd for 
C22H22N2O5S: C, 61.96; H, 5.20; N, 7.57. Found: C, 61.70; H, 5.17; N, 
6.51.
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( l/^ lS V l-^ -A m in o p h en o x jO -l-p h en y l-l-A ^ -to lu en esu lfo n y l)-!
am inopropane (70)
(\R,2S)-1 -(2-Nitrophenoxy)-1 -phenyl-2-A/-(4-toluenesulfonyl)-2- 
aminopropane (118) (231 mg, 0.54mmol) and 10%Pd on carbon (25mg) were 
taken up in abs. ethanol (100ml). The reaction was carried out as for 6 8  above 
to give a pale brown powder (179mg, 84%). Tic (methanol-DCM, 1:9 v/v); Rf 
0.69; m.p. 174-175 °C; [a ] D 23 +60.4 (c 1.01, CHC13); 6 H (CDC13) 0.96 (d, 
3H, 7  7.0), 2.23 (s, 3H), 3.73 (ddq, 1H, 7  2.9, 7.0, 9.7), 3.84 (br. s, 2H, 
NH2 ), 4.88 (d, 1H,72.9), 5.47 (d, 1H,79.7, NH), 6.15 (dd, 1 H ,7 1.2, 8.2),
6.37 (ddd, 1H, 72.0, 6.7, 8.2), 6.63 (dd, 1H,72.0, 7.9), 6 . 6 6  (m, 1H), 7.09 
(d, 2H, 7 8.5), 7.13 (d, 1H, 77.0), 7.13 (d, 1H, 7 8.2), 7.18 (m, 1H), 7.23 
(m, 2H), 7.61 (dd, 2H, 71.8, 8.2); 6 C (CDC13) 15.67 (CH3), 21.94 (CH3),
54.89, 82.50, 114.032, 115.86, 118.80, 122.01, 126.30, 126.94,
128.16, 128.83, 129.90, 136.52 (ipso), 137.65 (ipso), 138.39 (ipso),
143.39 (ipso), 145.76 (ipso); HRMS (El) m/z 396.1502 (calcd for 
C2 2 H24N2 0 3S (M+) 396.1508); Anal. Calcd for C2 2H2 4N2 0 3 S: C, 66.64; H, 
6.10; N, 7.07. Found: C, 66.70; H,6.18; N, 7.02.
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( /^ ^ -P h en y l^ -A ^ S -ch lo ro ^ ^ -d in itro p h en y l^ -a m in o eth a n o l (72)
1,5-Dichloro-2,4-dinitrobenzene (71) (200mg, 0.84mmol) was taken up in 
MeCN (11ml). To this was added (/?)-phenylglycinol (115mg, 0.84mmol) and 
Et3N (164ml, 1.18mmol). The reaction was stirred at room temperature for four 
days, the solvent was evaporated and the product purified by flash column 
chromatography (ethyl acetate-light petroleum, 3:7 v/v) to give an orange oil 
(72, 257mg, 91%). Tic (ethyl acetate-light petroleum, 3:7 v/v) Rf 0.29; [a]o23  
+186.9 (c 1.02, CHC13); IR (neat) vmax 3546, 3352; 5H (CDC13) 2.68 (br. s, 
1H, OH), 3.93 (dd, 1H, J  6.5, 11.4), 4.08 (dd, 1H, J  4.0, 11.4), 4.76 (dd, 
1H, 7  6.1, 10.1), 6.76 (s, 1H), 7.37 (m, 5H), 8.98 (s, 1H), 9.18 (br. d, 1H,
76.0, NH); 6 c (CDC13) 59.60, 66.35, 117.46, 126.46, 126.68, 128.77,
129.46, 134.84 (ipso), 135.57 (ipso), 136.85 (ipso), 146.30 (ipso);




(R)-Phenylglycinol (127mg, 0.93mmol) was taken up in dry MeCN (8 ml) and 
to the solution was added l,5-Dichloro-2,4-dinitrobenzene (71) (lOOmg,
0.42mmol) followed by triethylamine (165|il, 1.18mmol). The reaction was 
carried out as for 72 above and yielded a yellow solid (73, 166mg, 90%). Tic 
(methanol - dichloromethane, 1:9 v/v) Rf 0.45; m.p. 99-100°C; [(x]d30 -44 (c
1, DCM); IR (nujol mull) vmax 3343, 1622, 1573, 1546, 1411;
5h (CDC13) 1.75 (s, 2H, OH), 3.74 (dd, 2H, J  6.2, 10.9), 3.86 (br. d, 2H, J
10.9), 3.96 (dd, 2H, J  5.1, 10.2), 5.19 (s, 1H), 7.20 (dd, 4H, J  1.6, 8 .6 ),
7.39 (m, 2H), 7.45 (dd, 4H, J  7.8, 8 .6 ), 8.93 (d, 2H, J  5.1, NH), 9.23 (s, 
1H); 5c (CDCI3) 59.80, 66.76 (CH2), 124.90 (ipso), 126.87, 128.70,
129.22 (ipso), 129.33, 137.31 (ipso), 147.62; HRMS (FAB) m/z 439.1618 
(calcd for C22H23N40 6 (MH+) 439.1618); Anal. Calcd for C2 2 H2 2N4 0 6: C, 




„  Me 
NOo
1,5-Dichloro-2,4-dinitrobenzene (71) (150mg, 0.63mmol) was taken up in dry 
MeCN (8 ml). (lR,2S)-norephedrine (96mg, 0.63mmol) was added, followed by 
triethylamine (55.8 pi) and the reaction was stirred at room temperature under
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argon for three days. After this time the reaction was still incomplete by tic and 
so the reaction was heated at 90°C for a further day. Evaporation of the solvent 
and purification by flash column chromatography yielded a yellow powder (74, 
164mg, 74%). Tic (ethyl acetate - light petroleum, 3:7 v/v) Rf 0,30; m.p. 163- 
165 °C; [a ] D 2 4 +92 (c 1.0, CHC13); IR (KBr) vmax 3594, 3340; 8 H (CDCI3)
1.25 (d, 3H, J 6 .6 ), 2.33 (br. s, 1H, NH), 4.05 (m, 1H), 4.97 (d, 1H, J3.9), 
7.00 (s, 1H), 7.38 (m, 5H), 8.69 (d, 1H, J  8 .6 , NH), 9.04 (s, 1H); 8 c
(CDCI3) 15.40(CH3), 54.58, 76.40, 116.85, 126.41, 127.25, 128.86,
129.00, 129.17 (ipso), 134.50 (ipso), 135.84 (ipso), 139.69 (ipso), 146.34 
(ipso); HRMS (FAB) m/z 352.0707 (calcd for C 15H15CIN3 O5 (MH+) 
352.0701); Anal. Calcd for Cl5Hl4CW3Os: C, 51.20; H, 4.00; N, 11.90. 




ph'^ YNY<5T N^ " Ph
l,5-Dichloro-2,4-dinitrobenzene (71) (301.8mg, 1.27mmol) and (\R,2S)~ 
norephedrine (404.8mg, 2.67mmol) were taken up in dry MeCN (8 ml) and to 
the solution was added triethylamine (760pl, 5.5mmol). The reaction was 
stirred at room temperature for 30 hours after which tic analysis showed the
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reaction to be incomplete. The reaction was heated at reflux for 2 days. The 
product was purified by flash column chromatography (gradient elution; 1 0 0 % 
DCM to methanol - DCM, 5:95 v/v) to give the product after drying in vacuo, 
as a yellow powder (75, 570mg, 96%). Tic (methanol - dichoromethane, 3:7 
v/v) Rf 0.63; m.p. 99-98 °C. [a ] D 30 + 1 1 . 8  (c 1.0, CH2 C12); IR (nujol mull) 
V m a x  3460, 3341, 1619, 1571, 1455, 1409; 8 H (CDC13) 1.24 (d, 6 H, J  6 .6 ),
2.03 (s, 2H, OH), 3.91 (m, 2H), 4.96 (d, 2H, J  4.0), 5.92 (s, 1H), 7.34 (m, 
10H), 8.53 (d, 2H, NH), 9.18 (s, 1H); 8 c (CDC13) 14.77 (CH3), 53.98, 
75.79, 91.32, 124.11 (ipso), 126.16, 128.30, 128.65, 129.78, 140.20 
(ipso), 147.79 (ipso); HRMS (FAB) m/z 467.1934 (calcd for C2 4 H2 7N4 0 6  
(MH+) 467.1931); Anal, calcd for C2 4 H2 6N4 0 6: C, 61.79; H, 5.62; N, 12.01. 
Found C, 61.40; H, 5.78; N, 11.70.
l^-ZV-BisK/^-l-hydroxy-l-benzylethyll-ljS-dinitro-Z^-diaminobenzene
(76) OH H H OH
Ph 0 2N N 02 Ph
1,5-Dichloro-2,4-dinitrobenzene (71) (260mg, l.lmmol) and (S)-
phenylalaninol (365mg, 2.41 mmol) were taken up in dry MeCN (12ml). To the 
solution was added triethylamine (670pl, 4.8mmol). The reaction, carried out 
in similar fashion to 75, afforded a yellow powder (318mg, 62%). Tic («-
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hexane - ethyl acetate, 1:1 v/v) /?f 0.16; m.p. 133-134 °C; [a]o30 - 8 8  (c 1.0, 
DCM); IR(KBr)vmax 3463, 3351; 6 H (CDC13) 1.98 (br. s, 2H, OH), 2.94 
(dd, 2H, J6 .4 , 13.7), 3.03 (dd, 2H ,/5 .9 , 13.7), 3.75 (m, 3H), 5.71 (s, 1H),
7.26 (m, 10H), 8.57 (d, 2H, 7 7.3, NH), 9.15 (s, 1H); 5C (CDC13) 37.52, 
56.04, 63.41, 91.36, 124.18 (ipso), 126.98, 128.83, 129.25, 129.71,
137.08 (ipso), 148.14 (ipso); HRMS (FAB) m/z 467.1932 (calcd for 
C2 4 H2 7N4 O6 (MH+) 467.1931); Anal. Calcd for C2 4 H2 6N4 O6 : C, 61.79; H, 




O2NX^ ^ N O ^ 0
l,5-Dichloro-2,4-dinitrobenzene (71) (300mg, 1.26mmol) was taken up in dry 
MeCN (8 ml) and to the solution was added (/?)(-)-cyclohexylethylamine 
( 188.2 j l l 1, 1.26 mmol) and triethylamine (210.8pl, 1.51 mmol). The reaction 
was carried out as for 72 above to obtain a yellow solid (397mg, 96%). The 
product was recrystallised from ethyl acetate-w-hexane (5:95 v/v) to give a 
yellow powder. Tic (ethyl acetate - w-hexane, 2:8 v/v) Rf 0.55; m.p. 105-106 
°C; [a]D22 -126.8 (c 1.1, CHCI3); IR(KBr): v w  3347.5;
5h (CDCI3) 1.19 (m, 5H), 1.27 (d, 3H, 6 .6 ), 1.57 (m, 1H), 1.79 (m, 5H),
3.59 (dq, 1H../6.6, 14.4), 6.95 (s, 1H), 8.52 (d, 1H,.77.8), 9.07 (s, 1H);
183
8 C (CDCI3) 17.47 (CH3), 26.09 (CH2), 26.16 (CH2), 26.25 (CH2), 28.97 
(CH2), 29.23 (CH2), 43.08, 54.13, 116.03, 127.16, 128.60 (ipso),
133.87 (ipso), 135.71 (ipso), 146.25 (ipso); HRMS (El) m/z 327.0982 
(calcd for C14H18CIN3O4 (M+) 327.0986); Anal. Calcd for Ci4Hi8C1N30 4 : C, 
51.3; H, 5.54; N, 12.82. Found C, 51.20; H, 5.55; N, 12.70.
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6.5 EX PER IM ENTAL FO R CH APTER 4
Thiophene-2-carboxaldehyde-(/?)-l-cyclohexylethyl imine (86)
Me
(/?)-(-)-1-Cyclohexylethylamine (318|il, 2.14mmol) was taken up in anhydrous 
methanol (4ml) and the solution was stirred, under argon, at 80°C. To this hot 
solution was added 2-thiophenecarboxaldehyde (200|il, 2.14mmol) in 
anhydrous methanol (1ml) over a period of 35 minutes. The reaction was 
stirred for 5 hours after which IR analysis showed that the reaction was 
complete. The solvent was evaporated in vacuo, to leave a colourless oil (8 6 , 
470mg, 100%). IR (neat) vmax 1634; 5H (CDC13) 0.89 (m, 2H), 1.18 (m,
3H), 1.21 (d, 3H, J  6.4), 1.47 (m, 1H), 1.73 (m, 5H), 2.96 (dq, 1H, J6 .4 ,
13.2), 7.05 (dd, 1H, J  3.9, 4.9), 7.27 (dd, 1H, J  1.0, 3.4), 7.36 (d, 1H, J
4.9), 8.29 (s, 1H); 5c (CDC13) 19.84 (CH3), 26.21 (CH2), 26.39 (CH2), 
26.57 (CH2), 29.81 (CH2), 30.08, 43.62, 71.82, 127.23, 128.25,
129.74, 142.85 (ipso), 151.81; HRMS (FAB) m/z 222.1316 [calcd for
Ci3 H20NS (MH+) 221.1317].
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(S)-l-[(2 ,5-dim ethylim ino)thiophene]-l-phenyIethane (87)
(»S)-a-Methylbenzylamine (276 j l l 1, 2.14mmol) and taken up in dry methanol 
(5ml). The solution was heated to 80°C and 2,5-thiophene-2,5- 
biscarboxaldehyde (150mg, 1.07mmol) was added in methanol solution (2ml) 
over a period of 30 minutes. The reaction was allowed to reflux for 15 hours 
until complete. The solvent was evaporated to leave a colourless solid (372mg, 
100%) A portion was recrystallised from DCM - cyclohexane (1:1 v/v) to give 
colourless crystals. M.p. 166-167 °C; IR (nujol mull) vmax 1621, 1459, 1376; 
[a ] D 19 +673 (c 1.0, DCM); 5H (CDC13) 1.56 (d, 6 H, J  6.7), 4.52 (q, 2H, J  
6 .6 ), 7.22 (s, 2H), 7.24 (m, 2H), 7.33 (m, 4H), 7.40 (m, 4H), 8.37 (s, 
2 H); 8c(CDC13) 25.48 (CH3), 69.69, 126.80, 127.06, 128.61, 130.03, 
145.16 (ipso), 145.35 (ipso), 152.55, 152.59; HRMS (FAB) m/z 347.1590 
[calcd for C2 2 H2 3N2S (MH+) 347.1583]; Anal, calcd for C2 2H2 2N2 S: C,





(R)-Phenylglycinol (440mg, 3.21 mmol) was taken up in dry methanol (5ml). 
To the refluxing solution was added 2-thiophenecarboxaldehyde (300pl,
3.21 mmol) and the reaction carried out as for 8 6  above to give near colourless 
crystals (623mg, 84%). The product was recrystallised from DCM - 
cyclohexane (1:1 v/v) to give colourless plates (426mg, 57%). M.p. 101-102 
°C; [a ] D 2 3 +154.5 (c 0.99, CHC13); IR (neat) vmax 3364 (br), 1632; 8 H
(CDC13) 2.49 (br. s. 1H, OH), 3.87 (dd, 1H, J  4.4, 11.2), 3.95 (dd, 1H, 7
11.3, 8.2), 4.46 (dd, 1H,74.4, 8.3), 7.04 (dd, 1H,73.7, 5.1), 7.25 (dd, 1H, 
72.4,6.4), 7.28 (dd, 1H, 71.0, 3.4), 7.34 (dd, 2H 76.8, 8.3), 7.40 (m, 3H), 
8.43 (s,lH ); 8 c (CDCI3 ) 67.66 (CH2), 75.68, 127.37, 127.48, 128.55, 
129.34, 131.17, 140.44(ipso), 142.105(ipso), 155.89; HRMS (FAB) m/z 
232.0793 [calcd for C 13Hi4NOS (MH+) 232.0797]; Anal. Calcd for 





(5)-Phenylalaninol (486mg, 3.21 mmol) was taken up in anhydrous methanol 
(5ml) and to the refluxing solution was added 2-thiophene carboxaldehyde 
(300pl,3.21 mmol) in methanol as for 8 6  above. The reaction yielded a 
colourless solid (798mg, 100%) which was recystallised from DCM -
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cyclohexane (1:1 v/v) to give colourless needles (198mg, 25%). [oc]d24 -335.4 
(c 1.1,CHC13); IR(KBr) vmax 1630; 8 H (CDC13) 2.19 (br. s. 1H, OH), 2.82 
(dd, 1H, J  8.5, 13.4), 2.92 (dd, 1H, J  5.1, 13.4), 3.46 (dt, 1H, J  5.8, 7.7),
3.76 (dd, 1H, J  3.7, 11.0), 3.82 (dd, 1H, 7  7.3, 11.2), 6.98 (dd, 1H, 7  3.7, 
5.1), 7.13 (m, 4H), 7.22 (m, 2H), 7.34 (d, 1H, 7  4.9), 7.99 (s, 1H); 8 c 
(CDC13) 38.65 (CH2), 65.64 (CH2), 74.00, 126.09, 127.26, 128.17,
128.97, 129.62, 130.82, 138.45(ipso), 141.63(ipso), 155.47; HRMS
(FAB) m/z 246.0954 [calcd for C 14Hi6NOS (MH+) 246.0593].
Thiophene-2,5-dicarboxaldehyde-bis[(S)-l-hydroxy-3-phenylprop-2- 
yljimine (90)
(.S)-Phenylalaninol (216mg, 1.43mmol) was taken up in dry MeOH (5ml). The 
solution was brought to reflux and to it was added 2,5-thiophene 
dicarboxaldehyde (lOOmg, 0.71 mmol). The reaction was carried out as for 8 6  
above and yielded colourless crystals (291 mg, 100%). M.p. 113-116 °C; 
[a ] D 23 -780 (c 1.0, CHCI3); IR (neat) vmax 3364, 1628; SH (CDC13) 2.82 (dd, 
2H, 7  8.5, 13.4), 2.84 (br. s, 2H), 2.93 (dd, 2H, 7  4.6, 13.4), 3.49 (dddd, 
2H, 73.9, 4.4, 7.3, 8.3), 3.79 (dd, 2H, 73.9, 11.2), 3.85 (dd, 2H, 77.3, 11.2),
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6.90 (s,2H), 7.10 (d, 2H, 7  8.3), 7.12 (d, 2H, 7  6.4) 7.14 (dd, 2H, 7  6.4,
1.0) 7.18 (d,4H, 77.8), 7.88 (s, 2H);
5c (CDC13) 38.75 (CH2), 65.75 (CH2), 74.29, 126.15, 128.25, 129.66, 
130.52, 138.44 (ipso), 144.07 (ipso), 155.39; HRMS (FAB) m/z 407.1787 
[calcd for C2 4H27N2 0 2S (MH+) 407.1794].
Thiophene-2-carboxaldehyde-[(l/?,25)-l-hydroxy-l-phenylprop2-yl]imine
(91)
N ^ M e
H C T * P h
(l/?,2iS)-Norephedrine (324mg, 2.14mmol) was taken up in dry methanol 
(6 ml). To the refluxing solution was slowly added 2-thiophene carboxaldehyde 
(200pl, 2.14mmol) and the reaction carried out as for 86 above to give a yellow 
oil (527mg, 100%). [a]D30 +50.2 (c 1.95, CH2C12); IR (neat) vmax 3366,
1631.
8h (CDC13) 1.13 (d, 3H, 76.4), 3.25 (br. s., 1H), 3.55 (q, 1H, 75.4), 4.78 
(d, 1H, 7  3.4), 6.90 (dd, 1H, 73.6, 5.0), 7.12 (d, 1H, 73.5), 7.16 (d, 1H, 7
7.0), 7.23 (m, 3H), 7.33 (d, 1H, 7  6 .8 ), 8.24 (s, 1H); 6 C (CDC13)
15.99(CH3), 70.42, 76.53, 126.51, 127.11, 127.23, 127.89, 128.91,
130.47, 141.17 (ipso), 142.29(ipso), 153.55; HRMS (FAB) m/z 246.0964 
[calcd for Ci4 Hi6NOS (MH+) 246.0953].
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Thiophene-2-carboxaldehyde[(S)-l-hydroxy-3m ethylbut-2-yl]im ine (92)
HO'
(S)-Valinol (802mg, 7.78mmol) was taken up in anhydrous methanol (10ml) 
and activated 3 A sieves were added. The solution was brought to reflux and 2- 
thiophenecarboxaldehyde (726pl, 7.77mmol) was added; the reaction was 
carried out as for 8 6  above. The crude product was recrystallised from diethyl 
ether to give colourless needles (821mg, 54%). M.p. 79-80 °C; [oc]d27 -
98.06 (c 1.0, CHC13); IR (nujol mull) vmax 3274, 1631.
6 h (CDCI3) (major isomer) 0.86 (d, 3H, J  6 .6 ), 0.95 (d, 3H, J  6 .6 ), 1.92
(dqq, 1H, J  6 .6 , 6 .6 , 7.0), 2.06 (br.s, 1H), 2.92 (ddd, J  3.9, 7.0, 7.4), 3.79 
(m, 2H), 7.06 (ddd, 1H, J  1.2, 3.5, 5.1), 7.29 (dd, 1H, J  1.2, 3.5), 7.39 (dt, 
1H, J  1.2, 5.1), 8.34 (s, 1H); 5H (CDC13) (minor isomer) 0.91 (2 x d, J  6 .6 ), 
1.07 (2 x d, J  6 .6 ), 1.65 (dqq), 3.12 (m), 3.47 (m), 4.02 (m), 5.69 (s),
5.79 (s), 6.98 (m), 7.14 (dd, J  1.2, 3.5), 7.25 (dd, J  1.2, 5.1); 5H (CD3CN) 
0.86 (d, 3H, / 6 .8 ), 0.90 (d, 3H, J 6 .8 ), 1.85 (sex, 1H, J  6.6), 2.55 (br. m, 
1H, OH), 2.91 (ddd, 1H, /3 .7 , 6.1, 8.2), 3.53 (ddd, 1H, J  5.7, 8.2, 11.0), 
3.70 (ddd, 1H, J 3.7, 6 .6 , 11.0), 7.11 (dd, 1H, J 3.6, 5.0), 7.37 (dd, 1H ,/1 .0 , 
3.5), 7.47 (d, 1H, J  5.1), 8.35 (s, 1H); 5c (CDC13) 19.93 (CH3), 20.04 
(CH3), 30.36, 64.51 (CH2), 64.81, 79.07, 127.50, 129.04, 130.76,
142.30 (ipso), 155.11; HRMS (El) m/z 197.0859 [calcd for C,0 H15NOS (M+)
190
197.0874]; Anal, calcd for Ci0 H,5NOS: C, 60.88; H, 7.66; N, 7.10. Found 




(5)-Valinol (467mg, 4.53mmol) was taken up in dry methanol (10ml). 3A 
molecular sieves were added together with 2,5-thiophenecarboxaldehyde 
(317mg, 2.26mmol). The reaction was carried out as for 8 6  above to give a 
yellow solid. This was recrystallised from diethyl ether to give a yellow 
crystalline powder (545mg, 78%). M.p. 97-98 °C; [a]o27 -103.4 (c 1.03,
CHC13); IR (nujol mull) vmax 3284, 1630; 6 H (CD3CN) 0.86 (d, 6 H, J  6 .8 ), 
0.90 (d, 6 H, J  6 .8 ), 1.87 (dqq, 2H, J  6 .6 , 6 .8 , 6 .8 ), 2.60 (br. s, 2H), 2.93 (m, 
2H), 3.54 (m, 2H), 3.69 (dd, 2H, J  11.0, 3.3), 7.33 (s, 2H), 8.31 (s, 2H); 
5c (CDCI3) 19.72 (CH3), 20.08 (CH3), 30.43, 64.81(CH2), 78.94,
130.43, 144.82 (ipso), 154.90; HRMS (El) m/z 310.1722 [calcd for
C 16H2 6N2O2 S (M+) 310.1715]; Anal, calcd for C 16H26N2 O2 S: C, 61.90; H, 




MeA, M  N ^ M e
PhN°  OH H O ^ P h
To a refluxing solution of (lR,2S)(-)-norephedrine (151 mg, lmmol) in 
anhydrous methanol was added 2,5-thiophenedicarboxaldehyde (70 mg, 
0.5mmol) and the reaction was carried out as for 8 6  above. The reaction 
afforded a white solid which was recrystallised from cyclohexane - DCM (1:1 
v/v) to give colourless needles (69mg, 29%). Mp 130-131 °C; [a]o3 0 +128.7 
(c 1.0, CHCI3); IR (KBr) 3446, 1617.
8 h (CDCb) 1.13 (d, 6 H, J  6 .6 ), 2.91 (br. s, 2H), 3.64 (m, 2H), 4.83 (d, 
2H ,J4.4), 7.23 (s,2H), 7.28 (m, 2H), 7.36 (m, 8 H), 8.29 (s, 2H);
8 c (CDCI3) 16.12, 70.56, 76.87, 126.59, 127.36, 128.09, 130.31,
140.96, 144.97, 153.55; HRMS (FAB) m/z 407.1786 [calcd for
C2 4H2 7N2 O2 S (MH+) 407.1794]; Anal. Calcd for C2 4H2 6N2 O2 S: C, 70.91; H, 
6.45; N, 6.89. Found C, 70.70; H, 6.46; N,6.91.
2-hydroxybenzaldehyde[(l/?,2S)-l-hydroxy-l-phenylprop-2-yl]imine (95)
(1/^^-N orephedrine (285mg, 1.88mmol) was taken up in dry methanol (6 ml) 
and to the solution was added salicylaldehyde (200j l i 1, 1.88mmol). The reaction 
was carried out as for 8 6  above to yield a yellow oil (484mg, 100%). [a]o 15
+116.9 (c 0.59, CHC13); IR (DCM) vmax 1632.
5h (CDCI3) 1.20 (d, 3H, J  6.3), 3.54 (dq, 1H, J  5.9, 6.4), 4.63 (d, 1H, J
5.4), 6.77 (dd, 1H, 77.8, 7.3), 6 . 8 6  (d, 1H, J 8.3), 6.92 (d, 1H, J 7.8), 7.20 
(dd, 1H, J  1.0, 8.3), 7.25 (m,5H), 8.08 (s, 1H); 6 c (CDCI3) 17.78 (CH3), 
69.37, 77.20, 117.00, 118.35 (ipso), 118.62, 126.76, 127.57, 127.95, 
131.33, 132.27, 140.81 (ipso), 161.47 (ipso), 164.38; HRMS (FAB) m/z 
256.1332 (calcd for Ci6 H 18N 0 2 (MH+ 256.1338).
Pyrrole-2-carboxaldehyde [(l/?,25)-l-hydroxy-l-phenylprop-2-yl]imine 
(96)
(lR,2iS)-Norephedrine (332mg, 2.2mmol) was taken up in dry methanol (8 ml) 
and to solution was added pyrrole-2-carboxaldehyde (209mg, 2.2mmol) 
following a similar procedure to 8 6  above. The reaction yielded an off-white 
crystalline powder (299mg, 60%). M.p. 80 °C; [ct]D30 +9.45 (c 2.0, CH2C12); 
IR (DCM) vmax 3290, 1634. 6 H (CDC13) 1.11 (d, 3H, 6.4), 3.52 (m, 1H),
4.87 (d, 1H, J2.8), 6.16 (m, 1H), 6.48 (d, 1H, 3.4), 6.59 (br. s, 1H),
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7.27 (d, 1H, J  7.9), 7.36 (m, 2H), 7.41 (d, 2H, J  7.3), 8.06 (s, 1H); 6 c 
(CDCI3) 15.44 (CH3), 71.09, 77.31, 109.68, 115.46, 122.34, 126.36, 
127.24, 128.19, 129.56 (ipso), 141.69 (ipso), 151.65; Anal, calcd for
Ci4Hi6N20: C, 73.66; H, 7.06; N, 12.27. Found C, 73.50; H, 7.10; N, 
12.30.
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6.6 EX PER IM ENTAL FO R C H APTER 5
(1R, l^-A-Benzyl-l-amino-l-phenylpropan-l-ol (98)
(l/?,2S)-Norephedrine (939mg, 6.2mmol) and sodium cyanoborahydride 
(392mg, 6.2mmol) were taken up in anhydrous methanol (10ml). To this was 
slowly added benzaldehyde (692mg, 6 .5mmol) in similar fashion to 99. The 
crude product was taken up in EtOAc and the organic solution washed with 
saturated NH4 CI solution and then with brine. The combined organic phases 
were dried over Na2 S0 4  and the crude product purified by flash 
chromatography (eluent: w-hexane - ethyl acetate, 8 : 2  v/v) affording a 
colourless oil (1.072g, 72%). Tic (methanol - DCM, 1:9 v/v) Rf 0.38; [a ] D 23  
-24.0 (c 0.48, CHCI3 ); IR (thin film) vmax 3407 (br); 5H (CDC13) 0.85 (d, 
3H, /6 .4 ), 2.94 (dq, 1H, /3 .8 , 6.5), 3.14 (br. s, 2H), 3.78 (d, 1H, J  13.2), 
3.84 (d, 1H, J  13.2), 4.75 (d, 1H, J 3.8), 7.26 (m, 10H); 5c (CDCI3 ) 14.75 
(CH3), 51.45 (CH2), 58.18, 73.56, 126.39, 127.38, 127.56, 128.38,
128.47, 128.85, 139.77 (ipso), 141.58 (ipso); HRMS (FAB) m/z 242.1544 
[calcd for Ci6 H20NO (MH+) 242.1545].
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(l/?,2S)-l-Phenyl-2-./V -(2-thiophenylm ethyl)aiiiino propan-l-o l (99)
H N ^ M e  
HO^ Ph
(1/^^-N orephedrine (610mg, 4.0mmol) and NaCNBH3 (255mg, 4.1 mmol) 
were taken up in dry methanol (15ml). To this solution was added a solution of4
2-thiophenecarboxaldehyde (414pl, 4.4mmol) in methanol (2ml) over 1.5 
hours. The mixture was stirred at room temperature for 2 days, the solvent 
evaporated and the residue taken up in ethyl acetate. This was washed with 
NaHCC>3 solution and the aqueous phase back extracted three times with ethyl 
acetate. The combined organic phases were dried over Na2 SC>4 . The solids 
were filtered off and the solvent evaporated to leave a crude oil. Purification by 
flash column chromatography (gradient elution, DCM followed by methanol - 
DCM, 5:95 v/v) gave a pale yellow oil (348mg, 35%). Tic (methanol - DCM, 
1:9 v/v) Rf0.41; [<x] D 22 -19.8 (c 1.82, CHC13); IR (thin film) vmax 3405 (br); 
8 h (CDCI3) 0.90 (d, 3H, J  6.4), 3.03 (dq, 1H, 3.8, 6.5), 4.02 (dd, 1H,
0.7, 14.2), 4.10 (dd, 1H, J0.7, 14.2), 4.76 (d, 1H, 3.8), 6.95 (m, 1H), 
6.98 (dd, 1H, J3.5,5.0), 7.24 (dd, 1H, 1.2, 5.0), 7.28 (m, 1H), 7.34 (m,
4H); 8c (CDCI3) 15.07 (CH3), 46.03 (CH2), 57.65, 73.86, 124.80,
125.21, 126.44, 126.99, 127.36, 128.35, 141.54 (ipso), 144.09 (ipso); 
HRMS (FAB) m/e248.1117 [calcd for C,4 Hi8NOS (MH+) 248.1109],
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(l/^ lSV /V -trity l-l-am ino-l-phenylpropan-l-o l (100)
Me NH
CPh3
(lR,2,S)-Norephedrine (910mg, 6 mmol) was taken up in dry DCM (10ml) and 
to the solution was added Et3N (980ml, 7mmol). The solution was cooled to 
0°C and trityl chloride (1.5 lg, 5.4mmol) was added. The reaction was stirred 
for 2 0  minutes, then allowed to warm to room temperature and stirred 
overnight. The reaction was then washed with ammonium chloride solution 
and the aqueous phase was back extracted three times with DCM. The 
combined organics were dried over Na2 SC>4 , the solids were filtered off and the 
solvent evaporated. The crude product was then purified by flash 
chromatography (DCM eluent) to give the product after evaporation of the 
solvent and drying in vacuo as a colourless foam (2.02g, 95%).
Tic (methanol - DCM, 1:9 v/v) R{ 0.74; [a ] D 2 2 +79.6 (c 0.54, CHC13); IR
(KBr Disc) vmax 3419 (br); 5H (CDC13) 0.63 (d, 3H, 76.6), 2.14 (br. s, 1H),
2.69 (br. s, 1H), 2.94 (dq, 1H, 73.1, 6 .6 ), 3.85 (d, 1H, 73.1), 7.05 (dd, 2H,
71.2,7.0), 7.12 (dd, 1H, 75.5, 7.4), 7.18 (d, 1H, 75.1), 7.19 (d, 2H, 77.4), 
7.20 (d, 2H, 7  7.0), 7.28 (d, 3H, 7  5.1), 7.29 (t, 1H, 7  5.5), 7.30 (d, 3H, 7
7.4), 7.58 (dd, 4H, 7  1.2, 7.4), 7.59 (d, 2H, 7  7.0); 5c (CDC13) 15.64
(CH3), 54.30, 71.89 (ipso), 74.78, 125.76, 126.85, 128.13, 128.19,
129.06, 142.35 (ipso), 146.79 (3 x ipso); HRMS (FAB) m/z 394.2180
[calcd for C2 8H28NO (MH+) 394.2171].
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(L R ^SV T V -^-B rom obenzyl^-am ino-l-phenylpropan-l-ol (102)
.OH
Me NH Br
(lR,2*S)-Norephedrine (505mg, 3.3mmol) and NaCNBH3 (210mg, 3.3mmol) 
were taken up in dry methanol (8 ml). To this solution was added 2- 
bromobenzaldehyde (650mg, 3.5mmol). The reaction was carried out as for 98 
above to give a colourless oil (102, 516mg, 48%).
Tic (methanol - DCM, l,9v/v) Rf 0.42; [a ] D 2 3 -18.4 (c 1.63, CHC13); IR
(thin film) vmax 3400 (br); 5H (CDC13) 0.86 (d, 3H, J  6 .6 ), 2.68 (br. s, 2H), 
2.95 (dq, 1H, J  3.9, 6 .6 ), 3.93 (dd, 2H, J  3.5, 13.6), 4.80 (d, 1H, J  3.9),
7.14 (dt, 1H, J  1.7, 7.6), 7.23 (m, 1H), 7.28 (dd, 1H, 1.2, 7.4), 7.32 (m,
4H), 7.36 (dd, 1H, J 2.4, 7.4), 7.54 (dd, 1H, J  1.2, 7.8); 6 c (CDC13) 15.09 
(CH3), 51.64 (CH2), 58.01, 73.39, 124.41 (ipso), 126.30, 127.31,
127.80, 128.32, 129.15, 130.70, 133.20, 138.97 (ipso), 141.38 (ipso); 
HRMS (FAB) m/z 320.0644 [calcd for Ci6 Hi9BrNO (MH+) 320.0650].
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(l/?,2£)-N -(2,6-dichlorobenzyl)-2-am ino-1-phenyl propan-l-o l (103)
Cl H N ^ M e  
H O ^ P h
To a solution of (lR,25)-norephedrine (805mg, 5.3mmol) in methanol (10ml) 
was added 2,6-dichlorobenzaldehyde (976mg, 5.57mmol). The solution was 
cooled to 0°C and to it was added NaCNBH3 (343mg, 5.46mmol). After 10 
minutes stirring the solution was allowed to warm to room temperature and 
was stirred for 4 days. The pH of the solution was maintained between 6-7 by 
periodic additions of 2M HC1. The reaction was then quenched with 2M HC1 , 
and the products extracted using dichloromethane. The aqueous phase was 
washed a further two times with dichloromethane and the combined organics 
were dried over MgSC>4 . The crude product was then purified by flash column 
chromatography (gradient elution; 100% DCM to 5% methanol-DCM) to give 
the product as a colourless powder (650mg, 39%). Tic (methanol-DCM, 1:9 
v/v) Rf 0.76; m.p. 75°C; [a]D21 +26.2 (c 1.03, abs. ethanol); IR (KBr Disc) 
vmax 3414 (br); 5H (CDC13) 0.81 (d, 3H, J6.2), 1.61 (br. s, 1H), 2.95 (dq, 
1H, 7  3.9, 6.6), 3.64 (br. s, 1H), 4.12 (d, 1H, J  12.9), 4.24 (d, 1H, J  12.9), 
4.92 (d, 1H, J  3.9), 7.16 (dd, 1H, J  7.3, 8.8), 7.23 (m, 1H), 7.32 (m, 6H); 
5c (CDC13) 15.28 (CH3), 46.37 (CH2), 57.71, 72.79, 126.16, 127.13,
128.21, 128.63, 129.25, 135.65 (ipso), 136.11 (ipso), 141.29 (ipso);
HRMS (FAB) m/z 310.0764 [calcd for Ci6H18C12NO (MH+) 310.0766]. Anal.
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To a solution of (l/?,2S)-norephedrine (805mg, 5.3mmol) in methanol (10ml) 
was added cyclohexane carboxaldehyde (603mg, 5.37mmol). The solution was 
cooled to 0°C and to the solution was added NaCNBH3 (343mg, 5.46mmol). 
Using a procedure similar to 103, the reaction afforded a colourless powder 
(860mg, 6 6 %). Tic (methanol - DCM, 2:8 v/v) Rf 0.37; m.p. 8 6 °C; [a ] D 19 
+96.6 (c 1.04, EtOH); IR (KBr Disc) vmax 3414 (br); 5H (CDC13) 0.79 (d, 
3H, J  6.2), 0.94 (m, 2H), 1.22 (m, 3H), 1.42 (m, 1H), 1.69 (m, 3H), 1.80 
(dd, 1H, J  12.5, 1.6), 2.49 (dd, 1H ,J7.0, 11.3), 2.58 (dd, 1H ,7 6.3, 11.3),
2.88 (dq, 1H, 3.9, 6.5), 4.74 (d, 1H, J  3.9), 7.29 (m, 5H); 6 C (CDC13)
15.27 (CH3), 26.45 (CH2), 26.48 (CH2), 27.09 (CH2), 31.84 (CH2), 31.86 
(CH2), 38.77, 54.35 (CH2), 58.83, 73.01, 126.23, 127.10, 128.21,
141.61 (ipso); HRMS (FAB) m/z 248.2010, [calcd for Ci6 H26NO (MH+) 
248.2014]; Anal, calcd for Ci6 H25NO: C, 77.68; H, 10.19; N, 5.66. Found 
C, 77.80; H, 10.10; N,5.81.
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(l/?,2iS)-jV-(4-toluenesulphonyl)-2-am ino-l-pheiiyl propan-l-o l (105)
To a solution of (li?,25)-norephedrine (1.34g, 8 .8 mmol) and p-toluene sulfonyl 
chloride (1.69g, 8 .8 mmol) in dichloromethane (10ml) was added triethylamine 
(1.48ml, 10.6mmol) and the reaction was stirred for 22 hours at room 
temperature. The reaction was then washed with water and extracted three 
times with DCM. The combined organics were dried over Na2 SC>4 and the 
remaining Et3N was removed by azeotroping with ethanol. This afforded, after 
evaporation of the solvent, a colourless solid (2.79g, quant.). Tic (methanol - 
DCM, 1:9 v/v) Rf0.61; [a]D26 -11.3 (c 1.24, CHCI3 ); IR (CDCI3) vmax 3506, 
3280; 5h (CDCI3) 0.83 (d, 3H, J  6.8),2.42 (s, 3H), 2.52 (br. s, 1H, OH), 
3.57 (br. s, 1H), 4.79 (d, 1H), 5.00 (br, d, 1H, 8.2, NH), 7.28 (m, 7H),
7.78 (d, 2H, J8.2); 8c (CDCI3 ) 14.64 (CH3), 21.99 (CH3), 55.51, 76.05, 
126.29, 127.26, 127.68, 128.45, 129.99, 137.89 (ipso), 140.68 (ipso),
143.62 (ipso);
(l/^iSVTV-terf-Butyloxycarbonyl^-amino-l-phenyl propan-l-ol (106)
To a solution of (li?,2,S)-norephedrine (1.687g, 11.2mmol) in DCM (10ml) was 
slowly added di-ter/-butyl dicarbonate (2.315g, 1 0 .6 mmol) and the reaction 
was allowed to stir for 2  hours until no more evolution of CO2 could be seen. 
The reaction was then extracted with 1M KHSO4  and the aqueous layer was 
washed twice with DCM. The combined organic layers were collected, dried 
over Na2 SC>4 and the solvent evaporated in vacuo to give colourless felted 
needles (2.195g, 82%). Tic (methanol-DCM, 1:9 v/v) Rf 0.65; [a ] D 2 6  -61.3 
(c 1.01, CHCI3); m.p. 91°C;
5h (CDCI3) 0.98 (d, 3H, J6.7), 1.46 (s, 9H), 3.01 (br. s, 1H), 3.99 (s, 1H),
4.70 (s,lH ), 4.84 (d, 1H, J 2.1), 7.27 (m, 1H), 7.34 (m, 4H); 6 c (CDCI3) 
15.17 (CH3), 28.80 (CH3), 52.37, 77.17, 80.08 (ipso), 126.51, 127.60, 
128.31, 141.03 (ipso), 156.84 (ipso); HRMS (El) m/z 251.1514, [calcd for 
C 14H2 1NO3 (M+) 251.1521]; Anal, calcd for C 14H2 1NO3 : C, 66.91; H, 8.42; 




Cyclohexane carboxaldehyde (340mg, 3.0mmol) was taken up in methanol 
( 1 0 ml) and to the solution was added (li?,2 S)-2 -amino-l,2 -diphenylethanol 
(587mg, 2.75mmol). The mixture was cooled to 0°C and NaCNBH3 (182mg, 
2.9mmol) was added. The reaction was stirred at 0°C for 45 mins with the pH 
of the solution being maintained at ca. pH6  by addition of 1M HC1. The 
reaction was then left to stir for two days at room temperature, then acidified 
with HC1 solution to pH 1-2. The methanol was evaporated and to the aqueous 
phase was added NaOH bringing the pH to 14. The aqueous suspension was 
then washed three times with DCM and the combined organic phases were 
dried over Na2SC>4 and filtered. The crude product was purifed by flash column 
chromatography (gradient elution; DCM to MeOH - DCM (1:9 v/v)). A DCM 
solution of the product was washed with 1M HC1. The layers were separated, 
the aqueous phase back extracted 5 times with DCM and the combined organic 
phases were dried over Na2SC>4 and filtered. The bulk of the solvent was 
evaporated and 5% NaOH solution was added. The layers were separated and 
the aqueous phase back extracted with DCM three times. The combined 
organic phases were once again dried over Na2S0 4 . The suspension was 
filtered and the solvent evaporated to give, after drying in vacuo, a colourless 
crystalline powder (353mg, 42%). Tic (methanol - DCM, 1:9 v/v) Rf 0.44; 
m.p. 90°C; [a ] D21 +28.5 (c 1.0, CHCI3);
8 h (CDCI3) 0.89 (m, 2H), 1.96 (m, 3H), 1.41 (m, 1H), 1.70 (m, 5H),
2.37 (dd, lH ,y  6 .8 , 11.8), 2.42 (dd, 1H, J  6.4, 11.5), 3.51 (d, 1H, J  8 .6 ), 
4.53 (d, l H , / 8 .6 ), 6.98 (d, 1H ./5 .5 ), 6.99 (d, 1H ./5 .9 ), 7.07 (d, 1H, J
5.9), 7.07 (d, 1 H ,/7.4), 7.17 (m, 4H), 7.21 (m, 2H); 8 c (CDC13) 26.11
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(CH2), 26.13 (CH2), 26.74 (CH2), 31.35 (CH2), 31.51, 38.35, 54.28 
(CH2), 70.86, 77.59, 126.72, 127.23, 127.47, 127.71, 128.12, 139.98 
(ipso), 141.06 (ipso); HRMS (FAB) m/z 310.2171 [calcd for C2 iH28NO 
(MH+) 310.2171]; Anal, calcd for C2 ,H27NO: C, 81.51; H, 8.79; N, 4.53. 




CK)-(+)-Styrene oxide (508mg, 4.23mmol) was taken up in anhydrous 
acetonitrile (3ml). To this solution was added benzylamine (2.27g, mmol) 
slowly over a period of five minutes. The mixture was then cooled to 0°C and 
to it was added a solution of 3M UCIO4  in EtOAc (1.41ml, 4.23mmol) over 10 
minutes. The reaction was stirred at 0°C for one hour and then allowed to 
warm to room temperature and stirred for a further 22 hours. The reaction was 
then cooled to 0°C and water (21ml) was added. The reaction was allowed to 
stir at this temperature for 40 mins and then the white precipitate was collected 
by suction filtration. The solid was washed with water and then dried overnight 
in vacuo to give a colourless crystalline power (112, 580mg, 60%) which was 
recrystallised from isopropanol to give colourless needles (460mg, 48%).
[a]D21 -56.1 (c 1.0, CHCI3) Lit. [a]D25 -54.6 (c 1.22, CHC13)63; IR (KBr 
Disc) vmax 3142.7 (br); 5H (CDC13) 2.29 (br. s, 2H), 2.75 (dd, 1H, 9.0,
12.1), 2.94 (dd, 1H, 3.7, 12.3), 3.81 (d, 1H, 13.3), 3.86 (d, 1H, 13.3),
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4.73 (dd, 1H, J3 .5 , 9.0), 7.30 (m, 1 0 H); 8 C (CDC13) 53.87 (CH2), 54.85 
(CH2), 72.09, 126.01, 127.36, 127.71, 128.29, 128.57, 128.70,
140.03 (ipso), 142.57 (ipso); HRMS (FAB) m/z 228.1383 [calcd for 
Ci5 Hi8NO (MH+) 228.1389]; Anal, calcd for C 15H 17NO: C, 79.26; H, 7.54; 




To a refluxing solution of (^)-(-)-phenylglycinol (487mg, 3.55mmol) in dry 
methanol (4ml) over 3 A sieves was added over 40 minutes a solution of 
benzaldehyde (377mg, 3.55mmol) in methanol (2ml). The reaction was stirred 
at 80°C for 4 hours and, after cooling to room temperature, the solvent was 
evaporated. The crude product was taken up in DCM and dried over Na2 SC>4 . 
The solids were filtered through a pad of Na2 SC>4 under suction and the solvent 
evaporated to leave a colourless oil. IR analysis showed it to be the desired 
imine. The oil was taken up in absolute ethanol (15ml) and the solution cooled 
to 0°C. Excess NaBFL* (188mg, 4.97mmol) was added and the mixture was 
stirred at 0°C for 20 minutes after which time the reaction was complete by IR. 
To the reaction was then added water (0.5ml) and the mixture was stirred for a 
further 30 minutes. The solvent was then evaporated and the residue taken up 
in ethyl acetate. The organic layer was washed three times with water. The 
organic phase was dried over Na2 SC>4 and the solids filtered under suction.
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Evaporation of the solvent and drying in vacuo resulted in a colourless solid. 
This was purified by flash column chromatography (gradient elution, 100% 
DCM to MeOH - DCM, 3:97 v/v) to give a colourless solid (507mg, 63%). The 
product was recrystallised from DCM - cyclohexane, 1:1 v/v, to give colourless 
needles.
Tic (methanol-DCM, 1:9 v/v) Rf 0.54; [a] D22 -80.3 (c 0.66, abs. EtOH); IR 
(KBr) Vmax 3251, 3142 (br); 5H (CDClj) 2.08 (br. s, 2H), 3.56 (dd, 1H, /  
8 .8 , 10.7), 3.60 (d, 1H, J  12.5), 3.71 (dd, 1H, J  4.5, 10.7), 3.76 (d, 1H,
12.9), 3.82 (dd, 1H, 4.3, 8 .6 ), 7.31 (m, 10H); 8 c (CDCI3) 51.21 (CH2), 
63.75, 66.75 (CH2), 126.97, 127.14, 127.57, 128.09, 128.32, 128.58,
139.90 (ipso), 140.33 (ipso); HRMS (FAB) m/z 228.1385 [calcd for 
Ci5H,8NO (MH+) 228.1388],
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6.7 GENERAL PROCEDURE FOR TRANSFER
HYDROGENATION OF KETONES.
Procedure A
To a dry flask under argon was added [(p-cymene)RuCl2 ]2  (5 mol% [Ru]) and 
ligand (10 mol%). These were taken up in 2-propanol (ensuring final ketone 
concentration of 0.1M) and the solution was then heated at reflux for 1 hour. 
After this time, the dark red solution was allowed to cool to room temperature 
and KOH (0.5M solution in 2-propanol, 5 mol. eq. to [Ru]) was added. The 
mixture was stirred for a short time and the flask then placed in a bath at 
reaction temperature. To the solution was then added ketone (20 mol. eq. to 
Ru). The mixture was stirred for a given time and aliquots were removed for 
analysis. These aliqots were immediately quenched with diethyl ether and 
passed through a pad of silica to remove any metal.
Procedure B
To a dry flask under argon was added [(p-cymene)RuCl2 ]2  (5-6 mol% [Ru]) 
and ligand (5-6 mol%). These were taken up in 2-propanol (ensuring ketone 
concentration of 0.1M) and the solution was then heated at reflux for 1 hour. 
After this time, the dark red solution was allowed to cool to room temperature 
and KOH (0.5M solution in 2-propanol, 5 mol. eq. to [Ru]) was added. The 
mixture was stirred for a short time and the flask then placed in a bath at
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reaction temperature. To the solution was then added ketone (20 mol. eq. to 
Ru). The mixture was stirred for a given time and aliquots were removed for 
analysis.
Procedure C
To a dry flask under argon was added [(p-cymene)RuCl2 ]2  (1 mol% [Ru]) and 
ligand (2 mol%). These were taken up in 2-propanol (ensuring ketone 
concentration of 0.1M) and the solution was then heated at reflux for 1 hour. 
After this time, the dark red solution was allowed to cool to room temperature 
and KOH (0.2M solution in 2-propanol, 5 mol. eq. to [Ru]) was added. The 
mixture was stirred for a short time and the flask then placed in a bath at 
reaction temperature. To the solution was then added ketone (100 mol. eq. to 
Ru). The mixture was stirred for a given time and aliquots were removed for 
analysis. These aliquots were immediately quenched with diethyl ether and 
passed through a pad of silica to remove any metal.
Product Analysis
Reactions were analysed by chiral HPLC, chiral GC and H-NMR.
1-phenvl ethanol
GC Column: p-Dex column; Column temperature: 115 °C; Carrier 
Pressure: 100 KPa; Retention times: ketone- 20.2 mins, (R) alcohol-
33.2mins, (iS) alcohol 2- 36.1 mins.
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HPLC Column: Chiralcel OD; Eluent: «-hexane - 2-propanol, 98:2 v/v; 
Flow rate: lml/min; Retention times: (R)-isomer - 12mins, (S)-isomer - 
15mins
4-bromo-a-methvlbenzvl alcohol
HPLC Column: Chiracel OD; Eluent: w-hexane- 2-propanol, 98:2 v/v; Flow 
rate: lml/min; Retention times: ketone - 6.9 mins, alcohol peaks 17.5 mins 
and 19.2 mins (absolute stereochemistry undetermined).
1 -(2-napthvOethanol
HPLC Column: Chiracel OJ; Eluent: w-hexane- 2-propanol, 94:6 v/v;
Flow rate: lml/min; Retention times: ketone - 10.9 mins, alcohol peaks - 13.9 
mins and 17.1 mins (absolute stereochemistry undetermined).
4-methoxv-g-methvlbenzvlalcohol
GC Column: P-Dex column; Column temperature: 135 °C; Carrier 
Pressure: 200 KPa; Retention times: ketone- 28.1 mins, alcohol peaks -
31.3 mins and 32.8 mins (absolute stereochemistry undetermined).
HPLC Column: Chiracel OD column; Eluent: n-hexane- 2-propanol, 98:2 
v/v; Flow rate: lml/min; Retention times: ketone - 10.5 mins, alcohol 
peaks - 21.8 mins and 25.2 mins (absolute stereochemistry undetermined).
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